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General Introduction  
1. LOW BACK PAIN  
 
1.1.Definition 
 
According to the International Association for the Study of Pain, pain is defined as “an unpleasant 
sensory and emotional experience, associated with actual or potential tissue damage, or described in 
terms of such damage” [1]. Persistent pain on the other hand, means “pain that persists beyond the 
expected healing time” [2]. Low back pain (LBP) is commonly defined as pain perceived in the region 
of the lumbar and gluteal area and can either be related to a range of musculoskeletal conditions or 
have no known underlying pathology. In the last case, LBP is defined as non-specific LBP [3].  
By definition, no structural musculoskeletal aberration is presumed in non-specific LBP, but according 
to the WHO International Classification of Functioning, Disability and Health (ICF), symptoms of LBP 
such as a loss of function, limitations in activities and restriction in participation can cause a temporary 
or permanent decrease in health status [3].  
 
1.2.Epidemiology 
 
Up to 80% of the adult population gets affected by LBP [4–9]. Non-specific LBP patients represent 85% 
of all LBP patients seen by doctors and physical therapists [10]. In general, LBP can be seen as a normal 
feature in the aging process. However, for some, LBP evolves into a disabling chronic pain condition 
precluding daily activities, work and relationships. Ten percent of all patients suffering from acute 
episode of LBP, deal with unsuccessful recovery and develop chronic and disabling LBP [11–14]. As a 
consequence, considerable healthcare and socioeconomic costs occur [15]. The majority of all 
healthcare resources are allocated to this chronic low back pain (CLBP) group [16]. In Belgium, the total 
amount of direct and indirect costs due to CLBP are estimated between 270 million and 1.6 billion 
euros per year [17]. The majority of these costs are related to work loss and reduced productivity 
[3,15,18–21].  
 
 
 
 
1.3.Heterogeneity in the low back pain population 
 
The course of non-specific LBP is extremely variable between patients. As a consequence, the non-
specific LBP is a very heterogeneous group. Variations in severity of pain and the level of dysfunctions 
are seen within the complete population [22]. Also variations in time are seen between patients. LBP 
can be staged by symptom duration into acute, subacute, recurrent and chronic CLBP. Acute low back 
pain is defined as pain below the costal margin and above the inferior gluteal fold for up to 6 weeks, 
whereas continuous pain not exceeding 12 weeks, is defined as subacute low back pain [23,24]. Pain 
beyond those 12 weeks of duration is categorized as chronic low back pain (CLBP) [25]. A portion of 
patients with acute LBP progresses to CLBP [11]. A history of previous LBP is the main predictor for 
developing recurrent LBP episodes [26–29]. In fact, it is hypothesised that recurrences in some patients 
worsen over time and lead to chronicity [30]. It is however stated that non-specific CLBP itself is a 
complex and multifactorial problem. Even within the CLBP group, several authors argue for large 
heterogeneity and suggest that the non-specific CLBP group consists of several distinct subgroups, 
each marked by different characteristics and mechanisms of symptom production [31]. According to 
other authors, LBP is rather characterized as an episodic disease, defined by pain flares alternated by 
periods of less pain complaints and disability or even complete remission [32,33]. This type of LBP is 
called recurrent low back pain (RLBP) and is typically characterized by episodes of pain flares preceded 
and followed by a period without LBP [32]. To date, it is unknown why some people recover after every 
episode of LBP and others develop CLBP.  
This dissertation tries to contribute to the knowledge on the etiology of non-specific LBP, by studying 
and comparing different mechanisms in different subgroups of LBP patients: firstly, muscle structure 
properties and muscle function characteristics and secondly, central pain processing. Insight in the 
differences in both peripheral (muscle related) and central mechanisms and their interrelations, may 
eventually steer the development of proper treatments and prevention measures to avoid the 
occurrence and recurrence of LBP. 
 
 
  
2. STUDY POPULATION 
 
Until now, few research distinguishes RLBP from the CLBP group, even though the RLBP patients 
recover after every episode, whereas the CLBP is not, which reflects different working mechanisms in 
both groups. It is crucial to gather insight into the pathogenic mechanisms which trigger and underpin 
LBP recurrence or chronicity to prevent recurrence and probably the progression to chronicity. To 
address this issue, first the characteristics of different LBP groups need to be defined. Furthermore, 
the different LBP subgroups will be compared to two reference groups: healthy controls and patients 
with fibromyalgia. 
 
2.1.Recurrent low back pain 
 
RLBP is a succession of repeated LBP episodes alternated by periods of remission. RLBP patients in this 
dissertation suffer from non-specific LBP and are in a current state of remission. According to the 
definition of a LBP episode, launched by De Vet et al., an episode of LBP is defined as a pain flare of at 
least 24 hours, followed by a pain free episode of at least 1 month [32]. Because this definition is not 
based on quantitative evidence, concomitant parameters of LBP recurrence are added: a pain flare is 
characterized by an increase of at least 2 points on a numeric rating scale for pain and/or at least 5 
points on the Roland Morris Disability Questionnaire [34], whereas a pain free episode is characterized 
by a 0/10 on a numeric rating scale for pain and/or a score of less than 2 points on the Roland Morris 
Disability Questionnaire [35]. Moreover, pain flares occur with a frequency of at least 2 episodes in 12 
months [36]. Finally, the RLBP patients already suffer from LBP for at least 6 months and the LBP 
complaints are of that content, that the patients intend to apply for medical help.  
 
2.2.Chronic low back pain 
 
CLBP is frequently characterized as LBP for at least 3 months [5]. This time span encompasses the 
expected healing time of tissue injury in most situations [2]. Because non-specific CLBP is a complex, 
multi-dimensional problem, characterized by both physical and psychosocial features, this group is 
very heterogeneous [31], e.g. altered central pain processing is suggested in only a subgroup of CLBP 
[37]. To come towards this heterogeneity, this doctoral thesis separates a subgroup of non-continuous 
CLBP from the continuous CLBP group. Patients in the continuous CLBP group experience pain during 
every day of the week.  Patients in the non-continuous CLBP group, have pain for maximum 3 to 4 days 
per week and are seen as being a phase between RLBP and continuous CLBP.  
 
2.3.Fibromyalgia 
 
Patients with Fibromyalgia are involved in this research setting because it is established that both 
generalized lowered pressure pain thresholds, resembling enhanced pain facilitation, [38] and deficits 
of the endogenous pain inhibitory system [39,40] are present in this population. This group, 
characterized by predominant central sensitization pain, is considered as a reference group, with 
whom the LBP groups are compared.  
According to the American College of Rheumatology (2010), fibromyalgia patients are characterized 
by a score of ≥ 7 on the widespread pain index and a score of ≥ 5 on the symptom severity scale OR a 
score on the widespread pain index between 3 and 6 and a score of ≥ 9 on the symptom severity scale 
[41,42].  
 
2.4.Healthy controls 
 
Because pain processing is supposed to be normal in healthy persons, the three LBP groups are 
compared to patients with fibromyalgia on the one hand and healthy controls on the other hand. The 
healthy control group and the fibromyalgia group can be seen as the two extremes of a so called 
“musculoskeletal pain continuum”, with on the one end no pain and on the other end the patients 
with chronic widespread pain. The different LBP patients are hypothesised to float between those 
three extremes [Figure 1]. 
Healthy persons were therefore not allowed have any current pain source anywhere in their body and 
should never have asked any advice concerning LBP to a medical doctor or physiotherapist.  
 
 
Figure 1: A musculoskeletal pain continuum in this dissertation. 
Healthy controls RLBP
Non-
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Continuous 
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3. MUSCLE CHARACTERISTICS 
 
3.1.Morphological changes in lumbar muscle structure 
 
Muscle degeneration characterized by either a decrease in cross-sectional area (CSA) size [43–48], an 
increased fat infiltration [49–52] at the expense of healthy muscle tissue, alterations in fiber type 
distribution [53] or deterioration in muscle quality [54] are reported in LBP patients. Up to date, the 
exact working mechanisms behind these muscular changes remain unclear. Several authors, however, 
intended to explain these muscle alterations. Their proposals are pictured below.  
 
3.1.1. Theories behind muscle structure alterations  
 
Another possible mechanism behind muscle alteration is disuse due to deconditioning [43,53]. A 
decreased level of physical activity in daily life could lead to physical deconditioning and low levels of 
physical fitness [55]. It is proposed that inactivity causes changes in muscle composition [53] and a 
decrease in muscle mass [56,57] due to large protein loss [58]. In the case of deconditioning, a 
generalized deterioration is expected.  
Some studies however established localized effects and argue the theory of disuse [44,59,60]. One 
possible perpetuating factor behind deterioration in muscle structure is a decrease in neural drive, 
leading to a decreased ability to voluntary activate muscles. Wasting at levels of the symptoms, might 
be explained by inhibition due to pain through a long-loop reflex. This reflex inhibition is the reduction 
of alpha motoneuron excitability due to afferent noxious input from musculoskeletal structures [61]. 
Additionally, altered recruitment patterns install inhibition of deep muscles and over-activation of 
superficial muscles, which might introduce selective atrophy of the deep muscles [43,62]. Ultimately, 
this decrease in neural drive mechanism prevents movement of the musculoskeletal structures and 
provides protection [44].  
Furthermore, localized changes in muscle fibers from a single lumbar segment might point out a 
process of denervation is occurring [62]. Selective denervation leads to atrophy [63], fat infiltration 
[63] and changes in muscle fibers [64] and is therefore an alternative mechanism possibly explaining 
clinical findings in LBP. 
Finally, a recent experimental animal study combined the previous suggestions and revealed structural 
remodelling of the muscle tissue rather than general muscle atrophy [65]. A dramatic remodelling of 
muscle fiber populations, adipose tissue and connective tissue occurs following experimental 
intervertebral disk injury. This study concluded that acute effects in muscles are due to reflex inhibition 
and muscle regeneration processes, whereas in a later phase atrophy occurs due to disuse and/or 
degeneration [65].  
 
3.1.2. Changes in muscle structure in low back pain 
 
Results concerning muscle alterations in LBP patients are however not univocal. Some studies 
demonstrate atrophy and/or fat infiltration in the lumbar muscles in CLBP patients, whereas others, 
were not able to establish structural alterations [43,45,50,59,66,67] [Chapter1, Part 1]. Beside 
macroscopic changes, also microscopic changes are reported in patients with various types of CLBP. 
Higher portions of fast twitch glycolytic fibers (type II fibers) in the lumbar muscles are seen at the 
expense of slow twitch oxidative fibers (type I fibers), leading to lowered fatigue resistance of the 
paraspinal muscles and higher vulnerability of the lumber spine [53,68]. However, conclusive evidence 
concerning fiber type distribution is limited in non-specific CLBP [69]. Nevertheless, alterations in fiber 
type distribution in LBP might be of interest, since this provides insight in not only the fiber type 
distribution as a structural feature in LBP, but also determines possible fatiguability in the lumbar 
muscles in LBP patients. 
In RLBP patients, the situation seems different compared to CLBP patients. An enhanced muscle fat 
index, reflecting the amount of fat infiltration in lean muscle tissue, is reported in the lumbar muscles 
in the absence of a decrease in CSA and visual fat infiltration [54]. These results indicate a deterioration 
in muscle quality in RLBP, rather than clear atrophy and apparent fat infiltration, which might result in 
alterations in lumbar muscle performance [54,70]. Moreover, those modifications in muscle structure 
do not seem to resolve after resolution of the symptoms [54,70–73] and might therefore contribute 
to the reoccurrence of LBP. The evidence concerning alterations in lumbar muscle structure in RLBP is 
however limited.  
The inconsistencies in the current literature pictured above, make it difficult to draw firm conclusions 
whether structural changes occur in patients with LBP. Collecting the available study results on muscle 
structure might provide insight in the structural changes in LBP. Recently, a qualitative systematic 
review performed by Fortin and Macedo determined overall atrophy in CLBP patients compared to 
healthy persons. This review however lacks a RLBP group and provides no information concerning 
lumbar muscle fat infiltration. Moreover, the included population consists of a mixture of specific and 
non-specific LBP patients. As a consequence, an overall picture concerning muscle structure in RLBP 
and CLBP patients is missing. By conducting a systematic literature study, registering muscle 
characteristics (CSA, fat infiltration, and fiber type distribution) in non-specific acute LBP, RLBP and 
CLBP, the current state of art concerning muscle structure characteristics is represented [Chapter 1, 
Part 1].  
After performing this systematic review, many inconsistencies concerning muscle characteristics 
remain in LBP. Generalization of observations across different groups of LBP might contribute to this 
lack of clarity. It can be hypothesised that subgroups of LBP are characterized by alterations in muscle 
characteristics, whereas others are not. Identification of those subgroups might therefore enhance the 
comprehension on recurrence and chronicity of LBP. Currently, it’s unknown what influence the 
continuation of pain complaints has on muscle structure and muscle function. Besides the work of our 
research group, few research in non-specific LBP makes the distinction between RLBP and CLBP, even 
though both groups are defined by a totally different clinical picture. The amount of muscle alterations 
in LBP subpopulations might provide insight in the phenomenon why RLBP patients recover after an 
episode and CLBP patients suffer from persistent pain and disability. Knowledge concerning specific 
structural muscle characteristics in those groups might provide insight in the mechanisms behind 
recurrence and chronicity of LBP. This dissertation will therefore investigate the lumbar muscle 
structure in both RLBP and CLBP [Chapter 1, Part 2]. 
 
3.2.Aberrations in lumbar muscle function 
 
Besides alterations in muscle structure, also muscle function might play a crucial role in the occurrence, 
recurrence and persistence of LBP. Alterations in muscle activity and muscle recruitment might 
compromise the spinal health and contribute to the (re)occurrence and chronicity of LBP [73]. Some 
theories have been proposed to explain the relation between pain and alterations in muscle activity. 
Below an overview of proposed mechanisms which emerge to explain the alterations in muscle activity 
accompanied by pain.  
 
 
 
 
3.2.1. Theories behind muscle function alterations  
 
A first theory trying to explain alteration in muscle function is the pain-spasm-pain theory, or vicious 
circle theory. This theory hypothesizes a vicious circle in which pain elicits increased muscle activity 
through an excitatory effect of the muscle nociceptors on the gamma-motor neurons. This sustained 
muscle activity, regardless of the kind of muscle work, results in ischemia and an accumulation of pain-
inducing metabolites which leads to more pain [74,75].   
More variable changes in muscle activity due to pain are found in the pain adaptation theory. This 
theory states that muscle activity depends on the nature of muscle work. Decreased activity occurs in 
muscles which are painful or produce painful movements, whereas muscle activity enhances in the 
antagonist muscles [76]. This mechanism reduces the amplitude and velocity of the painful movement 
and the force produced by the relevant muscles [73].  
Since numerous observations are not congruent with the above two theoretical models, a modified 
adaptation theory is proposed by Hodges and Tucker [73]. Five key elements on micro level (motor 
neuron discharge) and macro level (behaviour in the whole muscle) are proposed to create a more 
flexible adaptation mechanism. (1) In order to protect the painful part, a redistribution of activity 
within and between muscles due to unequally distribution of input to motor neurons occurs. (2) As a 
result of this redistribution within and between muscles, changes in mechanical behaviours, such as 
modified velocity, range of motion, force, stiffness… etc. might follow. (3) These adaptations to pain 
ultimately intend to protect tissues from further pain or damage. Rather than a one-sided change, this 
theory proposes that the nervous system possesses multiple options to protect tissues: activity might 
be increased, decreased or redistributed, as long as the ultimate goal of protecting is achieved. (4) The 
changes occur at multiple levels of the motor system (motor neurons, spinal cord, cortex… etc.) and 
are complementary, additive or competitive. (5) Finally, the benefits of protection are short-term but 
musculoskeletal consequences might be long-lasting [73].  
An even more contemporary theory aiming to understand why people move differently in pain is 
proposed by Hodges and Smeets [77]. They introduce multiple mechanisms, determining the large 
variability in motor output in patients with pain. First, movement adaptation may either follow or 
precede pain and/or injury. A large and/or repetitive load might eventually lead to nociception. 
Alternatively, inappropriate motor behavior, such as habitual postures or movement patterns, might 
lead to abnormal tissue loading and/or injury and eventually result in nociception. Second, motor 
adaptations range from subtle redistribution of activity between and within muscles to complete 
avoidance of movement, activity and participation. Third, adaptations of movement are individual and 
might be driven by several personal constructs such as anatomy, history, believes and habitual 
postures and movements. Fourth, the overall purpose of adaptation of the motor system is protection 
of the painful, injured or threatened body part, which is useful in acute situations but may be harmful 
in the longer term. Fifth, the long-term consequences depend on the type of pain (nociceptive pain, 
peripheral neuropathic pain or central sensitization pain). In the case of nociception pain, motor 
adaptations are relevant when peripheral nociception is ongoing, due to sensitization or due to a new 
pain source because of loading alterations secondary to modified movements. In patients with 
neuropathic pain, secondary changes might occur due to altered behavior. In central sensitization pain, 
altered motor behavior might act as the peripheral trigger maintaining the enhanced neural signalling 
in the central nervous system, movement is relevant in the possible incongruence between sensory 
input and motor output and stress induced analgesia due to physical activity is absent. Sixth, multiple 
mechanisms are involved in movement adaptations and interact with each other. Spinal mechanisms 
for excitation and inhibition from noxious stimuli, reflex adjustments, reorganization of the motor and 
sensory cortical representations, cognitive emotional mechanisms and sensory dysfunctions can be 
either complementary, summative or competitive mechanisms involved in the association between 
pain and movement [77].  
 
3.2.2. Changes in muscle funct ion in low back pain 
 
The above pictured therories illustrate that many factors might be involved in the association between 
pain and motor output. A lot of research has been done on this concern, but many questions remains 
unanswered.  Morover, results on muscle function in LBP patients are not straightforward. Patients 
with CLBP examined by electromyography (EMG) exhibit higher global trunk muscle activity compared 
to asymptomatic subjects as a compensatory strategy to enhance the reduced spinal stability [78]. As 
a consequence, increased paraspinal muscle fatiguability in LBP is common in those patients [79]. As 
far as we know, little research evaluating metabolic activity by mfMRI in lumbar muscles was done in 
CLBP. The only study evaluating the metabolic activity by mfMRI in CLBP patients, found also an 
increased muscle activity in CLBP patients who underwent surgery, compared to HC [80]. No research 
on muscle activity after exercise in non-specific CLBP was found.  
In RLBP patients in remission of pain, contradictory results on muscle activity are reported in literature. 
Some studies found a decreased activity measured by EMG in the lumbar muscles of RLBP patients 
during pain remission, compared to healthy subjects [72,81], suggesting an inhibitory response to pain. 
Others found enhanced metabolic activity of the lumbar muscles in RLBP patients in remission 
compared to healthy participants, measured by Magnetic Resonance Imaging (MRI), indicating an 
enhanced but less efficient working mechanism in the lumbar muscles in RLBP [70,82]. Studies 
evaluating muscle activity by MRI during induced experimental pain revealed reduced generalized 
muscle activity in RLBP patients in remission and in healthy persons. This inhibitory response was 
generalized and widespread, despite the fact that the experimental pain was unilateral and 
unisegmental [83,84]. It seems that muscle activity does not normalize despite the resolution of the 
LBP symptoms. This continuous altered loading on spinal structures during remission might be a 
determining factor in the recurrence of LBP. But the exact working mechanisms are still unclear.  
Although results concerning muscle activity in both CLBP patients and RLBP are not straightforward, it 
can be assumed that muscle activity changes in patients experiencing nociception and hampers normal 
spinal motor control. The interaction between pain and movement is however complex and not fully 
understood. Among other things, also psychosocial factors might influence this relationship. According 
to the fear avoidance model, fear of injury, pain or movement might lead to redistributions in motor 
output leading to both enhanced or reduced muscle activity [77,85]. These alterations in motor output 
might contribute to the occurrence, recurrence and persistence of non-specific LBP and subsequent 
disabilities. In this dissertation, the lumbar muscle function in different LBP populations will be 
examined to contribute to this knowledge [Chapter 2, Part 2]. 
 
 
In summary, alterations in muscle structure and muscle function are present in LBP. It is however 
unclear to what extent atrophy, fat infiltration, muscle quality deterioration, changes in fiber type 
distribution or alterations in muscle activity occur in the different LBP groups. To assign proper 
treatment programs for different LBP groups, it is essential to gain more insight in the amount of 
changes in respectively RLBP, non-continuous CLBP and continuous CLBP. It is hypothesized that the 
more continuous the chronicity occurs in patients, the more functional and structural changes are 
present in the lumbar muscles of those patients. This hypothesis will be investigated in Chapter 2 of 
this dissertation.  
  
3.3.Evaluation techniques for muscle alterations 
 
3.3.1. Evaluation of cross-sectional area and fat infiltration  
 
Different techniques are applied to evaluate the CSA and fat infiltration in muscles. Computed 
Tomography [43,66,86] and Ultra Sound Imaging  [45,50,59,67] are frequently used to evaluate 
structure characteristics in muscles in non-specific LBP. Also MRI [54,87] is frequently used to 
investigate musculoskeletal deformities. Its excellent spatial resolution permits high quality imaging of 
muscle structure, enabling the evaluation of the CSA and fat infiltration of the lumbar muscles [88]. 
Recent interest arose for an advanced MRI-technique: the multi-point DIXON fat mapping MRI 
technique. This method is based on the chemical shift between water and fat, since water and fat have 
distinct resonance frequencies. The phase difference between water and fat is used to separate these 
two components, resulting in a quantitative measurement of the signal fraction of water and fat. The 
DIXON method produces an accurate estimation of the fat fraction and is therefore a useful 
quantitative evaluation method to estimate fatty degeneration in patients with, e.g., lumbar disc 
pathology [51,89,90]. Although biopsies remain the golden standard for quantification of fat tissue in 
muscles, emerging evidence demonstrated that the non-invasive DIXON-MRI technique provides a 
reliable and time-efficient measure [91,92]. Also the CSA can be measured through this method. 
Therefore, in this dissertation, the CSA, the fat infiltration and the muscle fat index (as a reflection of 
the increased relative amounts of intramuscular lipids in lean muscle tissue) are examined by use of 
this DIXON-method [Chapter 2, Part 2].  
 
3.3.2. Evaluation of muscle activity 
 
A lot of research on muscle activity has been done by surface [72,93–97] and fine-wire [72,81,95,98,99] 
EMG. Muscle functional MRI (mfMRI) can also be used to characterize lumbar muscle activity during 
trunk extension exercise [88,100,101]. This technique offers a non-invasive method to exercise-related 
muscle activation by evaluating the metabolic activity in muscle tissue. In particular, the changes in 
signal intensities due to an increase in the relaxation time of tissue water following exercise, can be 
measured [88,93,100,102]. A previous study, performed by our research group, evaluating muscle 
activity by mfMRI and EMG, indicated that mfMRI is a valid tool to assess lumbar back muscle activity 
[101]. Moreover, the intra- and inter-rater agreement for mfMRI appears excellent [84]. As a 
consequence, mfMRI is a reliable measurement tool for both resting state and exercised-related 
muscle activation, with a small amount of measurement error [88]. Knowledge on lumbar muscle 
activity in LBP patients contributes to the insight in occurrence, recurrence and persistence of the 
etiology of LBP and mfMRI is a promising tool to evaluate the metabolic activity in muscles after 
activation. Therefore, mfMRI is used in this dissertation to evaluate the muscle activity in different LBP 
populations [Figure 2].  
 
 
Figure 2: Patient position in the MRI-scanner. 
 
In order to activate the lumbar muscles in a standardized way, a modified static-dynamic Biering-
Sörensen test is used, since a high and reproducible activity of the lumbar lower back muscles is 
obtained during a static-dynamic trunk extension [84,100]. Subjects are installed in prone position on 
a variable angle chair, positioned at 45° of trunk flexion. The hands of the subject are placed on the 
ipsilateral shoulders and the legs are strapped to the chair. Subjects raise the upper body from the 
start position in 2 seconds, hold it for 5 seconds at the horizontal position and again lower the upper 
body to the start position in 2 seconds. Tactile feedback is used to adjust the performance and a 
metronome is used (60 beats/minute) to standardize the timing of the movements. Exercise volume 
and load is set at 10 repetitions of 40% of the subjects’ personal one repetitions maximum (1RM) 
(figure 1). The individual 1RM is indirectly determined from the maximum amount of trunk extensions 
performed with their own upper body weight, which is assessed on a separate day 3-10 days before. 
The Holten diagram is used to calculate the exercise weight corresponding to the personal 40% of 1RM. 
If this exercise weight is lower compared to the subject’s trunk weight, a load-pulley system assisted 
in performing the trunk extensions [70,93], [Figure 3]. 
 
Figure 3: Static-dynamic Biering-Sörensen test to activate the lumbar erector spinae and multifidus. 
 
3.3.3. Evaluation of f iber type distribution 
 
Muscle fiber characteristics are usually examined through muscle biopsy samples [103–105]. An 
alternative method indicating muscle fiber type distribution, is the resting state mfMRI measurement 
[70]. Higher resting state T2-values are related to more oxidative slow twitch fibers, due to higher 
proportions of protein components, like mitochondria and myoglobin molecules, and a higher blood 
supply. Lower T2-rest values on the other hand are related to a relative higher amount of glycolytic 
fibers [106,107]. Higher portions of fast twitch glycolytic fibers in the lumbar muscles, seen at the 
expense of slow twitch oxidative fibers possibly lead to lowered fatigue resistance of the paraspinal 
muscles which might result in higher vulnerability of the lumber spine [53,68]. As mentioned above, 
the inter- and intra reliability of the mfMRI technique is excellent [84]. To evaluate muscle fiber 
characteristics, the non-invasive resting-state assessment by mfMRI is used to evaluate fiber type 
distribution in lumbar muscles of different LBP groups in this dissertation.  
 
 
  
4. PAIN PROCESSING  
 
A mismatch seems to exist between LBP complaints and structural deformations in the lumbar spinal 
region. The impairments in musculoskeletal structures in LBP patients are often disproportionate to 
their complaints [108]. Some evidence states that structural changes within the spine have little 
meaning in the context of non-specific CLBP [31]. Moreover, spine degenerations, present in large 
portions of individuals without LBP complaints, are indications of lumbar degeneration processes 
rather than consequences of the LBP itself. Imaging-based degenerative features are likely 
unassociated with pain [109]. A lack of correlation between structural deformations and LBP is 
therefore argued.  
As a consequence, the need arises to look for alternative mechanisms playing a role in the origin, 
recurrence and maintenance of LBP complaints. A possible influencing factor in LBP is the alteration in 
pain processing mechanisms. More specifically, in some patients the responsiveness of the central 
neurons system increases and results in localized and generalized hypersensitivity, leading to chronic 
widespread pain [110]. Chronic widespread pain in the absence of tissue damage suggests that 
pathophysiological central mechanisms might contribute to the chronicity of LBP [111,112]. 
 
4.1.Peripheral sensitization 
 
When tissue damage occurs, e.g. in some acute LBP episodes, a release of pro-inflammatory mediators 
in the local environment follows almost immediately [113]. As a result, high-threshold nociceptors are 
activated, activation thresholds are lowered and stimulation responses are increased. Enhanced 
excitability and hypersensitivity of the peripheral nociceptors in the area of the injury occurs. This 
phenomenon is referred to as local hypersensitivity or peripheral sensitization, and serves as a 
protection mechanism [114]. Consequently, pain responses to both mechanical and thermal stimuli at 
innocuous (allodynia) and noxious (hyperalgesia) levels, will augment by the decrease in local pain 
thresholds [115], referred to as primary hyperalgesia. In many chronic pain conditions, like idiopathic 
LBP, temporomandibular joint pain and osteoarthritis, pain hypersensitivity depending on activation 
of sensitized nociceptors in the periphery by low-intensity mechanical or thermal stimuli are 
established [116].  
 
 
4.2.Central sensitization 
 
In case of sustained LBP, prolonged noxious input may occur, which may result in neuroplastic changes 
in the spinal cord and brain, referred to as central sensitization [117]. Central sensitization leads to 
pain hypersensitivity in regions beyond the area of nociceptive input, which is called secondary 
hyperalgesia [118] (= hyperalgesia in an area adjacent to, or remote of, the site of injury). This form of 
hyperalgesia is not caused by sensitization of nociceptive nerve endings but due to changes in the 
processing of sensory information in the central nervous system [117]. Although the tissue damage 
might recover over time, local and generalized hypersensitivity can persist. Widespread, diffuse pain 
sensitivity, caused by aberrations in the spinal and supraspinal nociceptive modulation, is seen in many 
chronic pain conditions like fibromyalgia [39,40,119], chronic fatigue syndrome [120,121], chronic 
whiplash associated disorders [122] and is referred to as generalized hyperalgesia.  
 
4.3.Pain modulation 
 
Central sensitization as a consequence of sustained nociceptive input is however only expected in a 
subgroup of CLBP [37,123] and is dependent upon the interaction between bottom-up excitation and 
top-down pain modulation. Two mechanisms provide a representation of the descending pain 
modulatory capacities of the central nervous system: pain inhibition and pain facilitation. Alterations 
in central pain processing in chronic pain conditions are characterized by a general imbalance between 
both. Possibly the interplay and efficiency of different pain modulating systems determine whether a 
patient evolves to a stadium in which central sensitization is dominant or not. Pain facilitation is 
regulated in two directions: bottom-up and top down, whereas pain inhibition is regulated top down. 
Below an elucidation on this matter is presented. 
 
4.3.1. Bottom-up excitation 
 
Sustained nociceptive input may give lead to an exaggerated efficiency of the nociceptive transmission, 
also referred to as the wind-up of central neuronal activity. The wind-up phenomenon represents a 
temporarily increased discharge in the dorsal horn nociceptive neurons after intense and sustained 
peripheral stimulation [124] and can be observed in normal human subjects during the stimulation 
[125,126]. In order to evoke wind-up, a minimal stimulation frequency of 0.3-0.5 Hz is required [127] 
[Figure 4].  
 
Figure 4: A representation of equal pain stimulation over time resulting in increased pain sensations 
during equal pain stimulation and no return to baseline when the stimulation ends. 
 
In chronic pain conditions like fibromyalgia however, wind-up is increased and the after sensation is 
more intense, remains longer and occurs more frequently compared to healthy persons [119]. A 
mechanism involved in the enhancement of wind-up in these patients is the long-term potentiation 
of synaptic responses. Long-term potentiation is the temporary strengthening of the synaptic 
interaction between two neurons that outlasts the duration of a stimulus for at least 30 min, a few 
hours, or days to months [117]. This synaptic plasticity is reported in the spinal cord and in multiple 
brain areas and is known to contribute to conditions such as learning and creation of memories but 
also in the persistence of pain [128]. The wind-up phenomenon in combination with neuronal plasticity 
in the form of long-term potentiation might facilitate the bottom-up nociceptive output of the dorsal 
horn, leading to enhanced pain [124,129] [Figure 5]. 
Figure 5: Long-term potentiation. 
 
 
Temporal summation (TS) is a frequently used parameter to investigate the bottom-up sensitization 
in pain patients, since it is ought to be involved in the onset or maintenance of clinical pain [119,130–
134]. The response of TS mimics the initial phase of the wind-up phenomenon, or the so called 
increased response of second order neurons in the central nervous system to repetitive noxious 
stimulation [132] and is the consequence of long-term potentiation [135,136] and impaired pain 
inhibition [2,136].  
 
4.3.2. Top-down regulation 
 
The intensity of perceived pain is modulated by descending pathways. Endogenous descending pain 
modulatory systems, originating from the supra-spinal areas, can be both inhibitory and facilitatory. 
Descending inhibitory control and descending facilitation are recognized as parallel mechanisms in 
pain transmission and appear to be modulatory [137]. The balance between both systems determines 
the net descending pain modulation. In healthy conditions, a balanced interplay between both, 
regulated at a supra-spinal level, creates a protective environment for tissue healing. In persistent pain 
however, an imbalance between the facilitatory and the inhibitory working mechanisms in favor of 
pain facilitation might occur and underpin the development and maintenance of chronic pain 
syndromes [137–141]. Despite a lot of research in this field, it is still unknown why this balance 
between descending inhibitory control and descending facilitation is disturbed in some pain 
conditions. Cognitive-emotional top-down processes might play a part in this disturbed pain 
regulation. It is established that psychosocial factors influence the perception and expression of pain 
through the descending pain modulatory pathways [142,143]. In LBP patients, emotional distress 
seems an important construct influencing the pain intensity and pain disability [144].   
To assess the efficacy of endogenous pain inhibitory mechanism, the test paradigm termed 
conditioned pain modulation (CPM) is often used. It is performed through a ‘pain-inhibits-pain’ test 
paradigm, in which nociceptive spinal neurons are suppressed by a second remote noxious stimulation 
[145]. More concrete, the application of a conditioning noxious stimulus on one area of the body is 
capable of inhibiting responses of the signals of the dorsal horn neurons evoked by noxious stimulation 
of other body areas [146]. As a result, the painful stimulation inhibits concurrent pain signals evoked 
from the heterotopic stimulation sites, resulting in pain inhibition in normal situations [147]. This 
analgesic CPM effect persists for a few seconds or even several minutes after the removal of the 
conditioned stimulus [148–150].   
The mechanism behind CPM is however complex and not yet fully understood. In research, CPM is 
elicited by a conditioning pain stimulus added to another painful test stimulus. The presence of a third 
pain source (e.g. the presence of clinical pain) might therefore interfere with the CPM mechanisms. 
While in chronic pain patients, CPM seems to fail [39,121,151–153], pain inhibition in patients with 
acute pain or patients in which no central sensitization is expected, is obscure [145]. To interpret the 
value of the CPM test paradigm, knowledge whether a present pain source in the body interferes with 
the test is warranted. Therefore, a systematic review investigating the current knowledge on the 
influence of present pain, pain induction or pain reduction on CPM was performed, preceding the 
experimental pain investigation. This systematic review intended to evaluate whether pain induction 
of pain inhibition changes the efficacy of CPM in adults by determining the influence of clinical 
(acute/chronic) and experimentally induced pain, or pain reduction on CPM [Chapter 2, part 1].  
Another way of assessing the efficacy of endogenous pain inhibition, is investigating the relationship 
between the stimulated surface area and pain response, also referred to as spatial summation (SS) 
assessment. When the noxiously stimulated tissue surface is gradually increased in healthy persons, 
the activated inhibitory efferents gradually counterbalance the nociceptive afferents, resulting in a 
reduced correlation between the stimulated surface area and the perceived pain [154] [Figure 6]. This 
means that in healthy subjects SS is not very distinct, while it is in chronic pain conditions [39,155]. In 
these patients, central sensitization and its facilitation of neuronal processing of the afferent 
nociceptive input can lead to increased sensitivity in local and adjacent structures. This indicates that 
spinal neurons expand their receptive fields, resulting in facilitated spatial excitability when larger 
areas are stimulated [155]. Enhanced SS is seen as an indicator for central sensitization [156] and 
therefore of special interest in chronic pain conditions. Mechanisms behind SS in chronic pain 
populations such as patients with fibromyalgia, osteoarthritis and CLBP however remain unclear 
[39,155,157,158]. Furthermore, most previous studies focused on assessing SS by thermal stimuli, 
whereas pressure-pain stimuli is less common [155,158].  
 
Figure 6: Gradually increased noxiously stimulation of the tissue surface in healthy persons results in 
a reduced correlation between the stimulated surface area and the perceived pain, also known as 
Spatial Summation. 
 
4.4.Pain processing in low back pain 
 
Like in other chronic pain conditions, modulation of nociception may be an important factor in 
determining LBP and its prognosis. Possibly sensitized central pain mechanisms might be involved in 
the transition from acute to chronic widespread pain [156]. Altered pain processing rather than 
alterations in motor control is the prime prognostic factor for developing chronic whiplash associated 
disorders after a whiplash injury [159]. A review, analyzing the available research on central 
sensitization and altered central pain processing in patients with CLBP, concluded however that the 
responsiveness of CLBP patients to various stimuli to date is conflicting [37]. Some studies 
demonstrated enhanced pain responses in widespread areas, whereas others did not. Also firm 
conclusions regarding impaired endogenous pain modulation cannot yet be drawn. These conflicting 
results might be the consequence of the heterogeneity within the LBP population. Altered central pain 
processing is indeed only suggested in a subgroup of LBP [123,160]. Besides, very few research makes 
the distinction between RLBP and CLBP, increasing the heterogeneity in the included LBP groups. The 
challenge is to compare subgroups of LBP with different levels of chronicity in order to discover which 
patients might be characterized by altered pain processing. This dissertation will therefore investigate 
pain processing in clearly defined LBP populations (RLBP, non-continuous CLBP and continuous CLBP) 
and compare the results to HC, in which normal pain processing is expected, and to patients with 
fibromyalgia, in which alterations in pain processing are established.  
 
4.5.Evaluation of pain processing 
 
Gold standards for assessing central pain mechanisms are currently lacking. Quantitative sensory 
testing has been advocated to investigate indirect signs of central sensitization in order to explore the 
mechanisms underlying local and widespread musculoskeletal pain. Quantitative sensory testing by 
algometry is a sensitive measurement tool to evaluate both pain bottom-up and top-down pathways 
[116]. Since pain processing is a complex issue, a combination of quantitative sensory testing measures 
like pressure pain thresholds, TS, SS and CPM are commonly used for characterizing central pain 
modulation. 
 
4.5.1. Manual algometry 
 
Manual algometry is able to assess pressure pain thresholds in healthy subjects and pain patients 
[161–164], [Figure 7]. By measuring pressure pain thresholds on symptomatic and asymptomatic areas 
in LBP patients, local and widespread hyperalgesia can be established. Lowered pressure pain 
thresholds at symptomatic areas may represent primary hyperalgesia due to sensitized nociceptors 
within the injured peripheral musculoskeletal structures, although, tissue healing theoretically occurs 
within 3 months. By measuring pressure pain thresholds outside the area of primary nociception, 
widespread hyperalgesia or secondary hyperalgesia can be detected. Lowered pressure pain 
thresholds at local and remote sites are indicative for central sensitization [112,165]. Also for 
assessment of TS, manual algometry is a sensitive and reliable tool [130].  
Because this tool is user friendly and easy to apply in clinical practice, various pain measurements 
(pressure pain thresholds and TS) in this dissertation are assessed by manual algometry. 
 Figure 7: Manual algometry 
 
4.5.2. Cuff algometry 
 
An alternative method to assess quantitative sensory testing is a computerized cuff algometry 
(NociTech, Denmark, and Aalborg University, Denmark), [Figure 8]. Cuff algometry is already used in 
different chronic pain populations like fibromyalgia [38], patients with lateral epicondylalgia [166], 
chronic whiplash associated disorder [167] and in patients with knee osteoarthritis [155].  
This computer controlled pain assessment method works through a 13-cm wide silicone tourniquet 
cuff (VBM, Sulz, Germany) with 2 equal-sized chambers [168]. The application of the stimulus is 
initiated and controlled by a computer, ensuring a stable compression rate and reducing variability. An 
electronic visual analogue scale allows continuous recording of the pain intensity [169]. Moreover, the 
tissue volume which can be assessed, is larger [170]. The computer-controlled cuff algometer is 
demonstrated to be specific for the assessment of deep tissue sensitivity and is proven to be a reliable 
and sensitive method for assessment of pain sensitivity, comparable to the manual pressure algometer 
[171]. Besides pressure pain thresholds, also SS and CPM can be assessed with this device [168,171].  
Because input from deep tissues might produce more robust dorsal horn hyperexcitability and 
plasticity than input from cutaneous tissues [137] and the cuff algometer appears to be a more 
standardized and user-independent method for pain assessment, this device is additionally used to 
evaluate pain measures (pressure pain thresholds, SS and CPM) in this dissertation.  
    
Figure 8: Computerized cuff algometry 
  
5. THE ASSOCIATION BETWEEN MUSCLE CHARACTERISTICS AND PAIN 
PROCESSING  
 
To date it is still unknown why some people recover after every pain episode and others develop 
chronic pain complaints. Research related to the pathogenic mechanisms that trigger, underpin and 
maintain LBP are vital to understand the recurrence of LBP flares and the progression of some LBP 
patients to chronicity.  
As described above, both muscle characteristics seem different between LBP populations. However 
literature is not univocal on muscle characteristics, atrophy and fat infiltration are presented in some 
CLBP patients, whereas RLBP patients, even in remission, are rather characterized by a degeneration 
in muscle quality in the absence of clear atrophy and fat infiltration.  
Besides the established alterations in low back muscle morphology, a relationship between muscle 
characteristics in LBP and the experience of pain is assumed. Experimental pain research in healthy 
persons and RLBP patients in remission established changes in motor output of the lumbar muscles 
during movement [83,84,172]. These alterations point at a direct association between pain and motor 
output. Furthermore, it is hypothesized that alterations in motor output due to pain might also be 
associated to peripheral adaptations activity [173]. As a result, a link between pain and muscle 
structure can be presumed. Another experimental study in pigs found atrophy and histological changes 
in the multifidus muscle a few days after injury induction [62]. These findings confirm muscle changes 
occur after injury (and assumed pain) and suggest an association between pain and muscle structural 
alterations. The mechanisms behind the decrease of muscle mass is yet unknown, but an alteration in 
neural drive is suggested. The basis for the change of this neural drive however remains unclear.  
It can be hypothesized that these changes in neural drive are influenced by pain processing 
mechanisms. As described above, the responsiveness of the central neurons system seems increased 
and pain processing mechanisms are disordered in pain patients [110]. In CLBP, impaired pain 
processing is possibly present in a subgroup of CLBP patients and not in the other LBP populations [37].  
 
 
 
  
 
 
 
 
 
 
 
Time aspects might influence the relationship between pain and structural muscle alterations. Previous 
work established a relation between “the time elapsed since the last pain episode” and lean muscle 
CSA and total CSA in lumbar muscle tissue of RLBP patients. Recovery from atrophy might therefore 
occur during pain remission periods [54]. Moreover, deterioration in muscle quality seems related to 
the frequency of previous pain episodes in RLBP [54]. As a result, the time period of pain resolution as 
well as the frequency of pain episodes might play a role in the alteration process of lumbar muscle 
structure.   
As far as we know, the relation between the pain processing and muscular alterations in LBP is 
unexplored. Nevertheless, understanding of this association might provide insight in the recurrence 
and chronicity of LBP. Therefore, this explorative study examined to investigate the association 
between pressure pain thresholds (as a proxy for pain processing) on the one hand and alterations in 
CSA, fat infiltration and muscle fat index of the lumbar erector spinae and multifidus muscle on the 
other hand. Since the relationship between muscle structure and pain processing might be influenced 
by the frequency of pain episodes, we investigated this association in three LBP groups: RLBP patients 
in remission, CLBP patients with non-continuous LBP complaints and CLBP patients with continuous 
LBP complaints [Chapter 3, Part 1].  
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6. OUTLINE AND AIMS 
 
6.1.Background of the dissertation 
 
To recapitulate, hereby an overview of the state of art in pain processing and muscular alterations in 
LBP: 
- Despite a lot of research, results concerning muscle characteristics are not straightforward. 
Findings on muscular alterations are not univocal in CLBP and scarce in RLBP. Furthermore, 
knowledge concerning muscle activity by mfMRI is scarce in CLBP and contradictory in RLBP. 
- Alterations in pain processing mechanisms are expected in a subgroup of CLBP, but research 
concerning central sensitization is contradictory in CLBP and, as far as we know, non-existing 
in RLBP.  
- The association between pain processing and muscular deformations is unexplored in LBP. 
In this dissertation, the knowledge on lumbar muscular characteristics, central pain processing 
mechanisms and the relationship between lumbar muscle characteristics and central pain processing 
mechanisms, fundamental to recurrent and chronic LBP complaints, will be enlarged.  
As indicated above, large heterogeneity exists within the LBP population. Few research distinguishes 
between RLBP and CLBP patients, even though some LBP patients seem to recover after every episode, 
whereas others do not. Therefore, both recurrent and chronic patients with LBP complaints are 
incorporated. It is also stated that the CLBP group on its own, is a heterogeneous patient group. In 
research, no subdivisions within the CLBP group are currently made. Different working mechanisms in 
subgroups of CLBP might influence the characteristics in those groups. It is crucial to gain more insight 
in the mechanisms contributing to the chronicity of LBP. There is one previous study that found a 
relation between “the time elapsed since the last pain episode” and the lean muscle CSA and total CSA 
in lumbar muscles of RLBP patients [54]. Although this finding was established in a RLBP group, it is 
possible that small periods of pain remission might also influence muscle and pain processing 
characteristics in CLBP. Therefore, the CLBP patients in this dissertation will be split into a non-
continuous and a continuous CLBP group, in which non-continuous CLBP is seen as a phase between 
RLBP and continuous CLBP. Subjects in the continuous CLBP subgroup suffered daily from LBP 
complaints, whereas those in the non-continuous CLBP subgroup suffered from LBP for three to four 
days a week. 
 
6.2.Content of the dissertation 
 
This doctoral thesis consists of three major chapters.  
The first goal of this dissertation is to record the differences and similarities in lumbar muscle 
characteristics in three different LBP groups: RLBP, non-continuous CLBP and continuous CLBP. In the 
first chapter, a systematic review concerning the changes in CSA, fat infiltration and muscle fibre type 
illustrates the current knowledge as well as the gaps in knowledge concerning muscle structure 
alterations in LBP [Chapter 1, Part 1]. A second manuscript in this chapter outlines experimental 
research which evaluates the muscle structure and muscle activity in the lumbar erector spinae muscle 
and multifidus muscle in RLBP, non-continuous CLBP and continuous CLBP. This approach is innovative, 
since few research makes distinctions within the LBP population [Chapter 1, Part 2]. 
A second goal of this dissertation is to evaluate pain processing mechanisms in three different 
LBP groups: RLBP, non-continuous CLBP and continuous CLBP. The second chapter contains a 
systematic review reporting on the effect of pain on the CPM paradigm, which is an important 
construct in the evaluation of pain processing mechanisms [Chapter 2, Part 1]. Second, a manuscript 
outlines the experimental research on pain measurements in RLBP, non-continuous CLBP, continuous 
CLBP. A lot of research has focused on fibromyalgia patients compared to healthy controls and 
established altered pain processing mechanisms in fibromyalgia patients, whereas normal pain 
processing is suggested in healthy subjects. To accurately investigate pain processing in the three LBP 
populations, results were compared to these two additional groups. This way, a complete spectrum 
was created with healthy subjects on the one end, representing a population with normal pain 
processing and fibromyalgia patients on the other, representing a population with altered pain 
processing. The three LBP groups were expected to float in between those two [Chapter 2, Part 2]. 
A final goal in this dissertation is to explore the association between muscle characteristics and 
pain processing mechanisms in patients with LBP. Therefore, a last explorative chapter is dedicated to 
the association between muscle structure alterations and pain processing in recurrent, non-continuous 
chronic and continuous CLBP patients. This research will provide insight in the recurrence and 
chronicity of LBP [Chapter 3, Part 1]. 
 
 
 
 
6.3.Hypotheses of the dissertation 
 
Chapter 1 
- A decrease in CSA and/or an increase in fat infiltration and muscle fat index in the lumbar 
multifidus and erector spinae muscles is expected in continuous CLBP, compared to RLBP. Non-
continuous CLBP are seen as an intermediate group between continuous CLBP and RLBP. 
Therefore, non-continuous CLBP are expected to have more atrophy and/or fat infiltration in 
the lumbar muscles compared to RLBP as well as less muscular deformities compared to 
continuous CLBP.  
- Metabolic activity in the lumbar multifidus and erector spinae is expected to be enhanced in 
continuous CLBP and non-continuous CLBP compared to RLBP. The non-continuous CLBP 
patients are expected to have enhanced metabolic activity in the lumbar muscles compared 
to RLBP patients as well as a decreased metabolic activity compared to continuous CLBP 
patients. 
Chapter 2 
- Continuous CLBP patients are expected to be characterized by alterations in pain processing 
mechanisms, whereas RLBP and non-continuous CLBP patients are characterized by normal 
central pain processing.  
Chapter 3 
- In the LBP population, an association between muscle structures and pressure pain thresholds 
is expected. Patients characterized by high pressure pain thresholds are hypothesized with 
large total CSA, large muscle CSA, low fat CSA and high muscle quality (=low muscle fat index) 
and vice versa.  
- It is hypothesized that the association between pressures pain thresholds and muscle structure 
characteristics is influenced by the subgroup of LBP patients.  
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ABSTRACT 
Background: Lumbar muscle dysfunction due to pain might be related to altered lumbar muscle 
structure. Macroscopically, muscle degeneration in low back pain (LBP) is characterized by a decrease 
in cross-sectional area and an increase in fat infiltration in the lumbar paraspinal muscles. In addition 
microscopic changes, such as changes in fiber distribution, might occur. Inconsistencies in results from 
different studies make it difficult to draw firm conclusions on which structural changes are present in 
the different types of non-specific LBP. Insights regarding structural muscle alterations in LBP are 
however important for prevention and treatment of non-specific LBP. 
Objective: The goal of this article is to review which macro- and/or microscopic structural alterations 
of the lumbar muscles occur in case of non-specific chronic low back pain (CLBP), recurrent low back 
pain (RLBP) and acute low back pain (ALBP).  
Study design: systematic review. 
Setting: All selected studies were case-control studies. 
Methods: A systematic literature search was conducted in the databases PubMed and Web of Science. 
Only full texts of original studies regarding structural alterations (atrophy, fat infiltration and fiber type 
distribution) in lumbar muscles of patients with non-specific LBP compared to healthy controls were 
included.  All included articles were scored on methodological quality. 
 
Results: Fifteen studies were found eligible after screening title, abstract and full text for in- and 
exclusion criteria. In CLBP, moderate evidence of atrophy was found in the multifidus whereas results 
in the paraspinal and the erector spinae muscle remain inconclusive. Also moderate evidence occurred 
in RLBP and ALBP, where no atrophy was shown in any lumbar muscle. Conflicting results were seen in 
undefined LBP groups. Results concerning fat infiltration were inconsistent in CLBP. On the other hand, 
there is moderate evidence in RLBP that fat infiltration does not occur, although a larger muscle fat 
index was found in the erector spinae, multifidus and paraspinal muscles, reflecting an increased 
relative amount of intramuscular lipids in RLBP. However, no studies were found investigating fat 
infiltration in ALBP. Restricted evidence indicates no abnormalities in fiber type in the paraspinal 
muscles in CLBP. No studies have examined fiber type in ALBP and RLBP. 
Limitations: Lack of clarity concerning patient definitions, exact LBP symptoms and applied methods. 
 
 Conclusions: The results indicate atrophy in CLBP in the multifidus but are inconclusive in the erector 
spinae and overall paraspinal muscle. No atrophy was shown in RLBP and ALBP. Fat infiltration did not 
occur in RLBP, but results in CLBP were inconsistent. No abnormalities in fiber type in the paraspinal 
muscles were found in CLBP.  
Key words: Low back pain, non-specific, chronic, recurrent, acute, muscle structure, lumbar, fat 
infiltration, cross-sectional area, fiber type, review. 
1. INTRODUCTION 
 
Lumbar muscle degeneration is a common feature in low back pain (LBP) (1,2). Macroscopically this 
muscle degeneration is characterized by a decrease in cross-sectional area (CSA) (1,3–7) and an 
increase in the amount of fat content (2,8–10) of the lumbar paraspinal muscles. Although changes in 
muscle size and fat infiltration of the lumbar muscles are frequently reported in LBP literature, 
inconsistencies in results make it difficult to draw firm conclusions whether structural changes are 
present in different types of non-specific LBP. This could be due to the generalization of previous 
observations across different types of LBP (specific vs non-specific LBP, and acute vs recurrent vs 
chronic LBP), while it is likely that each type of LBP is characterized by its own clinical picture and 
etiology.  
In addition to macroscopic changes, it has been proposed that microscopic changes as well, can occur 
in patients with non-specific LBP. For instance, micro-traumata of the deep muscular tissues can arise 
when the motion of the vertebra exceeds its physiological boundaries, which occurs when the demand 
for spinal muscle control is high (11–14). These micro-traumata could form a pain source during an 
episode of acute LBP (ALBP) or recurrent LBP (RLBP). Furthermore, it has been reported that patients 
with severe chronic LBP (CLBP) have a higher portion of type IIX (fast twitch glycolytic, previously called 
type IIB) at the expense of type I (slow twitch oxidative) fibers (15). In healthy people, the paraspinal 
muscles have been shown to contain more type I fibers, compared to other musculoskeletal muscles 
(16). Hence, the changes in fiber type, as seen in severe CLBP, could lead to lowered fatigue resistance 
of the paraspinal muscles which in turn results in higher vulnerability of the lumber spine (16). 
However, not all studies have been able to reveal differences in fiber type characteristics of non-
specific LBP patients (17). 
As shown by Falla and Farina (18), pain can affect muscle structure by compromising muscle function. 
Comprised muscle function due to pain can consequently lead to altered muscle structure (18). This 
theory could explain why macroscopic muscle degeneration in non-specific LBP is often established in 
paraspinal muscles, and in particular the multifidus muscle, as these muscles play an important role in 
providing lumbar stability (19). On the other hand, muscular inhibition and atrophy might be a direct 
consequence of pain, as pain-related nerve inhibition reduces lumbar muscle activity in order to 
prevent tissue damage (20). Indeed, some studies have found evidence that structural changes are 
strongly associated with the presence of (non-)specific LBP (8,21–23), whereas others could not find 
an association between the occurrence of (non-)specific LBP and structural changes in paraspinal 
muscles (24–28). To date, it is unclear whether structural changes of the lumbar musculature are cause 
or consequence of non-specific LBP. Insights regarding the fact whether structural muscle alterations 
occur and how the lumbar muscles specifically change in case of LBP are however important for the 
prevention and treatment of non-specific LBP. 
For the reasons described above, a systematic review of the existing literature will be performed to 
examine whether and which type of macro- and/or microscopic structural alterations of the lumbar 
muscles occur in case of non-specific LBP. In order to prevent ambiguities, this review will solely focus 
on the non-specific LBP population, and will present the results separately for ALBP, RLBP and CLBP.  
 
 
2. METHODS 
 
2.1. Eligibility criteria 
This systematic review is conducted according to the PRISMA-guidelines (http://www.prisma-
statement.org/). A PICOS-approach was applied to formulate the research question: Patient (P), 
Intervention (I), Comparison (C), Outcome (O) and Study design (S). This systematic review attempted 
to select those articles, which described ‘Which structural alterations (O) occur in lumbar muscles (P) 
of patients suffering from non-specific LBP (I)’. Studies were included if they reported changes in CSA, 
fat infiltration and fiber type distribution of the lumbar muscles in human adults suffering from non-
specific LBP, compared to healthy controls which are pain-free (C). For this purpose, only case-control 
studies (S) were included.  
2.2. Search Strategy 
A systematic search on the existing literature was conducted in August 2014. Two electronic databases 
were screened for articles: PubMed and Web of Science. The following key words were used to search 
the databases for eligible articles: low back pain, acute low back pain, recurrent low back pain, chronic 
low back pain, non-specific low back pain, low backache, low back ache, lower back pain, and lumbago. 
These synonyms were combined with the following search terms regarding outcome using the 
Boolean-term ‘AND’ in order to make the search as complete as possible: muscle atrophy, cross-
sectional area, muscle size, muscular size, muscular thickness, muscle thickness, muscular atrophy, 
muscle atrophy, muscle atrophies, adipose tissue, fat infiltration, fatty infiltration, fat deposition, 
intramuscular fat, fat tissue, fatty tissue, muscle fiber, fiber type, fiber size, fiber density, muscle 
structure, muscular structure, muscle morphology, muscular morphology, muscle composition and 
muscular composition.  
In addition, a hand search was conducted by screening the reference lists of all eligible articles and 
relevant reviews. The last author (L.D.), an expert in the area of LBP and the examination of structural 
properties of the spinal muscles, was asked to review the list of studies retrieved by the search strategy 
and to identify any missing relevant studies. 
2.3. Study selection  
After removing duplicates, title and abstract of the remaining articles were screened regarding 
fulfillment of the selection criteria. Afterwards full texts of the remaining articles were screened 
against these criteria to ensure eligibility. 
To be included, an article had to fulfill the following criteria: (1) case-control study (patients with non-
specific ALBP, RLBP, or CLBP compared to healthy subjects); (2) only living human adults (≥18 years 
old); (3) evaluating at least one of the following outcomes of LBP: CSA, fat infiltration, fiber type; (4) of 
the lumbar muscles. Only full texts written in English, Dutch, French and German were included in this 
review. Exclusion criteria were: (1) lumbar surgery; (2) spinal stenosis; (3) disk herniation, as these 
were considered as reasons for specific LBP. 
2.4. Risk of Bias 
The ‘checklist for assessing risk of bias of studies examining side effects and etiology’ presented on the 
website of the Dutch Cochrane Centre (http://dcc.cochrane.org/)) was used. This checklist contains 4 
evaluation criteria: 1) adequate definition of subject groups; 2) absence of selection bias; 3) blindness 
of intervention and outcome; 4) identification for possible confounders. The assessment of risk of bias 
was executed by 2 independent, blinded researchers (D.G. & J.V.O.). The results were compared and 
differences were discussed in case of disagreement. The risk of bias score was not decisive for inclusion 
in this review, but was taken into account when presenting the results. 
Afterwards a level of evidence (LOE) was assigned to each article, based on study design and risk of 
bias, using the guidelines of the EBRO-platform (Evidence-based guideline development in the 
Netherlands, www.cbo.nl). In order to draw correct conclusions, the level of conclusion will be 
determined based on the levels of evidence of the different studies per topic. 
 
2.5. Data Extraction 
Information was extracted regarding subject characteristics, definition of patient group, evaluation 
technique, outcome measure, lumbar test site and subject position and study results.  
 
3. RESULTS 
 
3.1. Study Selection 
The systematic search resulted in 794 articles. Additionally 2 articles were found through hand 
searching. After removing duplicates, 584 articles remained and were screened for inclusion based on 
title and abstract and if necessary, on full text. After this complete screening, 15 articles remained. The 
complete screening procedure and the exact reasons for exclusion during each screening phase are 
represented in the flowchart (figure 1). 
 
 
Figure 1: Flow chart of articles reviewed for study 
3.2. Study Characteristics 
Since the intention was to compare structural characteristics between non-specific LBP patients and 
healthy controls, only case-control studies were admitted. Clearly defined CLBP patients were found 
in 9 studies (1,4,8,17,22,27,29–31), whereas specifically defined RLBP patients were seen in 2 studies 
(33,36) and 1 study investigated clearly defined ALBP (3). Four studies however, reported only ‘LBP’ 
with varying definitions and no clear defined duration (28,33–35). One of these, subdivided LBP into 
‘previous LBP’ and ‘current LBP’ (34). Another study split the patient group into a group without hip-
pain and a group with hip-pain (33). Three articles included only patients with unilateral complaints 
(3,32,35), whereas 11 did not clearly mention if patients suffered from unilateral or bilateral LBP 
(1,8,17,22,27–31,33,34). Only 1 article subdivided the patient group into a bilateral and a unilateral 
LBP group (4). 
Fourteen studies evaluated CSA in lumbar muscles (1,3,4,8,22,27–35), whereas 5 studies evaluated fat 
infiltration (1,8,29,32,33) and 1 study examined the lumbar muscle fibers types (17). From all studies, 
6 applied ultra sound imaging (USI) (3,4,8,27,30,31,35), 4 applied magnetic resonance imaging (MRI) 
(28,32–34) and 3 applied computed tomography (CT) (1,22,29) to evaluate CSA and/or fat content of 
the lumbar muscles. The study investigating fiber type, used percutaneous spinal muscle biopsies 
which were obtained using the conchotome technique (17). The examined muscles varied among all 
articles: 12 studies investigated the isolated multifidus muscle (1,3,4,8,22,27,30–35); 5 studies 
investigated the isolated erector spinae muscle (1,29,32–34); 4 studies examined the complete 
paraspinal muscles (1,17,22,28). Fourteen articles investigated both left and right side of the lumbar 
muscles (1,3,4,8,22,26–35) but only in 8 studies, it was examined whether there were differences 
between both sides (3,4,27,30–33,35). Only 1 study did not clearly mention if the measurements were 
taken in one or both sides of the lumbar musculature (17). All characteristics extracted from the 
included articles are presented in the evidence table (Table 1 in Appendix). 
3.3. Risk of Bias 
The methodological quality of all included articles is presented in Table 2. In 75 % of the cases, both 
researchers agreed. The remaining items were discussed until agreement was reached. From all 
included studies, 1 scored 0/4 (3) and 1 scored 1/4 (27) which was considered as a high risk of bias, 
whereas 3 studies scored 2/4 which was considered as a moderate risk of bias (4,8,34). Six studies 
scored 3/4 (17,28–32) and 4 studies scored 4/4  (1,22,33,35) which were respectively considered as a 
limited and low risk of bias. Since all studies were case-controls, all articles received a ‘B’ level of 
evidence. 
 Table 2: Scoring 
 
  
 
Study 
CBO score Total CBO 
score 
LOE LOC 
1 2 3 4 5 6 7 
C
SA
 
CLBP 
Chan et al (2012) 0 1 0 / / / 1 2/4 B 
2 
Danneels et al 
(2000) 
1 1 1 / / / 1 4/4 B 
Hides et al 
(2008a) 
1 0 0 / / / 1 2/4 B 
Hultman (1993) 1 1 ? / / / 1 3/4 B 
Kamaz et al 
(2007) 
1 1 1 / / / 1 4/4 B 
Lee et al (2006) 1 1 ? / / / 1 3/4 B 
Scott et al (2014) 0 0 ? / / / 1 1/4 B 
Wallwork et al 
(2009) 
1 0 1 / / / 1 3/4 B 
RLBP 
D’hooge et al 
(2012) 
1 0 1 / / / 1 3/4 B 
2 
Hultman et al 
(1993) 
1 1 ? / / / 1 3/4 B 
ALBP Hides et al (1994) 0 0 0 / / / 0 0/4 B 3 
Undefined 
LBP 
Gildea et al (2013) 1 1 1 / / / 1 4/4 B 
3 
Hides et al 
(2008b) 
1 1 1 / / / 1 4/4 B 
McGregor et al 
(2002) 
1 0 ? / / / 1 2/4 B 
Yarjanian (2013) 1 0 1 / / / 1 3/4 B 
FA
T 
C
O
N
TE
N
T 
CLBP 
Chan et al (2012) 0 1 0 / / / 1 2/4 B 
3 
Danneels et al 
(2000) 
1 1 1 / / / 1 4/4 B 
Hultman et al 
(1993) 
1 1 ? / / / 1 3/4 B 
RLBP 
D’hooge et al 
(2012) 
1 0 1 / / / 1 3/4 B 
2 
Hultman et al 
(1993) 
1 1 ? / / / 1 3/4 B 
Undefined 
LBP 
Gildea et al (2013) 1 1 1 / / / 1 4/4 B 3 
FIBER 
TYPE 
CLBP 
Crossman et al 
(2004) 
1 1 ? / / / 1 3/4 B 3 
3.4. Outcome measures 
3.4.1. CSA 
Chronic low back pain 
Seven studies investigated lumbar muscle atrophy in the multifidus in CLBP (1,4,8,22,27,30,31). Six of 
these studies found a lowered CSA in the multifidus compared to healthy persons, for at least one 
lumbar level (1,4,8,22,30,31). At level L4, 3 studies found a lower CSA in CLBP (4,8,30). Two other 
studies made a distinction between the upper and lower endplate of L4 (1,22). One of these found a 
lowered CSA both at the upper and lower endplate of L4 (22), whereas Danneels et al (1) demonstrated 
that the multifidus, both with and without fat, was smaller only at the lower endplate, but not at the 
upper endplate. At L5, 1 study reported a lower CSA in the multifidus in CLBP (31), whereas 2 others 
found no differences (27,30). At lumbar levels L2-L3, no differences were seen between CLBP and 
healthy controls (1,4). One study even found a larger mutifidus at higher lumbar levels in CLBP 
compared to healthy persons (31). Two studies noted asymmetry at lower levels in CLBP (4,30). 
According to Hides et al (4) asymmetry was larger in unilateral CLBP compared to healthy subjects and 
to bilateral CLBP, indicating possible unilateral atrophy in unilateral CLBP(4). On the contrary, 1 study 
found no differences in asymmetry between healthy subjects and CLBP (31).  
One study separately reported on differences in CSA for the isolated erector spinae muscle but could 
not establish any differences between CLBP and healthy controls (1).  
Only 2 studies investigated CSA in the complete paraspinal muscle and could establish a lowered CSA 
in CLBP compared to healthy subjects at the lower endplate, but not at the upper endplate of L4 (1,22). 
At more cranial levels, no differences in CSA were established (1).  
Recurrent low back pain 
Two studies investigated CSA in erector spinae muscles at levels L3-L4, but none of them could 
establish differences in CSA between RLBP and healthy controls (29,32). One study established a 
decreased CSA in the erector spinae muscle of CLBP compared to RLBP at level L3 (29). 
Only 1 study searched for differences in CSA in multifidus in RLBP, but could not establish any 
difference in total muscle CSA or lean muscle CSA compared to healthy controls at any level. Also no 
pain-side related differences were seen (32).  
  
Acute low back pain 
Only one article studied atrophy in the multifidus in ALBP compared to healthy controls. The between 
side differences in healthy subjects (at L4) appeared smaller in comparison with ALBP (at all levels). A 
significantly larger asymmetry between symptomatic (L5) and asymptomatic (L2-L4) levels were 
reported in ALBP, whereas no differences between levels occurred in healthy controls. Below 
symptomatic levels, no atrophy was noted both in ALBP and healthy persons (3).  
Undefined low back pain 
Three articles discussed CSA in the multifidus muscle (33–35) of which 2 established a smaller CSA in 
LBP compared to healthy persons (33,35). One of these 2 latter studies detected a smaller CSA at both 
sides, at all lumbar levels (L2-L5) (35), whereas the other could only find differences at L3-L4 and L5 
level, but not at L2 (33). Conversely, a third study established a larger CSA in the multifidus in (previous 
and current) LBP compared to healthy controls. Moreover, CSA in previous LBP was larger compared 
to current LBP (34). 
Two articles considered differences in CSA in the lumbar erector spinae and found conflicting results 
(33,34). One of these studies could not find any differences between healthy controls and LBP at all 
lumbar levels (L2-L5) (33), whereas in the study of McGregor et al (34) a significant larger CSA was 
found in the healthy subjects versus previous LBP at L5-S1. Contradictory, in this latter study, the 
erector spinae appeared larger in both previous and current LBP, compared to healthy controls at L4-
L5. No differences were found between previous LBP and current LBP at L4-L5 (34).  
Only 1 study investigated muscle functional CSA in the complete paraspinal muscle at level L5-S1 but 
no differences were found when comparing non-radiating LBP to healthy controls (28). 
 
In summary, moderate evidence of atrophy can be found in CLBP (conclusion strength 2) since 6/7 
studies indicated the multifidus muscle is smaller when compared to healthy controls [1,4,8,22,30,31]. 
A lowered CSA in the paraspinal muscles in CLBP were only seen at the lower endplate of L4 (1,22) but 
no atrophy was found in the erector spinae muscle in CLBP (1). Moreover moderate evidence occurred 
in RLBP and ALBP (conclusion strength 2) in which no atrophy was shown in any lumbar muscle 
(3,29,32). Conflicting results were seen in the undefined LBP group (conclusion strength 2). One study 
found multifidus to be larger in LBP (34) whereas 2 others found multifidus to be smaller in LBP 
compared to healthy controls (33,35). In the erector spinae, 1 study could not find any difference for 
CSA (33) whereas another found the erector spinae to be smaller in the LBP group at level L5-S1, but 
conversely larger at L4-L5 (34). The solely study investigating paraspinal muscles could not establish 
atrophy in undefined LBP (28). 
 
3.4.2. Fat Content 
Chronic low back pain 
Two studies in this review investigated fat infiltration in CLBP in the isolated multifidus muscle 
providing conflicting results (1,8). One study established differences in fat content between healthy 
controls and CLBP at L4 (8), whereas the other researchers could not detect any difference between 
groups (1).  
Inconsistent results for the isolated erector spinae were also found in 2 studies (1,29). On the one 
hand, Hultman et al (29) found a significant difference between CLBP and healthy controls at L3, 
whereas Danneels et al (1) could not establish differences in fat content. 
Only one study investigated the total paraspinal muscle, but could not demonstrate differences 
between healthy persons and CLBP (1). 
Recurrent low back pain  
Two studies investigated fat infiltration in the erector spinae in RLBP and could not find any differences 
compared to healthy controls (29,32). An increase in fat content was however detected in CLBP 
compared to RLBP (29).  
One study investigated the multifidus and the total paraspinal muscle in unilateral RLBP patients 
during remission but could not find differences compared to healthy controls. Conversely, the authors 
of this study indicated that the muscle fat index (reflecting the amount of fat content in lean muscle 
CSA) was larger in RLBP compared to healthy subjects for all muscles at the upper and lower endplate 
of L4, but not at upper endplate of L3. No pain-side related differences were found (32).  
Acute low back pain  
No studies investigating fat content in lumbar muscles of non-specific ALBP were found through our 
search strategy. 
  
Undefined low back pain 
One study, which did not define the LBP group, was not able to establish differences in fat content nor 
in multifidus or erector spinae between the patient group and healthy controls (33). 
 
Results concerning fat infiltration in CLBP are conflicting (conclusion strength 3). Studies provided 
contradictory results for the isolated multifidus (1,8) and for erector spinae (1,29). The solely study 
investigating paraspinal muscles, did not find fat infiltration in CLBP (1). On the other hand, there is 
moderate evidence fat infiltration does not occur in RLBP (conclusion strength 2) since no fat infiltration 
in the erector spinae, multifidus or paraspinal muscles was found in RLBP (29,32). Conversely a larger 
muscle fat index for erector spinae and multifidus was found in RLBP, reflecting an increased relative 
amount of intramuscular lipids (32). In undefined LBP, no differences in multifidus and erector spinae 
were demonstrated (33) (conclusion strength 3). No studies were found investigating fat content in 
ALBP, so no conclusions can be made for this population.  
 
3.4.3. Fiber type 
Chronic low back pain 
Only 1 study examined the fiber type content in paraspinal muscles. No histomorphometric 
differences were found between healthy controls and CLBP, suggesting no significant atrophy of either 
fiber type in CLBP. Type I fibers size was slightly larger than type II fiber size, both in CLBP and healthy 
controls, but only significant in CLBP group (17).  
Recurrent and acute low back pain 
No studies investigating fiber type in lumbar muscles of patients with ALBP or RLBP were found. 
 
In summary, restricted evidence to date indicates that patients with CLBP show no abnormalities in 
paraspinal muscle fiber types (conclusion strength 3). As no studies have examined whether alterations 
in fiber type occurs in ALBP and RLBP, no conclusions can be made for these populations.  
 
  
4. DISCUSSION 
4.1. Results 
The main objective of this systematic review was to determine the evidence on structural changes in 
lumbar muscles in patients with non-specific LBP. Moreover, this review intended to summarize 
differences in muscle size (CSA), fat infiltration and muscle fiber characteristics in persons with non-
specific CLBP, RLBP or ALBP compared to healthy controls. 
The present study revealed different outcomes for CSA in different LBP-groups. In CLBP, moderate 
evidence is provided that the multifidus is smaller in CLBP compared to healthy controls at different 
levels for multifidus (1,4,8,22,30,31), while results about CSA in paraspinal muscles and the erector 
spinae muscle were less conclusive (1,22,29). These results are similar to the review of Fortin and 
Macedo (5) which investigated muscle morphology in patients with specific and non-specific LBP and 
found that both multifidus and paraspinal muscles were smaller in CLBP compared to healthy controls. 
According to Bierry et al (36), the multifidus is predominantly affected by atrophy in LBP, given that 
the multifidus is exclusively innervated by the medial ramus of the dorsal root of the spinal nerve, 
without segmental nerve supply, which is present in other spinal muscles. After pain onset, a 
combination of reflex inhibition and disturbance in coordination of trunk muscles occurs changes in 
the multifidus structure (1,19). Therefore, muscle training focused on multifidus activation is often 
considered as a key feature in the clinical approach of LBP (19,37). 
According to levels of lowered CSA in CLBP, results were similar amongst studies: lowered CSA was 
mainly found in more caudal lumbar levels (1,4,8,30,31) whereas at more cranial lumbar levels no 
conclusive results could been established (1,4,31). The review of Fortin and Macedo (5) established 
multifidus atrophy in CLBP was even larger in L5 compared to L4. An explanation for this can be found 
in the fact that the multifidus muscle becomes larger at lower levels (4). At the level L3, the multifidus 
is about one-sixth of the total paraspinal muscle whereas the multifidus muscle is one-third of the 
paraspinal muscle at the lower endplate of L4 (1). Due to a larger muscular mass in lower areas of 
lumbar muscles, clear atrophy can be rather expected in the lower lumbar areas. In the current review, 
however, 2 studies could not find any atrophy in the multifidus muscles in CLBP at L5 (27,30), but 1 of 
these studies included professional athletes who were attending physiotherapy. Being at different 
stages in rehabilitation might imply that some patients normalized their multifidus structures. In 
rehabilitation, muscle training on multifidus should preferably be focused on the lower levels, instead 
of general lumbar region.  
In RLBP and ALBP no differences could been shown in lumbar muscle size between patients and 
healthy controls (3,29,32). Possibly earlier reductions in muscle size during an episode of LBP, resolve 
in remission. This assumption is found in a correlation between CSA and ‘time that elapsed since the 
last LBP episode’ in the dissertation of D’hooge (32). To make this assumption more clear, a study 
should investigate muscle structure, as well during a pain flare as in pain remissions during different 
points in time. This is the only way, to examine the direct influence of clinical LBP on muscle structure 
and the effect of pain remission. Notable is the difference in CSA in erector spinae between RLBP and 
CLBP, indicating CSA is lowered in CLBP compared to RLBP (29). This result supports our hypothesis of 
differences in characteristics and etiology between LBP-groups.   
Studies investigating ambiguous LBP-groups could not find conclusive results towards CSA in lower 
back muscles (28,33–35). Like Crossman et al. (17) proposed, 2 groups of LBP might appear: LBP 
patients who stay active despite their discomfort and LBP patients reducing their physical activity as a 
protection mechanism resulting in deconditioning. The amount of physical activity despite LBP 
complaints might influence the muscle structure characteristics. Studies should take this into account 
when comparing groups and either match subject groups for daily activity levels or report when group 
differences exist regarding this confounding factor. Given the importance of well-functioning lower 
back muscles with regard to spinal functioning, rehabilitation of LBP complaints should contain general 
physical activity to ensure patients don’t get inactive and deconditioned. Special attention should be 
paid to multifidus activation exercises, since the multifidus is the most sensitive to atrophy. 
Besides activity levels as a confounding factor of fat content in the lumbar musculature, also BMI and 
subcutaneous fat levels might influence fat infiltration. More specifically, paraspinal muscle density 
has been shown to decrease when BMI increases (24). Some articles in this review reported that an 
increased fat infiltration in LBP is not related to BMI or other body composition parameters (8,22,29) 
whereas others just did not take this parameter into account.  
The amount of fat content in lumbar muscles is considered as a sign of atrophy (2). In CLBP a significant 
increase in fat infiltration compared to healthy controls was found in two studies (8,29) whereas 
another was unsuccessful in confirming these findings (1). Chan et al (8) found an increased fatty 
infiltration in CLBP, but the control group was much younger (25 years) compared to the patient group 
(37 years). The significant increase in muscle fat content in this patient group can possibly be explained 
rather by age difference than by LBP. Another included article investigated very young persons (<32 
years) and could neither find differences in fat infiltration between an undefined LBP group and 
healthy controls (33). These results also suggest the duration of LBP in young persons might be too 
short to cause structural changes. The role between fat content and age has been confirmed by 
McLoughlin (25), who found that fat infiltration is related to age and is not a sign of atrophy in the 
lumbar muscles. Other research supports the idea that an increase in fat content is rather caused by 
age (1,22,33,38) or by disuse (1,22) of the lumbar muscles than by the lumbar pain itself. So age 
differences could lead to misinterpretation of results concerning fat infiltration in lumbar muscles, 
therefore age should be taken into account as a confounding factor when investigating fat content. 
Both studies investigating fat content in RLBP in remission reported no macroscopic fat depositions in 
RLBP compared to healthy controls, speculating fat content was not reduced or was restored during 
the remission period (29,32). D’hooge et al (32) on the other hand also reported an increased muscle 
fat index (which reflects increased relative amounts of intramuscular lipids) in lean muscle tissue in the 
absence of alterations in muscle size or macroscopic fat infiltration. These results mainly presume that 
the quality of the muscle structure might be decreased during remission periods, contributing to 
recurrence of LBP, rather than muscle size being decreased. A decrease in CSA associated with an 
increase in fat infiltration in the multifidus in CLBP patients compared to healthy subjects, implies an 
increased infiltration of non-contractile material in lumbar muscles (8). As a consequence, lumbar 
muscle quality drops in LBP without visual changes in absolute muscle size. Studies incapable of finding 
differences in CSA might be masking a reduction in relative muscle size. Results in studies only 
measuring CSA without paying attention to fat infiltration, need careful interpretation, especially when 
confounders like age and BMI are not taken into account.  
No studies in this review reported on fat infiltration in non-specific ALBP. If the fat content is supposed 
to be a result of aging, long lasting inactivity, or long lasting LBP, it is not expected in persons 
experiencing ALBP, although a relation with fat infiltration was discovered by Mcloughlin et al (25). 
Longitudinal research could further unravel the relationship (cause or consequence) between fat 
infiltration and the etiology of LBP. 
According to fiber type characteristics, this review could not establish changes in non-specific CLBP. 
Crossman et al (17) found similar results regarding ranges of type I and II fiber dimension and 
distributions in healthy persons compared to CLBP, suggesting no abnormalities in paraspinal muscle 
fibers in CLBP symptom generation. However the review of Mannion (16) suggests the degree of 
abnormalities in musculature most likely depends on age, duration of symptoms, and physical 
(in)activity prior and after the onset of LBP. Crossman et al (17) matched both groups for age, but no 
information on physical activity was mentioned. D’hooge et al (39) on the other hand, found lower T2-
rest values for multifidus, but not for erector spinae, in non-specific RLBP in remission. These authors 
suggest a higher proportion of glycolytic fibers (type II) in multifidus muscles, which might lead to a 
reduced capability of the multifidus in stabilizing the spine because of fatigue. Few studies concerning 
fiber type characteristics in lumbar muscles of LBP patients are available. Based on the solitary study 
of Crossman et al (17), a sound conclusion on fiber characteristics in non-specific CLBP cannot be made. 
Hence, future studies examining fiber size, type and composition of the lumbar muscles in all non-
specific LBP populations are warranted. 
4.2. Study Limitations and suggestions for further research 
The current evidence should be interpreted in light of the study limitations of the individual studies. 
First of all, some studies did not clearly define the included patient population (CLBP, RLBP or ALBP) or 
included a mixture of LBP patients. This made it difficult to incorporate the results of these studies 
when drawing conclusions for specific types of non-specific LBP (28,33–35). Besides this, a lot of 
different definitions were applied to identify RLBP and CLBP, which might influence results and hamper 
conclusions. Future studies should define their study population sufficiently, and moreover, a global 
consensus regarding the definition for specific groups of non-specific LBP is wanted.  
Lack of clarity about LBP to be unilateral or bilateral was also common in the included studies, however 
the side of complaints might play an important role regarding structural changes. In addition, some 
studies pooled outcomes of muscles from the left and right body side when no significant differences 
were found between both. In other studies, left and right were examined separately, even when 
nothing was mentioned about side differences or the affected side, which might lead to improper 
conclusions. According to Bierry et al (36) atrophy ought to be concentrated ipsilateral to the side of 
pain and at the level of pain. These results were also found by Hides et al, in ALBP (3) and in cricketers 
with general LBP (35). Also in CLBP, studies have shown rather local muscle changes (1,4,31). Other 
studies conversely provide evidence of more generalized changes in LBP populations (26,32,33,35). 
The review of Fortin and Macedo (5) revealed significant differences in symptomatic and asymptomatic 
sides in CLBP patients. Generally one would expect complaints in persons with CLBP to be more 
widespread and generalized in the lumbar muscles, whereas in ALBP symptoms are more focal. Hence, 
it is recommended that when patients experience unilateral complaints each side should be examined 
separately. In case of bilateral complaints, mean values of the right and left side should be averaged 
only in case of no significant side differences, which should also be reported.  
Furthermore the position in which subjects were examined differed among studies. Some evaluations 
took place in upright position, others with the subjects in prone or supine position. When in supine 
position, which is often the case when MRI is applied, muscles might experience small amounts of 
flattening because of the body weight. In upright position, the human body needs a minimum of 
muscular activity to stabilize the spine, which might affect the lumbar muscle size. Thus when 
comparing results from upright position with results from prone or supine position the difference in 
position could lead to bias. 
The different applied techniques (USI, CT and MRI) to investigate CSA and fat infiltration in this review 
might also have an influence upon the conclusions which were made. Like Mengiardi (10) put forward, 
magnetic resonance spectroscopy could reveal increased metabolic fat content, whereas conventional 
MRI using a semi quantitative visual grading system could not reveal these differences. CT-scans on 
the other hand, have a poor ability to differentiate soft tissue types and therefore might not be 
favorable to investigate muscle characteristics (8) or the applied MRI-sequence might not have been 
sensitive enough for fat evaluation in lumbar muscles (40). Besides these issues, most applied 
techniques for calculating fat content, rely on qualitative visual analysis which is liable to interpretation 
and image windowing. Other more recent techniques such as Opposed-Phase Magnetic Resonance 
(26), Dixon (41,42), and proto magnetic resonance spectroscopy (10) are able to quantify fat fraction 
in tissues and are less sensitive for detection bias. Also blinding of the assessor for subject status is key 
to avoid the assessor of being prejudiced and influential for the results. However, not all studies took 
this methodological issue into account.  
A last limitation can be found in the designs of the included studies. A cross-sectional design, restrains 
us from drawing definite conclusions regarding temporal patterns and causality between structural 
characteristics and LBP. We are not aware of prospective studies investigating structural muscle 
changes in non-symptomatic LBP patients, although these studies are warranted to gain more insight 
into the etiology of LBP and the related muscle structure alterations.  
 
5. CONCLUSION 
 
This systematic review provided evidence for the presence of macroscopic changes in lumbar muscle 
structures of CLBP. There is moderate evidence for atrophy of the multifidus muscle in CLBP patients, 
whereas atrophy of the paraspinal and erector spinae muscles in CLBP is less clear. Especially a loss of 
muscle size is seen in the lower lumbar levels, but not in the more cranially lumbar levels. An increase 
in fat infiltration in CLBP, on the other hand, seems more likely to be due to age or by disuse of lumbar 
muscles, rather than to LBP itself. Thus far, microscopic changes do not seem to affect the lumbar 
muscles of CLBP, as patients have similar fiber characteristics as healthy people. No clear signs of 
macro- or microstructural changes of the lumbar musculature were established in RLBP and ALBP, but 
more research is warranted to confirm these conclusions. 
APPENDIX  
Study (year) 
Characteristics patient 
group;  
control group 
Definition 
patient group 
Evaluation 
technique 
Outcome 
measure  
Test site & 
position subjects 
Results 
Chan  
et al (2012) 
- CLBP (12m; 22-52y; 
mean age 36.6±2.9)  
- HC (12m;21-34y; 
mean age 25.2±1.1) 
CLBP: ODI ≥20% US - CSA 
- Fat area 
- MF  
 
At L4, bilateral 
 
In prone position; 25°: 
forward stooping; 45° 
forward stooping; 
upright standing 
CSA 
- CLBP < HC in all positions (p<0.001) 
 
Fat area 
- CLBP > HC (p<0.001) 
Crossman  
et al (2004) 
- CLBP (35m; 18-55y; 
mean age 41±11) 
- HC (32m; 18-55y; 
mean age 38±10) 
CLBP: 
continuous or 
recurrent LBP 
>6 months 
Muscle 
biopsy  
Type I 
fiber 
content 
- PS No histomorphometric group differences:  
- Fiber types by percent number: CLBP = HC 
- Mean fiber narrow diameter: CLBP = HC 
- Relative area occupied by type I: CLBP = HC 
- Fiber size type I or type II: CLBP = HC 
- Admixture of type I & type II fibers in CLBP & HC 
- Size type I fibers  > type II in CLBP & HC; in CLBP 
(p<0.01) 
Danneels  
et al (2000) 
- CLBP (17m; 15f; 25-
55y; mean age 
36.91±10.26) 
- HC (13m; 10f; 25-55y; 
mean age 37.34±9.78) 
CLBP: ≥1 year CT - CSA 
- Fat 
deposits 
- PS (MF, longissimus & 
iliocostalis) 
- Isolated MF 
- Isolated ES (longissimus 
& iliocostalis) 
 
At upper endplate L3; 
upper & lower endplate 
L4, bilateral 
 
In prone position 
CSA PS 
- CLBP = HC at upper L3 & L4, with and without fat 
(p>0.05) 
- CLBP < HC at lower L4 (with fat p=0.048; without 
fat p=0.036) 
CSA MF 
- CLBP = HC at upper L3 & L4, with and without fat: 
(p>0.05) 
- CLBP < HC at lower L4 (with fat p=0.009; without 
fat p=0.012) 
CSA ES 
- CLBP = HC at upper L3 p=0.79; upper L4 p=0.707; 
Lower L4 p=0.25 
 
Fat:  
- no group differences (p>0.05) 
D’hooge  
et al (2012) 
- RLBP, unilateral, in 
remission (6m; 7f; 
mean age 
32.09±11.52) 
- HC (6m; 7f; mean age 
32.09±11.52) 
RLBP: history of 
≥2 previous 
episodes (≥24h 
pain) of LBP 
followed by ≥1 
month pain 
free; onset >6 
months; 
interference in 
ADL 
MRI - Total CSA 
- Lean 
muscle 
CSA 
- Fat CSA 
- MFI 
- MF 
- ES 
 
At upper endplate L3; 
upper & lower endplate 
L4, bilateral 
 
In supine position 
Total CSA MF & ES 
- RLBP = HC at any level (MF p=0.337; ES p=0.627) 
Lean muscle CSA MF & ES 
- RLBP = HC at any level (MF p=0.276; ES p=0.752) 
 
Fat CSA MF & ES 
- RLBP = HC (p=0.640) 
MFI MF & ES 
- RLBP > HC bilaterally (at upper endplate L4 
p=0.014; at lower endplate L4 p=0.017) 
- LBP = HC at upper endplate L3 (p=0.380) 
Gildea  
et al (2013) 
- LBP (13) 
- LBP + hip (10) 
- HC (8) 
- TOTAL (31; 14m; 17f; 
mean age 23.7±3.6) 
LBP(+ hip): pain 
in lower back 
(+buttock or 
hip) 
MRI - CSA 
- Fat 
content 
- MF  
- ES  
 
At L2-L5 (at level of the 
intervertrebral discs), 
bilateral 
 
In supine position 
CSA MF 
- Group differences (p=0.049) 
- LBP < HC at L3, L4, L5 on both sides (p<0.024) 
- LBP+ hip < HC at L3 on both sides & at L4 on right 
side (p<0.027) 
- No differences at L2 (p>0.44) 
CSA ES 
- No differences (p=0.10) 
 
Fat MF 
- <10% fat content in all groups 
Fat ES 
- Not evident  
Hides  
et al (1994) 
- ALBP (16m; 10f; 17-
46y; mean age m 
29.2; mean age f 33.6) 
- HC (21m; 30f; 19-32 y; 
mean age m 25.0; 
mean age f 25.3) 
ALBP: suffering 
first episode of 
LBP, unilateral 
US CSA MF 
 
At L2-L5/L2-S1 (ALBP); 
at L4 (HC), bilateral 
 
In prone position 
- HC between side differences (at L4) < ALBP (at all 
levels) (p<0.001) 
- ALBP: difference in atrophy between symptomatic 
& other levels (p<0.05)  
- ALBP: No atrophy below symptomatic level 
- HC: No difference in levels (p>0.05) 
Hides  
et al (2008a) 
- CLBP (23m; 27f; mean 
age 46.8±13.2) 
- HC (27m; 13f; mean 
age 28.4±5.7) 
CLBP 
(central/bilater
al & unilateral): 
pain at T12-
gluteal fold; >3 
months 
US CSA MF 
 
At L2-L5, bilateral 
 
In prone position 
- CLBP < HC (p=0.001) 
- Asymmetry unilateral CLBP > HC (L4 p=0.003; L5 
p=0.001) 
- Asymmetry unilateral CLBP > bilateral CLBP (L4 
p=0.004; L5 p=0.016) 
- At L2-L3 no differences 
Hides  
et al (2008b) 
- LBP, unilateral (10m; 
mean age 21.9±2.5) 
- HC (16m; mean age 
21.4±2.0) 
LBP: current or 
previous LBP 
interfering with 
sports 
performance 
US CSA MF  
 
At L2-L5, bilateral  
 
In prone position 
LBP < HC at both sides, at all levels 
 
Hultman  
et al (1993) 
- CLBP (20m; mean age 
49±6) 
- ILBP(35m; mean age 
50±3) 
- HC (18m; mean age 
HC 50±3) 
- TOTAL (148; 49-51y) 
- ILBP: ≥1 
episodes; ≥2 
months pain 
free episode 
- CLBP: ≥3 years; 
sick leave ≥ 3 
months in 
previous year 
CT - CSA 
- RD 
ES 
 
At L3,  bilateral 
 
In supine position 
CSA 
- Mean values CLBP < HC < ILBP 
- CLBP < ILBP (p=0.037) 
- CLBP = HC (p>0.05) 
- ILBP = HC (p>0.05) 
 
RD 
- Mean values CLBP < HC < ILBP  
- CLBP < ILBP (p=0.000) 
- CLBP < HC (p<0.05) 
- ILBP = HC (p>0.05) 
Kamaz  
et al (2007) 
- CLBP (36f; 30-58y; 
mean age 43.2±6.9) 
- HC (34f; 31-61y; mean 
age 44.4±7.7) 
CLBP: ≥1 year CT CSA - PS (MF, iliocostalis, 
longissimus) 
- Isolated MF  
 
At upper & lower 
endplate L4  
 
In prone position 
CSA PS 
- CLBP = HC at upper endplate L4 (p=0.137) 
- CLBP < HC at lower endplate L4 (p=0.010) 
CSA MF 
- CLBP < HC at upper endplate L4 (p=0.002) 
- CLBP < HC at lower endplate L4 (p=0.001) 
Lee  
et al (2006) 
- CLBP (16m; 34-47y; 
mean age 39.9) 
- HC (19m; 35-47y; 
mean 41.7) 
CLBP: ≥1 year US CSA  
 
MF  
 
At L4 & L5, bilateral 
 
In upright standing; 25° 
forward stooping; 45° 
forward stooping; prone 
position 
- LBP < HC at L4 & L5 (generally) 
- LBP < HC at L4 upright (p<0.05) 
- Asymmetry in CLBP at L4, not in HC 
- No difference at L5 in standing 
- No difference at L4 or L5 in prone, 25° or 45° 
McGregor  
et al (2002) 
- PREVIOUS LBP (13; 
mean age 23.2±5.3) 
- CURRENT LBP (5; 
mean age 22.0±1.8) 
- PREVIOUS: 
time off 
training 
MRI CSA - ES  
- MF 
 
CSA MF 
- Previous/current LBP > HC (most prominent in 
previous LBP)  (p<0.0001) 
- Previous LBP > current LBP (p<0.001) 
Table 1: Evidence table. (ADL = activities of daily living; ALBP = acute low back pain; CLBP = chronic low back pain; CSA = cross-sectional area; ES = erector spinae; f = females; HC = healthy 
controls; ILBP =  intermittend low back pain; m = males; MFI = muscle fat index; LBP = low back pain; MF = multifidus muscle ; MRI = Magnetic resonance imaging; PS = Paraspinal; RD = 
radiological density; RLBP = recurrent low back pain; RUSI = rehabilitive ultrasound imaging; US = ultrasound imaging; VS =  versus; y = years) 
  
- HC (4; mean age 
21.0±2.2)  
- TOTAL (22; mean 
age22.6±4.3) 
- CURRENT: 
preventing full 
training 
At L4-L5 & L5-S1 disc 
interspace, bilateral 
 
In rowing position 
CSA ES  
- Previous/current LBP > HC at L4-L5 (p<0.001) 
- Previous LBP = current LBP at L4-L5 (p>0.05) 
- Previous/current LBP < HC at L5-S1 (tendency) 
- Previous LBP < HC L5-S1 (p<0.05) 
Scott  
et al (2014) 
- CLBP (20; 14m; 6f; 
mean age 31.9±7.2) 
- HC (20; 14m; 6f; 
mean age 31.3±7.6) 
CLBP: ≥3 
months 
RUSI CSA  MF 
 
At L5 
 
In prone position; sitting 
on stable surface; sitting 
on labile surface 
- CLBP = HC  at all positions 
- Asymmetry CLBP = HC 
 
Wallwork  
et al (2009) 
- CLBP (17; 8m; 9 f; 18-
60y; mean age 
41.9±13.7) 
- HC (17; 8m; 9 f; 18-
45y; mean age 
33.9±11.2) 
CLBP: ≥3 
months 
US CSA MF  
 
At L2-L5 
 
In prone position 
- CLBP < HC at L5 (P=0.001) 
- CLBP > HC at L2 (P=0.047) 
- Asymmetry CLBP = HC (P>0.05) 
Yarjanian  
et al (2013) 
- LBP (10; 4m, 6f; mean 
age 62.00±8.58) 
- HC (10; 5m; 5f; mean 
age 65.00±6.72) 
LBP: non-
radiating LBP  
without 
stenosis 
MRI Functional 
CSA 
(muscle 
isolated 
from fat) 
PS  
 
At L5-S1 disc level, 
bilateral 
LBP = HC (p=0.80) 
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ABSTRACT 
Background context 
Heterogeneity exists within the low back pain population. Some patients recover after every pain 
episode, whereas others suffer daily from LBP complaints. Until now, studies rarely make a distinction 
between recurrent low back pain (RLBP) and chronic low back pain (CLBP), although both are 
characterized by a different clinical picture. Clinical experiences also indicate that heterogeneity exists 
within the CLBP population. Muscle degeneration, like atrophy, fat infiltration, alterations in muscle 
fiber type and altered muscle activity, compromises proper biomechanics and motion of the spinal 
units in low back pain (LBP) patients. The amount of alterations in muscle structure and muscle 
function of the paraspinal muscles, might be related to the recurrence or chronicity of LBP. 
Purpose 
The aim of this experimental study is to evaluate differences in muscle structure (cross-sectional area 
and lean muscle fat index) and muscle activity of the multifidus (MF) and erector spinae (ES) during 
trunk extension, in patients with RLBP, non-continuous CLBP and continuous CLBP. 
Study design and setting 
This cross-sectional study took place in the University hospital of Ghent, Belgium. Muscle structure 
characteristics and muscle activity were assessed by magnetic resonance imaging (MRI). 
Patient sample 
Fifty five adults with non-specific low back pain (24 RLBP in remission, 15 non-continuous CLBP, 16 
continuous CLBP) participated in this study. 
Outcome measures 
Total cross-sectional area, muscle cross-sectional area, fat cross-sectional area, lean muscle fat index, 
T2-rest and T2-shift  were assessed. 
Methods 
A T1-weighted Dixon MRI scan was used to evaluate spinal muscle cross-sectional area and fat 
infiltration in the lumbar MF and ES. Muscle functional MRI was used to evaluate the muscle activity 
of the lumbar MF and ES during a lumbar extension exercise. Before and after the exercise, a pain 
assessment was performed. This study was supported by grants from the Special Research Fund of 
Ghent University (DEF12/AOP/022) without potential conflict of interest-associated biases in the text 
of the paper. 
Results 
Fat cross-sectional area and lean muscle fat index was significantly higher in MF and ES in continuous 
CLBP compared to non-continuous CLBP and RLBP (p<0.05). No differences between groups were 
found for total cross-sectional area and muscle cross-sectional area in MF or ES (p>0.05). Also no 
significant differences between groups for T2-rest were established. T2-shift, however, was 
significantly lower in MF and ES in RLBP compared to respectively non-continuous CLBP and continuous 
CLBP (p<0.05). 
Conclusion 
These results indicate a higher amount of fat infiltration in the lumbar muscles, in the absence of clear 
atrophy, in continuous CLBP compared to RLBP. A lower metabolic activity of the lumbar muscles was 
seen in RLBP replicating a relative lower intensity in contractions performed by the lumbar muscles in 
RLBP compared to non-continuous and continuous CLBP. In conclusion, RLBP differ from continuous 
CLBP for both muscle structure and muscle function, whereas non-continuous CLBP seem comparable 
with RLBP for lumbar muscle structure and with continuous CLBP for lumbar muscle function. These 
results underline the differences in muscle structure and muscle function between different LBP 
populations. 
Key words 
Low Back Pain, Magnetic Resonance Imaging, trunk muscles, muscle atrophy, fat infiltration, muscle 
activity. 
1. INTRODUCTION 
People with a history of low back pain (LBP) are known to have increased risk for recurrence [1,2], but 
little is known why some LBP patients transit to chronicity and others recover after every episode. 
Degeneration in muscle structure and alteration in muscle function of the lumbar erector spinae and 
multifidus might play a role in this feature. The paraspinal muscles play a crucial role in the dynamic 
control of the lumbar spine. Both the multifidus (MF) and erector spinae (ES) muscles are important in 
controlling segmental motion, by generating a compressional force on the lumbar spine and producing 
a lumbar extension movement when contracting bilaterally [3].  
Degeneration of these lumbar muscles compromises proper biomechanics and motion of the spinal 
units [4]. Muscle degeneration is characterized by a decrease in cross-sectional area (CSA) and an 
increase in fat infiltration [5,6]. The influence of pain on degeneration of the lumbar muscles is 
frequently investigated in LBP patients compared to healthy controls (HC). Remarkably, results in 
patients with chronic low back pain (CLBP) seem to differ from patients with recurrent low back pain 
(RLBP).  
In non-specific CLBP, studies established that MF muscle size is decreased [6–10], whereas CSA of ES 
is not altered [6,11]. In non-specific RLBP however, no decrease in CSA is found in the lumbar spinal 
muscles [11,12], suggesting CSA is either not reduced during a pain flare or recovery of muscle size 
occurred during pain remission.  
Results on fat infiltration in non-specific CLBP remain conflicting: one study found increased fat 
infiltration in non-specific CLBP in MF [8] or ES [11], whereas others could not find increased fat 
infiltration in any paraspinal muscles in CLBP [6]. In non-specific unilateral RLBP patients in remission, 
no fat infiltration is established. Notable is however the increased muscle fat index (MFI), in the 
absence of alterations in muscle size or macroscopic fat infiltration. This enhanced MFI reflects an 
increased relative amount of intramuscular lipids in lean muscle tissue and resembles therefore 
deterioration of muscle quality in RLBP in remission [12]. 
Among studies, a lot of different evaluation techniques are used to assess muscle structure 
characteristics: computed tomography [6,9,11], ultra sound imaging [7,8,10,13] or magnetic resonance 
imaging (MRI) [12,14] are frequently used techniques. Recent interest arises in chemical shift-based 
water-fat separation methods, like the multi-point DIXON fat mapping MRI technique. This method 
uses the phase difference between water and fat to separate these two components. The result is a 
quantitative measurement of the signal fraction of water and fat. This way, the DIXON method 
produces an accurate estimation of fat fraction and is shown to be a useful quantitative evaluation 
technique for fatty degeneration in patients with lumbar disc pathology [15–17]. 
Besides degeneration in muscle structures, the presence of LBP also affects muscle function of the 
lumbar muscles [18,19]. A lot of research on muscle function has been done by surface [20–25] and 
fine-wire [20,23,26–28] electromyography, measuring the myoelectric activity. An alternative way to 
assess muscle function is the muscle functional MRI (mfMRI) technique which evaluates exercise-
related metabolic muscle activity. In this technique, the amount of metabolic activity in muscle tissue 
before and after exercise is recorded and the change in signal intensities, due to the relaxation time of 
tissue water following exercise, is measured. This non-invasive technique is a reliable and valid tool for 
resting and exercise measurements in deep and superficial muscles [21,29–33]. Both techniques show 
a linear association for the lumbar paraspinal muscles [21].  
In RLBP, contradictory results concerning muscle function in remission of pain are reported. Some 
studies found decreased muscle activity in MF during pain remission periods [20,28], whereas others 
found the opposite [34]. Besides, after experimental pain induction, a decrease in muscle activity is 
seen, indicating an inhibitory muscle response due to pain [35,36]. Apparently, after pain onset, a 
combination of reflex inhibition and disturbance in coordination of trunk muscles causes changes in 
the MF [6,37] and despite a state of remission, the muscle function of RLBP patients remains altered. 
Patients with CLBP examined by electromyography exhibit higher global trunk muscle activity 
compared to asymptomatic subjects as a compensatory strategy to enhance the reduced spinal 
stability [38]. This increased muscle activity results in increased paraspinal muscle fatiguability [39]. As 
far as we know, few research concerning metabolic activity was performed in CLBP. The only study 
evaluating muscle activity by mfMRI in CLBP compared to HC, found an increased muscle activity in 
CLBP after surgery [40]. No previous research investigated differences in metabolic activity between 
RLBP and CLBP. 
In conclusion, results concerning muscle structure are scarce and inconsistent in RLBP. Also research 
concerning muscle activity by mfMRI remains ambiguous in RLBP and is, as far as we know, non-
existent in non-specific CLBP. In most studies, a (sub)group of LBP was compared with healthy controls. 
Little research is however done on the differences in lumbar muscle structure and muscle activity 
between RLBP and CLBP, although each subgroup of LBP patients is marked by its own characteristics. 
Moreover, clinical experience indicates heterogeneity within the CLBP population: some patients 
suffer daily from LBP, whereas others have pain days alternated with days of being pain free. Possibly, 
the amount of alterations in muscle structure and muscle function of the paraspinal muscles is related 
to the degree of recurrence or chronicity of LBP.  
Therefore, this experimental MRI-study evaluates the differences in muscle structure (CSA and fat 
infiltration), muscle quality (MFI) and muscle activity during trunk extension in the lumbar MF and ES 
between RLBP in remission, non-continuous CLBP and continuous CLBP. In this way, the influence of 
the continuation of pain complaints on muscle structure and muscle function can be examined. We 
hypothesize more fat infiltration, a smaller CSA and decreased muscle quality in continuous CLBP 
patients, compared to non-continuous CLBP and RLBP. We also hypothesize that muscle activity in 
continuous CLBP is dysfunctional compared to RLBP and non-continuous CLBP. 
 
 
2. METHODS 
 
a. Participants 
All subjects were recruited through advertisement in the University hospital of Ghent and through 
social media. Males and females between 18 and 65 years old with non-specific LBP were eligible for 
the study. Patients with neurological, respiratory, circulatory, continuous orthopaedic diseases or 
pregnancy in the previous year were excluded. Also subjects using antidepressants or analgesics 
(except for NSAID’s or paracetamol) taken two weeks prior to the testing, were excluded. Patients who 
underwent cognitive exercise therapy were also excluded from this study. 
To be included in the RLBP group, subjects are characterized by pain episodes alternated by pain free 
periods. According to the definition of a LBP episode, launched by De Vet et al., an episode of LBP is 
defined as a pain flare of at least 24 hours, followed by a pain free episode of at least 1 month [41]. 
Because this definition is not based on quantitative evidence, concomitant parameters of LBP 
recurrence were added: a pain flair is characterized by an increase of at least 2 on a NRS for pain and/or 
at least 5 on the Roland Morris Disability Questionnaire [42] and a pain free episode is characterized 
by a 0/10 on an NRS for pain and/or a score of less than 2 on the Roland Morris Disability Questionnaire 
[43]. The Roland Morris Disability Questionnaire measures the amount of disability for daily activities 
due to LBP. The scale ranges from 0 (no disability) to 24 (severe disability). Subjects in the RLBP group 
suffered from non-specific recurrent LBP during at least 6 months, with a frequency of at least 2 
episodes in the past year [44]. In addition, subjects in the RLBP group are in a state of remission. 
Conform the definition of CLBP, subjects in the CLBP group are characterized by LBP complaints for at 
least 3 months [45]. During the anamnesis, prior to the acceptance for participation in this study, the 
researchers detected 2 major groups in this CLBP population: a group suffering daily from LBP 
complaints and a group characterized by 3 to 4 pain days per week. The CLBP group was therefore 
subdivided into a group with non-continuous CLBP (3 to 4 pain days a week) and continuous CLBP (7 
pain days a week). All in- and exclusion criteria can be found in table 1.  
On the day of testing all subjects were asked to refrain from alcohol, nicotine, caffeine and all 
medication (including NSAID’s and paracetamol). Subjects were also instructed not to perform 
exhausting physical activities the day before. All subjects were provided with MRI-safety instruction 
and gave written informed consent prior to participation. The examinations took place in the University 
hospital of Ghent between September 2013 and November 2014. This cross-sectional study was part 
of a larger study, which was approved by the local ethical committee (EC UZ 22012/791).  
 
GROUP SPECIFIC INCLUSION CRITERIA 
GENERAL 
INCLUSION 
CRITERIA 
GENERAL EXCLUSION 
CRITERIA 
RLBP 
- in remission 
- ≥6 months 
- a frequency of ≥2 episodes in the past 
year  
- a pain flare of ≥24 hours[41], 
characterized by an increase of ≥2 on a 
NRS and/or ≥5 on the Roland Morris 
Disability Questionnaire 
- followed by a pain free episode of ≥1 
month, characterized by a 0/10 on an 
NRS and/or <2 on the Roland Morris 
Disability Questionnaire 
- non-specific 
- males and 
females 
- 18-65 years old 
- ≥1 years post-
natal 
- use of antidepressants or 
analgesics (except for 
NSAID’s or paracetamol), 
taken two weeks prior to 
the testing 
- neurological, respiratory, 
circulatory or severe 
orthopaedic diseases 
- pregnancy 
- cognitive exercise therapy 
Non-
continuous 
CLBP 
- ≥3 months 
- 3 to 4 pain days a week 
Continuous 
CLBP 
- ≥3 months 
- 7 pain days a week 
Table 1: In- and exclusion criteria of the study 
 
b. Procedure 
A 3-Tesla Siemens Trio-Tim whole-body MRI system (Siemens AG ®, Erlangen Germany) was used to 
acquire all T1-weighted and T2-weighted images. First, a T1-weighted Dixon scan was used to evaluate 
spinal muscle CSA, fat infiltration and MFI. Afterwards, mfMRI was used to evaluate the muscle activity 
of the lumbar MF and ES. For the T2-weighted mfMRI protocol, an image after 20’ of rest in a 
comfortable chair (T2-rest) and an image immediately after exercise (T2-exercise) were taken. Before 
and after the exercise, a pain assessment was performed. After the exercise, also the rate of perceived 
exhaustion was examined.  
 
c. Exercise protocol 
A static-dynamic, standardized, low-load lumbar extension exercise was performed to activate muscle 
activity of the MF and ES muscles [32,35]. Subjects were installed in prone position on a variable angle 
chair, which was positioned at 45° of trunk flexion. The hands of the subject were placed on the 
ipsilateral shoulders and the legs were strapped to the chair. Subjects had to raise the upper body from 
the start position in 2 seconds, hold it for 5 seconds at the horizontal position and again lower the 
upper body to the start position in 2 seconds. Tactile feedback was used to adjust the performance. To 
ensure appropriate timing, a metronome was used (60 beats/minute). Exercise volume and load were 
set at 10 repetitions of 40% of the subjects’ personal one repetitions maximum (1RM) (figure 1). The 
individual 1RM was indirectly determined from the maximum amount of trunk extensions performed 
with their own upper body weight, which was assessed on a separate day 3-10 days before. The Holten 
diagram was used to calculate the exercise weight corresponding to the personal 40% of 1RM. If this 
exercise weight was lower compared to the subject’s trunk weight, a load-pulley system assisted in 
performing the trunk extensions [21,31]. 
 
 
 
Figure 1 Static-dynamic extension exercise at 40% of 1 RM 
 
d. Assessment of pain and exhaustion  
Before the exercise, subjects were asked to rate their current pain and expected pain after the exercise 
on a numeric rating scale for pain (NRS: ‘0’=no pain, ‘10’=the worst pain imaginable). After the exercise, 
subjects were asked again to rate their current pain, the actual amount of pain during exercise and the 
perceived fatigue/exertion during exercise (BORG: scale to 20)  [46,47]. 
 
e. Dixon MRI 
For the MRI-scan, patients were installed supine on the MRI table, knees supported by a cushion 
making the hips flexed (30°). A flexible 6-element body-matrix coil was centered ventrally at L4, 
covering the complete lumbar region. A standard phased-array spine coil dorsally acted as a receiver 
coil [12]. A neck coil was installed to standardize the patients position (both shoulders positioned solid 
against the coil), but was not operational.  
On a sagittal localizing scan, a slap group of 36 slices, (3mm slice thickness and 22.2% oversampling) 
was positioned at the upper endplate of L4. Measurement parameters for this two-point DIXON 
fat/water separation were: 320mm FOV read, 6.59ms TR, 2.45ms TE1, 3.675ms TE2 with 5.01s 
acquisition time and a 0.7x0.7matrix. Signal intensities of the MRI-data were calculated in the Siemens 
environment, blind to the participant’s LBP status.  
The DIXON-scan resulted into a fat-image and a water image. To estimate the CSA of the total MF and 
ES (total CSA), the regions of interest (ROI) of each separate muscle were drawn on the fat images 
(figure 2A). MF and ES were bilaterally outlined on 2 slices at the height of L4. The total CSA of each 
muscle was calculated as the number of voxels in the respective region of interest, multiplied by voxel 
size. A mean value of both slices was calculated respectively for right and left ES and MF. The signal 
intensity for fat (SIfat) and the signal intensity for water (SIwater) of both the total MF and ES were 
also obtained on these regions of interests.  
The CSA of lean muscle tissue (muscle CSA) was calculated by the formula: “total CSA*(1-total MFI)” 
[48]. To estimate total MFI, the following formula was applied: “SIfat*100/(SIfat + SIwater)” [17,49].  
Muscle CSA subtracted from total CSA resulted in the CSA of fat tissue in the spinal muscles (fat CSA). 
To estimate an indication of the amount of fat in lean muscle tissue (lean MFI), the fat fraction in 
homogenous muscle tissue was estimated (Figure 2B). Therefore, the procedure above was repeated 
but in a homogenous muscle region instead of the total muscle region.  
 
 Figure 2A and 2B. Illustration of a DIXON fat and water image. 2A illustrates the ROI to define total muscle CSA and the 
belonging fat index. 2B illustrates the ROI to define lean muscle fat index. 
 
 
f. Muscle functional MRI 
On a sagittal localizing scan, 3 transversal slices were positioned equal with the upper endplate of L3, 
upper endplate of L4 and lower endplate of L4. A spin-echo multi-contrast sequence (SE_MC) was used 
for the acquisition of T2-weighted images. The following parameters were applied: repetition time (TR) 
1000ms; echo train of 16 echoes ranging from 10 to 162ms; acquisition matrix 256*176mm²; field of 
view (FOV) 340 mm; voxel size 1.3*1.3*5.0 mm³; scan-time 5min52s. The T2-weighted images were 
obtained before (T2-rest) and immediately after exercise (T2-exercise).  
The MRI images were converted into T2-maps for calculation of the mean transverse relaxation times 
of the muscle tissue within the selected ROI using the T2-Processor software (copyright P. Vandemaele, 
Eng., GIFMI UZ Gent). A T2-value per voxel (in ms) was calculated out of 15 echoes. Subsequently, 
regions of interest were manually traced on the T2-maps bilaterally for MF, ES, avoiding visual fat, 
connective tissue, or blood vessels (figure 3). Finally, for each ROI, the mean T2-value was calculated. 
The researcher processing the data was blinded to the participant’s LBP status.  
The change recorded between T2-rest and T2-exercise is referred to as the T2-shift, which relates to 
the amount of performed activity [33]. In order to estimate the T2-shift, the formula of “((T2-exercise 
-T2rest)/T2-rest)*100” was used. 
Besides information on muscle function, T2-rest reflects the molecular proton content of tissue by 
quantitative measurement of the transverse relaxation time at T2-rest and thus gives information 
about muscle characteristics [31].  
 Figure 3. Illustration of an T2-weighted axial MRI image at the level of upper L4 endplate demonstrating regions of interest 
of MF and ES. 
 
 
g. Statistical analysis 
First, the distribution of data was analyzed. If the data was observed to be not normally distributed, a 
transformation was applied in order to approximate normality. Data for which transformation offered 
no solace, non-parametric testing methods were applied. Subject characteristics (age, body mass 
index) were tested by Kruskal-Wallis. A Mann-Whitney U test was used for post-hoc pairwise 
comparison. Gender was tested by chi-square test.  
 Analysis for DIXON outcome 
To analyze group differences between total CSA, fat CSA, muscle CSA and lean MFI, an analysis of 
covariance (ANCOVA) was applied which included important covariants. The dependent variables in 
the analyses were total CSA, fat CSA, muscle CSA, and lean MFI, analyzed respectively for left and right 
MF and ES. The covariates in this model were body mass index and the logarithm of age, which were 
both mean centered. Prior to building the model, bivariate relations were depicted using a scatter plot. 
Only if a linear fit was deemed appropriate, the model was constructed. After building the model, 
homoscedasticity was analyzed by plotting the squared residual terms. In addition, normality of the 
error terms was analyzed together with the influence of a particular data point on the model (Cook’s 
Distance > 4/55). Each estimated model fulfilled these required assumptions. Post-hoc testing was 
done with the Tukey’s HSD test.  
 Analysis for mfMRI outcome (T2-rest and T2-shift) 
To address dependency between data, mixed model analyses was performed to analyze differences in 
T2-rest and T2-shift between LBP patients, with patients as a random factor. Model selection and 
model validation was based on statistical tests for parameter estimates, comparison of Akaike’s 
Information Criterion values and inspection of residual plots. These mixed models account for 
correlated measures by including a random intercept for “patients” and were adjusted for “group” 
(RLBP, non-continuous CLBP and continuous CLBP) and “vertebral level” (L4 lower endplate, L4 upper 
endplate and L3 upper endplate). Age and BMI were taken into account as covariates, but only age 
appeared influential on the outcome for T2-rest. Parameter estimation was performed by restricted 
maximum likelihood. Results were represented by muscle (MF or ES). After building the model, 
linearity, homoscedasticity, normality of the error terms was analyzed. Each estimated model fulfilled 
these required assumptions. 
Analysis of pain measurements 
To evaluate differences between groups for pain measurements (pain before exercise, pain during 
exercise, pain after exercise, expected pain after exercise and the rate of perceived exhaustion), one 
way ANOVA analysis were performed. Post-hoc testing was done with the Tukey’s HSD test. 
Analysis of correlations 
The relationship between structural and functional characteristics, pain measures and rate of 
perceived exhaustion was analyzed by the Pearson correlation tests.  
 
ANCOVA-models were built in R (statistical software, version 3.2.4; in R-studio, version 0.99.893). All 
other analysis were performed in SPSS (IBM SPSS statistics, version 23.0). A priori power calculations 
(By GPower) indicated 24 subjects in each group was needed to reach a power of 0.80. Statistical 
significance was set at p<0.050. 
 
 
  
3. RESULTS 
Demographics 
A total of 55 subjects (26 RLBP, 15 non-continuous CLBP, 16 continuous CLBP), between 20 and 64 
years of age, fulfilled the complete test protocol. In the RLBP group, 2 subjects reported being in a pain 
flare and were therefore excluded from the analysis. No significant difference in gender was seen 
between groups. The mean age was significantly higher in continuous CLBP compared to respectively 
RLBP and non-continuous CLBP (p=0.002; p=0.021). The body mass index was significantly higher in 
continuous CLBP compared to respectively RLBP and non-continuous CLBP (p=0.014; p=0.041). All 
descriptive information on the demographic variables and outcome measures can be found in table 2. 
Since there were no differences in left and right MF or ES for CSA or MFI and almost all participants 
suffered from central or bilateral LBP complaints, a mean value for left and right was used in all 
analyses. 
Muscle structure: cross-sectional area, fat infiltration, muscle quality and T2-rest 
Differences between groups were found for fat CSA in MF (p<0.001) and ES (p=0.003) and for MFI in 
MF (p<0.001) and ES (p<0.001). However, no significant differences between groups were found for 
total CSA in MF (p=0.417) or ES (p=0.395) or muscle CSA in MF (p=0.511) or ES (p=0.241). For T2-rest, 
a significant differences between groups was seen in MF (p=0.047) whereas a borderline significant 
difference was found in ES (p=0.052) when corrected for age. 
Fat CSA was significantly higher in continuous CLBP compared to respectively non-continuous CLBP 
and RLBP in MF (p<0.001; p<0.001) and ES (p=0.007; p=0.006). Also lean MFI was significantly higher 
in continuous CLBP compared to respectively non-continuous CLBP and RLBP in MF (p=0.006; p<0.001) 
and ES (p=0.001; p<0.001). No significant differences between groups were established post hoc. All 
parameter estimates can be found in table 3. 
 
Muscle function 
Differences between groups were found for T2-shift in MF (p=0.010) and ES (p=0.002).  
T2-shift was significantly lower in RLBP compared to respectively non-continuous CLBP and continuous 
CLBP in both MF (p=0.032; p=0.030) and ES (p=0.025; p=0.005). No differences between spine levels 
were seen (table 3). 
 RLBP (n=24) Non-continuous CLBP (n=15) Continuous CLBP (n=16) 
Demographic  
variables 
Age (years) 30.6 ± 9.8; [21 - 53]  33.9 ± 10.4; [20 - 54]  46.1 ± 14.5; [23 - 64]  
BMI (kg/m²) 22.8 ± 2.3; [18.6 - 28.8]  23.3 ± 1.6; [19.8 - 26.1]  25.0 ±3.1; [19.7 - 31.7] 
Gender 9m; 15f 7m; 8f 8m; 8f 
Muscle  
structure 
Total CSA MF (cm²) 5.92 ± 1.38; [4.20 – 8.98] 5.41 ± 1.15; [3.17 – 7.47] 5.98 ± 1.41; [3.54 – 8.14] 
Total CSA ES (cm²) 16.56 ± 3.90; [12.08 – 24.34] 14.98 ± 3.06; [8.57 – 21.44] 15.71 ± 3.10; [11.45 – 22.20] 
Fat CSA MF (cm²) 0.80 ± 0.27; [0.49 – 1.66]  0.77 ± 0.19; [0.49 – 1.13]  1.06 ± 0.26; [0.62 – 1.41]  
Fat CSA ES (cm²) 2.60 ± 0.79; [1.70 – 4.58]  2.31 ± 0.62; [1.14 – 3.51]  3.24 ± 1.01; [1.89 – 5.88]  
Muscle CSA MF (cm²) 5.12 ± 1.21; [3.41 – 7.45] 4.65 ± 1.08; [2.35 – 6.47] 4.92 ± 1.39; [2.76 – 6.80] 
Muscle CSA ES (cm²) 14.06 ± 3.46; [10.34 – 21.12] 12.67 ± 2.65; [6.64 – 17.93] 12.46 ± 2.83; [8.38 – 17.98] 
MFI MF (%) 7 ± 1; [6 - 10]  8 ± 2; [5 - 14]  10 ± 3; [6 - 17]  
MFI ES (%) 8 ± 2; [5 - 15]  9 ± 2; [6 - 13]  12 ± 4; [7 - 19]  
T2-rest MF 42829 ± 4294; [35014 - 60450] 40459 ± 4152; [31254.00 - 55746] 42116 ± 5685; [32127 - 63624] 
T2-rest ES 41427 ± 3159; [36166 - 52038] 39583 ± 2763; [31691 - 47460] 41925 ± 4998; [33447 -62330] 
Muscle  
function 
T2-shift MF 8 ± 9; [-12 - 34]  14 ± 11; [-3 - 39]  14 ± 9; [0 - 39]  
T2-shift ES 7 ± 8; [-15 - 30]  13 ± 12; [-1 - 55]  15 ± 10; [-9 - 38]  
Pain 
measurements 
Pain before exercise 0.091 ± 0.43 [0 - 2]  2.36 ± 2.02; [0 - 8] 2.41 ± 1.93; [0 - 7]  
Pain during exercise 1.68 ± 1.32; [0 - 5]  2.93 ± 2.06; [0 - 7] 3.13 ± 1.86; [0 - 8]  
Pain after exercise 1.14 ± 1.08; [0 - 3]  2.36 ± 1.60; [0 - 6]  3.44 ± 1.90; [0 - 8]  
Expected pain 2 ± 1.63; [0 - 6] 3.36 ± 2.24; [0 - 8] 3.25 ± 1.77; [1 - 8] 
RPE 9.27 ± 1.86; [7 - 13]  10 ± 1.47; [7 - 12] 10.94 ± 1.57; [8 - 13]  
Table 2: Descriptive details of the demographic variables and outcome measurements for pain measurements (expressed pain before exercise, during exercise and after exercise, the expected 
pain after exercise and the rate of perceived exhaustion), muscle structure (total cross-sectional are, fat cross-sectional area, muscle cross-sectional are, muscle fat index and T2-rest) and muscle 
function (T2-shift) of the multifidus and erector spinae muscle. (BMI=body mass index; CLBP=chronic low back pain; ES=erector spinae; f=females; m=males; MF=multifidus; n=number of; 
NRS=numeric rating scale; RLBP=recurrent low back pain; RPE=rate for perceived exhaustion). All values, except gender, are expressed by mean, standard deviation and range.  
 
 
Assessment of pain and exhaustion  
Differences between groups were found for pain before exercise (p<0.001), pain during exercise 
(p=0.024), pain after exercise (p<0.001) and the rate of perceived exhaustion (p=0.015). No significant 
difference between groups was found for “expected pain after exercise” (p=0.052). 
RLBP indicated significantly lower pain ratings compared to continuous CLBP before (p<0.001), during 
(p=0.035) and after exercise (p<0.001). Before exercise, RLBP also experienced significantly lower pain 
intensities compared to non-continuous CLBP (p<0.001). The rate of perceived exertion was 
significantly lower in RLBP compared to continuous CLBP (p=0.011) (table 3). 
 
Correlations  
Pain parameters 
In continuous CLBP, mainly the NRS-score after the exercise was positively correlated with T2-rest for 
MF and ES at the upper L4 and lower L4 level. The expected pain caused by the exercise in continuous 
CLBP was positively correlated with T2-shift in both MF and ES but only at the upper L3 level. The T2-
shift at upper L3 was also positively correlated with the NRS-score after exercise for MF but not for ES 
(table 4).  
Considering the complete population, a positive correlation was found between the MFI in MF and ES 
with the NRS-score after exercise. Also positive correlations between the T2-shift in MF and ES at the 
upper L3 level and respectively the NRS-score after exercise, the expected NRS-score and the rate of 
perceived exhausting were found (table 4).  
 
Structural and functional characteristics 
In the ES muscle of the total population, positive correlations between the T2-rest and fat CSA on the 
one hand and T2-rest and MFI on the other hand were revealed. Furthermore, a positive correlation 
was found between T2-shift and MFI in ES. To a lesser extent, some correlations in MF were found 
between MFI and T2-rest on the one hand and T2-shift on the other hand. Also a single positive 
correlation was found between the fat CSA and T2-rest in MF (table 5) 
 
 
 Δ continuous CLBP – non-continuous CLBP Δ RLBP – non-continuous CLBP Δ RLBP –continuous CLBP 
Estimates [CI] p-value Estimates [CI] p-value Estimates [CI] p-value 
 
Total CSA MF (cm²) 5.64 [-5.99 ; 17.27] P=0.475 5.12 [-5.36 ; 15.60] p=0.470 -0.52 [-11.01 ; 9.96] p=0.992 
Total CSA ES (cm²) 7.29 [-23.24 ; 37.82] P=0.833 15.77 [-12.23 ; 43.76] P=0.368 8.48 [-19.52 ; 36.47] P=0.745 
Fat CSA MF (cm²) 2.89 [1.10 ; 4.69] P<0.001* 0.38 [-1.23 ; 1.99] P=0.837 -2.51 [-4.13 ; -0.90] P<0.001* 
Fat CSA ES (cm²) 9.36 [2.27 ; 16.45] P=0.007* 0.73 [-5.67 ; 7.12] P=0.959 -8.63 [-15.03 ; -2.24] P=0.006* 
Muscle CSA MF (cm²) 2.75 [-8.15 ; 13.64] P=0.816 4.74 [-5.08 ; 14.6] P=0.479 1.99 [-7.83 ; 11.81] P=0.876 
Muscle CSA ES (cm²) -2.07 [-29.53 ; 26.39] P=0.982 13.82 [-11.37 ; 39.00] P=0.387 15.89 [-9.30 ; 41.07] P=0.288 
MFI MF (%) 0.02 [0.01 ; 0.04] P=0.006* -0.01 [-0.02 ; 0.01] P=0.322 -0.03 [-0.04 ; -0.02] P<0.001* 
MFI ES (%) 0.03 [0.01 ; 0.05] P=0.001* -0.01 [-0.03 ; 0.01] P=0.324 -0.04 [-0.05 ; -0.02] P<0.001* 
T2-rest MF 491.13 [-2756.37 ; 3738.627] P=1.000 2685.74 [-87.29 ; 5458.77] P=0.061 2194, 61 [-924.41 ; 5313.63] P=0.263 
T2-rest ES 804.69 [-1861.02 ; 3470.94] P=1.000 2261.258 [-15.21 ; 4537.73] P=0.052 1456.30 [-1104.21 ; 4016.81] P=0.496 
 
 
T2-shift MF -0.00 [-0.06 ; 0.06] P=1.000 -0.06 [-0.12 ; -0.00] P=0.032* -0.06 [-0.11 ; -0.00] P=0.030* 
T2-shift ES 0.01 [-0.05 ; 0.07] P=1.000 -0.06 [-0.12 ; -0.01] P=0.025* -0.07 [-0.13 ; -0.02] P=0.005* 
 
 Pain before exercise 0.05 [-1.29 ; 1.39] P=0.996 -2.26 [-3.52 ; -1.01] P<0.001* -2.32 [-3.52 ; -1.11] P<0.001* 
 Pain during exercise 0.20 [-1.32 ; 1.71] P=0.947 -1.25 [-2.66 ; 0.17] P=0.094 1.44 [-2.80 ; -0.08] P=0.035* 
 Pain after exercise 1.08 [-0.26 ; 2.42] P=0.134 -1.22 [-2.47 ; 0.03] P=0.056 -2.30 [-3.50 ; -1.10] P<0.001* 
 Expected pain -0.11 [-1.75 ; 1.53] P=0.986 -1.36 [-2.89 ; 0.17] P=0.092 -1.25 [-2.72 ; 0.22] P=0.110 
 RPE 0.94 [-0.54 ; 2.42] P=0.286 -0.73 [-2.11 ; 0.66] P=0.418 -1.67 [-2.99 ; -0.34] P=0.011* 
Table 3: Parameter estimates of muscle structure variables (total cross-sectional area, fat cross-sectional area, muscle cross-sectional area, muscle fat index and T2-rest) of the multifidus and 
erector spinae muscles, muscle function (T2-shift) of the multifidus and erector spinae muscles and pain measurements (CI=confidence interval; CLBP=chronic low back pain; CSA=cross-sectional 
area; ES=erector spinae; MF=multifidus; MFI=muscle fat index; RLBP=recurrent low back pain; RPE=rate of perceived exhaustion). Significance level is set at p<0.050 (*).  
 
 
 
 Table 4: Correlations between pain measurements (the NRS taken after the Biering-Sörensen exercise, the NRS representing 
the expected pain after the Biering-Sörensen exercise and the rate of perceived exhausting) and muscle structure/function 
(Fat cross-sectional area , MFI, T2-rest and T2-shift) in the lumbar multifidus and erector spinae muscles. (CSA=cross-sectional 
area; ES=erector spinae; low=lower level; MF=multifidus; NRS=numeric rating scale; RPE=rate of perceived exhaustion; 
up=upper level). Correlations are performed by Pearson correlation tests. Test results are represented by a significance value 
(P) and the Pearson Correlation coefficient (Rp). In all blanc spaces, no significant correlations were found. For MRI outcome 
measure not mentioned in the left column, no correlations were found. 
 
Table 5: Correlations between DIXON outcomes (fat cross-sectional area and muscle fat index in the multifidus and erector 
spinae muscle at level upper L4) and mfMRI outcome (T2-rest and T2-shift of the multifidus and erector spinae muscles at 
the levels lower L4, upper L4 and upper L3). (CSA=cross-sectional area; ES=erector spinae; low=lower level; MF=multifidus; 
up=upper level). Correlations are performed by Pearson correlation tests. Test results are represented by a significance value 
(P) and the Pearson Correlation coefficient (Rp). Yellow spaces are correlations in the same muscle. In all blanc spaces, no 
significant correlations were found.  
 
 NRS AFTER EXERCISE NRS EXPECTED RPE 
Fat CSA MF    
Fat CSA ES    
MFI MF Total: P=0.003; Rp=0.406   
MFI ES Total: P=0.011; Rp=0.355   
T2-rest low L4 MF Continuous: P=0.02; Rp=0.565   
T2-rest low L4 ES Continuous: P=0.04; Rp=0.517   
T2-rest up L4 MF Continuous: P=0.04; Rp=0.521   
T2-rest up L4 ES Continuous: P=0.03; Rp=0.549   
T2-rest up L3 MF    
T2-rest up L3 ES    
T2-SHIFT up L3 MF Total: P<0.050; Rp=0.531 
Continuous: P=0.005; Rp=0.665 
Total: P=0.007; Rp=0.368 
Continuous: P=0.028; Rp=0.548 
Total: P=0.010; Rp=0.355 
T2-SHIFT up L3 ES Total: P<0.050; Rp=0.483 
Continuous: P=0.048; Rp=0.501 
Total: P=0.015; Rp=0.335 
Continuous: P=0.034; Rp=0.532 
Total: P=0.026; Rp=0.308 
 FAT CSA MF FAT CSA ES MFI MF MFI ES 
T2-rest low L4 MF Total: p=0.041; 
Rp=0.280 
Total: p=0.016; 
Rp=0.327 
Total: p=0.013; 
Rp=0.334 
Total: p=0.042; 
Rp=0.277 
T2-rest low L4 ES Total: p=0.001; 
Rp=0.441 
Total: p=0.001; 
Rp=0.433 
Total: p=0.008; 
Rp=0.354 
Total: p=0.002; 
Rp=0.409 
T2-rest up L4 MF  Total: p=0.006; 
Rp=0.368 
Total: p=0.009; 
Rp=0.348 
 
T2-rest  up L4 ES Total: p=0.021; 
Rp=0.313 
Total: p<0.050; 
Rp=0.464 
Total: p=0.001; 
Rp=0.451 
Total: p=0.004; 
Rp=0.389 
T2-rest  up L3 MF  Total: p=0.002; 
Rp=0.405 
  
T2-rest  up L3 ES Total: 0.005; 
Rp=0.380 
Total: p<0.050; 
Rp=0.511 
Total: p<0.050; 
Rp=0.500 
Total: p<0.050; 
Rp=0.464 
T2-shift low L4 MF  Total: p=0.042; 
Rp=0.277 
Total: p=0.009; 
Rp=0.350 
Total: p=0.018; 
Rp=0.320 
T2-shift  low L4 ES   Total: p=0.013; 
Rp=0.333 
Total: p=0.023; 
Rp=0.308 
T2-shift  up L4 MF 
 
    
T2-shift  up L4 ES    Total: p=0.016; 
Rp=0.326 
T2-shift  up L3 MF  Total: p=0.006; 
Rp=0.371 
 Total: p=0.011; 
Rp=0.343 
T2-shift  up L3 ES    Total: p=0.009; 
Rp=0.350 
 4. DISCUSSION 
This experimental study evaluated differences in muscle structure, muscle quality and muscle activity 
in the MF and ES muscles between RLBP in remission, non-continuous CLBP and continuous CLBP. This 
way, the influence of the continuation of pain complaints on muscle structure and muscle function was 
examined. We hypothesized that lumbar muscles in continuous CLBP are characterized by more 
atrophy, a higher amount of fat infiltration, less muscle quality (or an enhanced lean MFI) and a 
dysfunctional muscle activity compared to RLBP and non-continuous CLBP. 
Results revealed indeed a smaller fat CSA and a lower amount of fat infiltration in RLBP and non-
continuous CLBP compared to continuous CLBP, but no differences were seen in total CSA or muscle 
CSA. Previous results concerning fat infiltration in non-specific CLBP compared to HC were conflicting: 
increased fat infiltration in MF and ES was seen in non-specific CLBP in 2 studies [8,11], whereas 
another found no differences between CLBP and HC [6]. In RLBP, enhanced fat infiltration does not 
occur according to the current literature [11,12]. To our knowledge, only one study compared CLBP 
with intermittent LBP and found increased fat content and less contractile tissue in non-specific CLBP 
compared to intermittent LBP [11]. The current study confirms these previous results by an increased 
fat CSA and enhanced lean MFI in continuous CLBP compared to RLBP. Because fat CSA, in the current 
study, is calculated by the fat fraction of the total muscle, also invisible fat droplets were taken into 
account. This quantitative measurement provides a very accurate representation of fatty infiltration in 
the muscle compared to (semi)-qualitative measurements used in previous research. In conclusion, 
one can conclude that fat infiltration is enhanced and the muscle quality is deteriorated in continuous 
CLBP compared to non-continuous CLBP and RLBP patients.  
No differences in total CSA or muscle CSA between groups were found. The current results indicate 
that the reduction in total CSA and/or muscle CSA might be similar in RLBP, non-continuous CLBP and 
continuous CLBP. This is however in contrast with a unique study, which compared CLBP with 
intermittent LBP and established a significant lower CSA in CLBP. Possibly the lack of differences in 
total CSA in the current study are masked by the changes in fat CSA. As Freeman proposes, the 
transition from muscle fibers into fat, results in fatty degeneration in CLBP [37]. A recent study of 
Hodges and colleagues demonstrated indeed an increase in adipose/connective tissue in the absence 
of muscle atrophy in the MF, 3-6 months after intervertebral disk injury in sheep [50]. If muscle tissue 
is replaced by fat tissue and/or connective tissue, differences in total CSA might be concealed. Another 
possible explanation for not finding significant differences between groups for total and muscle CSA is 
the large variance of muscle CSA. To overcome this issue, a larger test population is needed in future 
studies.  
Regarding muscle activity, the current study established a higher T2-shift in both non-continuous and 
continuous CLBP compared to RLBP. These results resemble an enhanced metabolic activity in the 
lumbar muscles of non-continuous and continuous CLBP compared to the RLBP patients. The only 
study evaluating lumbar muscle activity by mfMRI in CLBP, also found an increased metabolic change 
in CLBP who underwent surgery, compared to HC [40]. Enhanced metabolic activity is also found in 
RLBP patients despite their state of remission [31]. Possibly, the metabolic activity is enhanced in RLBP 
in remission compared to HC and even more enhanced in the non-continuous and continuous CLBP. 
Consequently, the frequency of pain days might worsen the amount of metabolic activity in the lumbar 
muscles.  
A higher T2-shift, caused by a standardized activity, resembles an enhanced metabolic activity of the 
lumbar muscles. This increased metabolic activity in continuous and non-continuous CLBP, possibly 
replicates a relatively higher intensity in contractions performed by the lumbar muscles. Muscle 
characteristics might influence the efficiency of performed muscle activity and be responsible for the 
enhanced metabolic residuals after contractions. In the total test population of the current study, a 
higher MFI and fat CSA was correlated to a higher T2-shift, mainly in the ES muscle. Lumbar muscles 
with more fat or connective tissue relative to muscle tissue contain less remaining muscle fibers able 
to perform muscle activity. As a result, a relatively higher workload is enforced to the remaining muscle 
fibers, leading to a potential faster acidification and a higher T2-shift. This strategy is maladaptive. 
Clinically, the lumbar muscles are fatigued more rapidly. The rate of perceived exhaustion was 
significantly higher in continuous CLBP compared to the RLBP patients, possibly resembling a more 
fatigued lumbar musculature in the continuous CLBP group. This ongoing impaired activity produces a 
continuous load on spinal structures and makes the spine susceptible to strain and further injuries. 
This process might be a contributing factor why non-continuous and continuous CLBP, unlike RLBP, do 
not recover after every pain episode. 
An enhanced T2-shift is established also in non-continuous CLBP compared to RLBP, but no enhanced 
fat infiltration is seen compared to RLBP. Therefore, another feature besides fat infiltration might 
contribute to the enhancement of metabolic residuals in the lumbar muscles. Differences in fiber type 
distribution also might influence the metabolic shift. Existing literature suggest that a lowered T2-rest 
indicates a higher portion of glycolytic fibers, whereas a higher resting state T2-value is related to more 
oxidative muscle fibers (type I fibers) [31,51–53]. A higher proportion of glycolytic fibers or anaerobic 
fibers (type II fibers) is reported in the back muscles of people with CLBP [54]. As a result, more 
metabolic substances are produced during contraction [31]. The non-continuous CLBP group indeed 
indicated lower mean T2-rest values compared to RLBP and continuous-CLBP, however not 
significantly different. Possibly the lack of power in the current study is responsible for not finding 
these differences. A priori power calculation revealed that 24 subjects in each group were needed. For 
both CLBP subgroups, this amount unfortunately was not reached. Therefore, it is possible that the 
sample size of LBP-subgroups in this dissertation was to small to detect additional differences between 
groups. Taken together, the enhanced metabolic activity seen in continuous CLBP might be due to fat 
infiltration, whereas the enhanced metabolic activity of the non-continuous CLBP groups might be due 
to a shift in fiber type towards glycolitic fibers at the expense of aerobic fibers.  
Significantly lower pain ratings were seen in RLBP compared to continuous CLBP before, during and 
after exercise just as for the rate of perceived exhaustion. Before exercise, RLBP also experienced 
significant lower pain intensities compared to non-continuous CLBP. These observations seem obvious 
since RLBP patients were in remission. The ongoing presence of pain is however not necessary for 
motor control changes to persist. Psychosocial factors, such as fear of movement have a similar effect 
and can explain changes in patients with musculoskeletal pain even when in remission [55]. In the 
current study, no significant differences were found between groups in the expected pain due to 
exercise, which indicates that all 3 included LBP populations have a similar anticipation of pain. Since 
no comparison was made with a control group, the current study is not able to state if the anticipation 
of pain due to movement is enhanced in the LBP groups, but future research could take this into 
account.  
In summary, muscle structure and muscle quality is deteriorated in continuous CLBP compared to non-
continuous CLBP and RLBP, whereas muscle function is less efficient in continuous CLBP compared to 
RLBP but not compared to non-continuous CLBP. Previous research established an increased MFI in 
the absence of clear atrophy [12] and alterations in muscle activity [31,20,28,34] in patients with RLBP 
in remission compared to HC. Deterioration of the lumbar muscle quality of the RLBP population is 
therefore present in the absence of clear atrophy. The results of the current study point out that 
enhanced fat infiltration, more deterioration in muscle quality and inefficient muscle work is present 
in the continuous CLBP group compared to the RLBP. Taken together, muscle quality starts to 
deteriorate in RLBP and declines further as a patient has back pain more frequently or more 
continuously. As a consequence, therapies concerning functional muscle regeneration could become 
more crucial in patients with more continuous pain. 
 
 
Limitations 
In the current study, some limitations should be considered. First of all, the amount of (in)activity was 
not investigated. Prolonged bedrest might worsen muscle degeneration, whereas physical training 
and/or a general physically active lifestyle might improve structural muscle conditions [56–58]. 
Besides, decreased general activity levels can influence the ratio between muscle and fat tissue, 
without affecting the CSA of the total muscle [59].  
Second, the division between non-continuous and continuous CLBP was made based on the amount 
of pain days per week. Consequently, the current study investigated muscle structure and muscle 
function in a spectrum of LBP patients. This spectrum consists of RLBP on the one end, suffering from 
pain episodes alternated by long pain free episodes and continuous CLBP suffering every day of LBP 
on the other end. All established differences in muscle structure, muscle quality, muscle function and 
pain measurements between groups in this study, clearly illustrate the different characteristics in RLBP, 
non-continuous CLBP and continuous CLBP and strengthens our choice to divide the CLBP group of this 
study into 2 subgroups (non-continuous and continuous CLBP). The non-continuous CLBP suffer from 
LBP during multiple days a week alternated by some pain free days and are therefore situated between 
the RLBP and the continuous CLBP patients. Because the division of the LBP groups was based on the 
frequency of pain flares and not on pain intensity, heterogeneity in current pain intensity exists within 
the study population. Pain ratings before exercise in the CLBP groups varied between 0 and 7 or 8. 
Therefore, a possible influence of pain on muscle structure and muscle activity cannot be ruled out. 
Besides a division based on the amount of pain flares, possibly other criteria are appropriate to define 
both groups. Future research should look into parameters, which might characterize the different CLBP 
groups more accurate.  
 
5. CONCLUSION 
No differences in lean muscle atrophy and total atrophy between RLBP, non-continuous CLBP and 
continuous CLBP are seen. Enhanced fat infiltration, MFI in lean muscle tissue, and metabolic activity 
after exercise are present in continuous CLBP compared to RLBP. Regarding muscle activity, increased 
activity induced metabolic changes are also found in the lumbar muscles in non-continuous compared 
to RLBP. In patients with continuous pain, lumbar muscles contain more fat infiltration and are 
characterized by a worse muscle quality compared to non-continuous CLBP. All these results indicate 
that RLBP, non-continuous CLBP and continuous CLBP are part of a complete spectrum of LBP 
complaints in which each subgroup is marked by different muscle characteristics. 
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ABSTRACT 
Objective 
Pain facilitation as well as pain inhibition might be present in chronic pain patients. A decreased efficacy of pain 
inhibition can be measured by conditioned pain modulation (CPM). The use of the CPM paradigm in scientific 
research has boosted over the last few years and is recognized for its high clinical relevance in chronic pain 
patients. It is however unclear whether the presence of pain and possible modulations of pain influences the 
efficacy of endogenous pain inhibition, measured by CPM. This systematic literature study aimed to provide an 
overview of the effects of clinical pain and experimental pain induction or pain reduction on CPM in adults.  
Methods 
A systematic literature search was conducted in the databases “Pubmed” and “Web of Science”. Only full texts 
of original studies regarding the effect of clinical pain and experimentally induced pain and pain reduction on 
CPM in adults were included. The included articles were scored on methodological quality and through a CPM-
paradigm.  
Results 
Twelve articles of good to moderate quality were included in this review. Some pain inhibitory medication and 
oral contraceptives inhibit the CPM mechanism. Removing chronic pain by surgery results in an improved CPM 
response. This effect is not observed when removing acute pain.  
Conclusion 
Analgesic medication and oral contraceptives might inhibit the CPM response. Moreover, there is limited 
evidence that pain relieving surgery improves the CPM response in chronic pain. Removal of acute pain did not 
alter the CPM response. The results merely suggest that only decreased CPM values (as in chronic pain patients) 
can improve after elimination of pain. 
Key words 
Pain inhibition, diffuse noxious inhibitory control, clinical pain, experimental pain, acute pain, chronic pain, 
conditioning stimulus 
 
  
1. INTRODUCTION 
 
According to the International Association for the Study of Pain (IASP), pain is an unpleasant sensory and 
emotional experience associated with actual or potential tissue damage or is described in terms of such damage 
(www.iasp-pain.org). Acute pain is a body’s warning when there is actual tissue damage. It ensures people to pay 
attention to the injury so further damage can be prevented. Chronic pain however is often less functional since 
patients still experience pain although the original source of tissue damage has usually been resolved. In these 
patients transmission of pain signals from the periphery to the spinal cord persists and might produce changes 
in the central nervous system, a phenomenon that is called central sensitization [27]. Recent research shows that 
augmented pain facilitation as well as reduced pain inhibition might occur in chronic pain patients, like whiplash 
disorders [25], chronic fatigue syndrome [22], rheumatoid arthritis [18], fibromyalgia [32] and chronic low back 
pain [10]. The capacity of pain inhibition can be measured by the Conditioned Pain Modulation (CPM) paradigm 
[32] previously termed as Diffuse Noxious Inhibitory Control or Heterotopic Noxious Conditioning Stimulation. 
Basically, CPM works through the “pain-inhibits-pain” principle in which an additional painful (conditioned) 
stimulus can suppress the initial experienced pain through the descending and inhibiting pathways. In that case 
it is quantified by calculating the amount of pain reduction in the test stimulus (TS) before/during/after the 
administration of a painful conditioning stimulus. Pain perception during/after this conditioning stimulus (CS) 
should be lower than before, since the conditioning stimulus activates the endogenous pain inhibitory system 
(i.e. CPM) [39]. This analgesic CPM effect can persist for a few seconds or even several minutes after the removal 
of the conditioned stimulus [6,28,33]. The CPM response is suggested to work through a spino-bulbo-spinal loop, 
with an ascending pathway in the ventrolateral funiculi involving the subnucleus reticularis dorsalis in the 
medulla oblongata and a descending pathway in the dorsolateral funiculi [4]. The mechanism behind CPM is 
however complex and not yet fully understood. 
CPM has been identified as an advanced measurement with high clinical relevance [29]. First of all, changes in 
the individual CPM response can predict the risk of developing postoperative chronic pain [41] as it has been 
hypothesized that a low CPM efficacy can be associated with higher pain morbidity [42]. Besides this, CPM might 
indicate whether a certain treatment actually reduces pain or not and can also be used as a pain inhibiting 
treatment modality on its own [43]. 
This CPM mechanism has been investigated in several populations with deviating methodologies. In patients with 
chronic pain CPM seems to fail most of the time [1,9,12,14,17,34] while results in acute patients or patients in 
which central sensitization is not assumed, are more obscure [42].  It is therefore not clear whether the presence 
of the pain itself plays an important role in the CPM response. Possibly CPM fails when an additional conditioning 
pain stimulus is administered, in the presence of 2 already existing pain stimuli (clinical pain and test stimulus). 
Briefly, this review tries to assess efficacy of endogenous pain inhibition by evaluating the influence of a 
conditioning pain stimulus on test pain, if patients are already in pain. The literature is scarce about the effect of 
changing pain status (induction or reduction) on CPM response. Therefore this systematic review is intended to 
evaluate whether pain induction or pain inhibition changes the efficacy of the CPM mechanism in adults by 
determining the influence of clinical (acute/chronic) and experimentally induced pain or pain reduction on CPM. 
The present study systematically reviews the scientific literature according to the PRISMA guidelines. 
 
 
2. METHODS 
 
2.1. Research question 
According to the PRISMA-guidelines, a PICO approach was applied to formulate the research question. This leads 
to the following question: “What is the influence of clinical (acute/chronic) and experimentally induced pain or 
experimentally reduced pain (I) on Conditioned Pain Modulation (O) in adults (P)? Studies were included if they 
examined the influence of clinical pain, experimentally induced pain or pain relief on CPM in human adults. 
 
2.2. Search Strategy 
The search strategy was conducted by 2 researchers (KK & HN) trained by DG & MM during October and 
November of 2012. DG is a PhD candidate. MM obtained the degree of PhD and is experienced in writing 
systematic reviews and training researchers in accomplishing systematic reviews. The electronic databases 
PubMed and Web of Science (WOS) were screened. Twelve key words were used in multiple combinations: 
conditioned pain modulation, diffuse noxious inhibitory control, heterotopic nociceptive conditioning 
physiology, heterotopic nociceptive conditioning stimulus, heterotopic nociceptive conditioning stimuli, 
heterotopic nociceptive conditioning stimulation, counterirritation, counterstimulation, heterotopic noxious 
conditioning physiology, heterotopic noxious conditioning stimulus, heterotopic noxious conditioning stimuli and 
heterotopic noxious conditioning stimulation. These 12 synonyms were combined with the following 4 key 
words: clinical pain, acute pain, induced pain and experimental pain. Reference lists of the included articles were 
screened in order to make the search as complete as possible. The complete search strategy is presented in 
Table1. 
 
2.3. Selection Criteria and Data-extraction 
After de-duplication the remaining articles were screened for title and abstract. In a final phase the remaining 
articles were screened based on full text. Both researchers evaluated all articles independently. When in doubt 
a consensus meeting was held with DG and MM. An article was only included if everyone agreed. To be included 
the articles had to fulfill the following criteria: 1) The study population consisted of adult men and women (≥18 
years). Articles concerning populations with neurological or psychological disorders were excluded, due to 
possible changes in the nervous system. 2) Only case-controls, cohorts, cross-over studies, cross-sectional studies 
and randomized controlled trials (RCT) were included. Expert opinions, reviews and congress proceedings were 
excluded. 3) The included study must deal with the effect of a change in pain (induction or reduction) on CPM. 
Studies were excluded if they only examined the pain efficacy of CPM. Studies focusing on the influence of 
attention on the CPM response were also excluded. 4) Only articles published in English, Dutch, French and 
German were included in this systematic review.  
Information was extracted from each included article on: type of intervention, characteristics of participants, 
study objective, results of intervention on CPM, applied test- and conditioning stimulus, involved body sites and 
CPM outcome measure (Table 2: Appendix). Two reviewers extracted the information (KK & HN) and two other 
reviewers checked the extracted information (DG & MM). 
 
2.4. Risk of Bias 
Checklists of the EBRO platform (Evidence-based guideline development in the Netherlands, presented on the 
website of the Dutch Cochrane Centre (http://dcc.cochrane.org/)) were used to assess methodological quality. 
The appropriate checklist related to the study design of the included study was applied. Because no specific 
checklist is available to evaluate cross-sectional studies the case-control checklist was used (with exception of 
the criteria regarding the control group and blinding). 
Secondly the methodological quality of the used CPM paradigm was assessed (CPM score). Six ‘yes or no’ 
questions were composed: 1) Is test stimulus and the conditioning stimulus clearly defined in the article? 2) Are 
the administered stimuli and the device used for application of these stimuli clearly described? 3) Is it clearly 
described at which body site the test and conditioning stimuli are administered? 4) Is the sequence and timing 
of administration of the stimuli clearly described?  5) Is the duration of the stimuli applications clearly described? 
6) Is the CPM outcome measure clearly described?  
The scores were converted into percentages to compare the methodological quality among studies with a 
different maximum score. 
Methodological quality was assessed by 2 independent, blinded researchers (KK & HN). The results were 
compared and differences were discussed in order to obtain a consensus. When consensus could not be reached, 
a third opinion was provided by the last author (MM). Afterwards a level of evidence (LOE) was assigned to each 
article using the guidelines of the EBRO platform and a level of conclusion (LOC) was determined for each topic.  
 
 Database Search terms Additional filters Results 
Total 
before  
de-
duplication 
Total after 
de-
duplication 
PubMed 
(1) OR (2) OR (3) OR (4) OR (5) OR (6) OR 
(7) OR (8) OR (9) OR (10) OR (11) OR (12) 
AND (clinical pain OR acute pain OR 
induced pain OR experimental pain) 
Language: English, 
French, Dutch, 
German 
83 
202 170 
Age: adult, 18+ 
Species: human 
WOS 
(1) OR (2) OR (3) OR (4) OR (5) OR (6) OR 
(7) OR (8) OR (9) OR (10) OR (11) OR (12) 
AND (clinical pain OR acute pain OR 
induced pain OR experimental pain) AND 
human AND adult NOT animal NOT child 
Language: English, 
French, Dutch, 
German 
119 
Table 1: Complete search strategy. (1)=”conditioned pain modulation”; (2)=”diffuse noxious inhibitory control”; 
(3)=heterotopic nociceptive conditioning physiology; (4)=heterotopic nociceptive conditioning stimulus; (5)=heterotopic 
nociceptive conditioning stimuli; (6)=heterotopic nociceptive conditioning stimulation; (7)counterirritation; 
(8)=counterstimulation; (9)=heterotopic noxious conditioning physiology; (10)=heterotopic noxious conditioning stimulus; 
(11)=heterotopic noxious conditioning stimuli; (12)=heterotopic noxious conditioning stimulation. 
 
 
Study Date Study design CBO design 
CBO 
CPM 
1 2 3 4 5 6 7 8 9 
Total CBO 
Total CPM 
Total CBO (%) 
Total CPM (%) 
LOE LOC TOPIC 
Baba et al. 2012 CO RCT 
CBO 1 1 1 1 1 / 1 1 1 7/8 87.5% 
B 
3 Medication 
CPM 1 1 0 1 1 1    5/6 83.3% 
Bouwense et al. 2012 RCT RCT 
CBO 1 0 1 1 1 0 1 1 1 7/9 77.8% 
A2 
CPM 1 0 1 1 0 1    4/6 66.7% 
Chua et al. 2011 CS CC 
CBO 1 / 1 1 / 1    4/4 100% 
C 
CPM 1 0 1 1 1 1    5/6 83.3% 
Le Bars et al. 1992 CS CC 
CBO 0 / 0 1 / 1    2/4 50.0% 
C 
CPM 1 0 0 1 1 0    3/6 50.0% 
Neziri et al. 2012 CO RCT 
CBO 1 1 1 1 1 1 1 1 1 8/9 88.9% 
A2 
CPM 1 0 0 1 1 1    4/6 66.7% 
Niesters et al. 2011 CO RCT 
CBO 1 0 1 0 0 1 1 0 1 5/9 55.6% 
B 
CPM 1 1 0 1 1 1    5/6 83.3% 
Ram et al. 2008 CC CC 
CBO 1 1 1 1 0 1    5/6 83.3% 
B 
CPM 1 1 1 1 1 1    6/6 100% 
Rezaii et al. 2010 CC CC 
CBO 1 1 1 1 0 1    5/6 83.3% 
B 
CPM 1 1 1 1 1 1    6/6 100% 
Graven-Nielsen 2012 Cohort Cohort 
CBO 1 1 1 1 0 1 0 1  6/8 75.0% 
B 
2 Chronic pain 
CPM 1 1 0 1 1 1    5/6 83.3% 
Kosek et al. 2000 Cohort Cohort 
CBO 1 0 1 1 0 1 1 0  5/8 62.5% 
B 
CPM 0 1 1 1 0 0    3/6 50.0% 
Valencia et al. 2012 Cohort Cohort 
CBO 1 1 1 1 0 0 1 0  5/8 62.5% 
B 
2 (Sub)acute pain 
CPM 1 0 1 1 1 1    5/6 83.3% 
Oono et al. (*) 2012 CO RCT 
CBO 1 0 0 0 0 1 0 1 0 3/9 33.3% 
B 
CPM 0 1 1 1 1 1    5/6 83.3% 
Table 2: Methodological quality (CBO, CPM), Level of evidence; level of conclusion (CBO=Centraal BegeleidingsOrgaan; CPM=conditioned pain modulation; LOE=level of evidence; LOC=level of 
conclusion; CS=cross sectional; RCT=randomised controlled trial; CC=case control; CO=cross over; 1=score fulfilled; 0= score not fulfilled; /=the answer is unclear; empty space=no question to 
be answered; (*)=CBO score < 50%) 
3. RESULTS 
 
3.1. Study Selection 
The search strategy resulted in 202 articles. After de-duplication 170 articles remained. Two articles were found 
by hand searching: one article was mentioned in the reference list of an included study while the other article 
was published after the research strategy was performed. Twenty-seven articles were included after screening 
for title and abstract. Studies were excluded based on study population, study design or intervention type. After 
screening for full text another 15 studies didn’t meet the inclusion criteria and were excluded based on 
intervention (research about genetics, sleep architecture or different ways to measure CPM) and study design 
(articles not investigating the change in CPM response or a lacking protocol). After the complete screening, 12 
studies were included in this systematic review. The entire selection process is represented in the flowchart of 
Figure 1. 
 
 
Figure 1: Flowchart of the selection process (n=number of articles) 
 
 
3.2. Study Characteristics 
Twelve articles were included: 3 cohort studies, 2 cross-sectional studies, 4 cross-over studies, 2 case-control 
studies and 1 RCT. The characteristics of each study were extracted and presented in the evidence table (Table 
2). Based on topic, articles were divided into 3 groups. Eight studies investigated the effect of medication on CPM 
on healthy subjects [3,5,21,32] while another 4 articles investigated the effect of medication on several patient 
populations, like chronic pancreatitis [7], cervical facet pain [8], chronic low back pain [20] and general chronic 
pain [31]. Two studies [11,15] examined the effect of surgery on CPM in patients with chronic osteoarthritis (OA). 
Another 2 studies examined the influence of acute pain or experimental pain on CPM: the first study [40] 
investigated the effect of (sub)acute shoulder pain in shoulder patients and the effect of experimental shoulder 
pain in healthy controls. The second study [25] investigated the effect of electrical induced pain in the 
temporomandibular joint.  
Most frequently, mechanical (pressure) or thermal (heat) stimuli were used as the test stimulus. Electrical, tactile 
and cold stimulus were also used as test stimulus. The sites of administration of these test stimuli were very 
different among studies. The Cold Pressor Test (CPT) was the most frequently used conditioning stimulus. Seven 
studies applied CPT: 6 studies [7,8,20,31,32,40] immersed the hand (and wrist) in ice cold water and 1 study [21] 
immersed the foot and leg in ice water. The duration of the CPT was generally about 120 seconds. A hot water 
bath, pressure stimuli, CO2 laser stimulation and a Tourniquet Test (a painful ischemic compression provoked by 
a cuff around the upper arm) were also used as conditioning stimulus. All stimuli are presented in the table in 
Appendix. 
 
3.3. Risk of Bias 
After the assessment of the methodological quality, 11 articles had a score of 50% or more. One article [25] had 
a CBO score of less than 50%. There was little information concerning the blinding of the research and the 
degree of execution of the protocol. Besides that, not all subjects received an equal treatment, apart from the 
intervention. Those who were afraid of needles received an altered procedure. 
Before the consensus meeting, an agreement of 89.29% and 87.50% between both assessors was reached for 
methodological quality and quality of the CPM paradigm respectively.  
Two articles [7,20] obtained a LOE ‘A2’. Eight articles [3,11,15,21,25,31,32,40] got a LOE ‘B’ and 2 studies [5,8] 
were classified as LOE ‘C’. A complete summary of the quality assessment is given in table 2. 
 
  
3.4. Synthesis of Results 
 
3.4.1. Medication 
The following medications were examined: Pregabalin [7], Tropisetron [20], Dexmedetomidine [3], Lidocaine and 
Bupivacaine [8], Ketamine [21], Opioids and Non-Opioids [31] and Oral Contraceptives [32], Morphine and 
Naloxone [5]. Some had no effect, some had a negative effect and some had a positive effect on the CPM 
response. 
No effect on CPM response 
Pregabalin is a medical drug with analgesic effects acting upon the descending pain processes. Potent binding of 
pregabalin at calcium channels results in a reduction in the release of excitatory molecules [35] . Bouwense et al. 
(2012) examined the effect of Pregabalin versus a placebo treatment on CPM response in patients with chronic 
pancreatitis. No difference in CPM response was seen in pancreatitis patients who received a treatment with 
Pregabalin in comparison to a placebo treatment (p>0.05).  
Neziri et al. (2012) evaluated the effect of Tropisetron (a 5-HT3 receptor antagonist with analgesic effect) on CPM 
in patients with chronic low back pain. This study was conducted using an intravenous injection of Tropisetron 
at 2 different doses, in a randomized, double-blind, placebo-controlled, crossover manner. Both in Tropisetron 
and placebo condition a significant difference in CPM response was found after treatment in comparison with 
baseline measurements (p=0.021). But no differences could be found between the Tropisetron and placebo 
group (p=0.617) indicating that Tropisetron has no effect on the CPM mechanism in patients.  
Negative effect on CPM response 
Dexmedetomidine (DEX) is a selective α2-adrenergic receptor agonist with analgesic effects when given in a low 
dosage and narcotic effects when administered intravenously in a higher, clinical dosage. One of the most 
important target sites of DEX is located within the Locus Coeruleus in the brainstem which reduces the release 
of noradrenalin [3]. According to the study of Baba, et al. (2012) DEX inhibits the CPM paradigm in healthy adults. 
DEX significantly inhibits pain reduction when administered in a low dosage (VAS: p<0.05; Somatosensory evoked 
potentials (SEP): p<0.01) and even more in a high dosage of DEX (VAS: p<0.001 en SEP: p<0.001). According to 
the authors of this article, DEX can be seen as a dose dependent inhibitor of the CPM mechanism.  
Chua et al. (2011) investigated the effect of diagnostic blocks (Lidocaine and Bupivacaine) on CPM and on 
Quantitative Sensory Testing. Both types of medications interact with sodium channels and ensure 
analgesia/anesthesia and are often administered intra-articular to inhibit pain or to reduce hyperalgesia. In this 
study, 9 subjects with chronic cervical facet pain were tested two times: after a first and after a second diagnostic 
block (respectively DB1 and DB2). These diagnostic blocks were evaluated in the face and in a pain-free reference 
area in the thigh.  DB1 and DB2 in the thigh and DB2 in the face lowered the CPM response significantly (p=0.008; 
p=0.021; p=0.015). DB1 in the face lowered the CPM response and the result approached significance (p=0.051). 
Ketamine, a NMDA receptor antagonist, was assumed to affect CPM in a positive way and thus contribute to a 
long-lasting analgesic effect in patients with chronic pain [21]. However, the opposite was proven. After Ketamine 
injection, there was no CPM response left. This drug even provoked a facilitatory pain response when a 
conditioning stimulus was applied in comparison with the pain response when no conditioning stimulus was 
applied (p<0.01). Consequently, ketamine blocks the analgesic effect of CPM. Niesters et al. (2011) concluded 
that Ketamine disturbed the balance between pain inhibition and pain facilitation in preference to pain 
facilitation.  
According to Ram et al. (2008) opioids also tend to facilitate pain during the CPM paradigm rather than enhancing 
pain inhibition. This study examined if the magnitude of CPM differs between a group taking opioids and a group 
taking non-opioid medication. The magnitude of CPM of the non-opioid treated group was significantly larger 
than the magnitude of CPM in de opioid treated group (p=0.003). Men had a significant lower CPM effect when 
injected with opioids in comparison to non-opioids (p=0.001). However, this difference was not seen in the 
female population (p>0.05). Besides that, the inhibiting effect of the opioids on CPM depended on the dosage 
and treatment duration. The higher the opioid dosage and the longer the duration of the treatment, the lower 
the CPM effect in the masculine population. 
In the study of Le Bars et al. (1992) the effect of Morphine (an opioid receptor agonist activating the µ-receptors) 
and Naloxone (an opioid receptor antagonist with high affinity for µ-receptors) CPM was measured. After a 
Morphine injection, there was no longer an inhibitory effect coming from the CPM mechanism (p<0.001).  
Besides the fact that plenty of analgesic drugs inhibit the CPM paradigm, oral contraceptives (OC) also inhibit 
CPM. Oral contraceptives inhibit the ovulation by suppressing the release of luteinizing hormone, which in turn 
suppresses the estradiol peak. According to Rezaii & Ernberg (2010) the endogenous pain modulation system, 
induced by an experimental acute pain, is less effective in women using OC in comparison to normal 
menstruating women not taking OC (p<0.05).  
Positive effect on the CPM response 
Naloxone, an opioid antagonist, blocks the µ-receptors in the central nerve system. Naloxone is given when 
addicted to Morphine or other medications. In the study of Le Bars et al. (1992) Naloxone was administered after 
a Morphine dose was administered. After a Naloxone injection the CPM response that was lowered because of 
the Morphine administration was normalized again (p<0.001). After a while, even a bigger CPM response was 
seen, compared to baseline. 
In general, these articles seem to suggest that medication currently used in pain management as 
Dexmedetomidine, Lidocaine, Bupivacaine, Morphine, Ketamine, opioids and oral contraceptives might lower 
the CPM effect and reduce the effect of pain inhibition. Although Pregabalin and Tropisetron had no effect on 
the CPM paradigm. Naloxone on the contrary, normalizes CPM effect and even increases pain inhibition again 
after a Morphine injection.  
3.4.2. Chronic Pain 
Two studies examined CPM before and after a surgical intervention in patients with osteoarthritis (OA). Graven-
Nielsen et al. (2012) examined patients with chronic knee OA, whereas Kosek & Ordeberg (2000) examined 
patients with hip OA. OA patients had a significantly decreased CPM response before surgery, in comparison to 
the healthy control group. Following joint replacement surgery, the CPM response was restored in chronic knee 
OA (p<0.0002) and in chronic hip OA (p<0.02). After surgery, the postoperative CPM response was comparable 
to the healthy control group. 
There is moderate evidence that removing the structural cause of chronic pain through surgical interventions, 
improves the CPM mechanism. 
 
3.4.3. (Sub)Acute Pain 
Valencia et al. (2012) and Oono et al. (2012) investigated CPM in subjects with (sub)acute pain. This study 
investigated shoulder pain in healthy controls and in a patient group with shoulder pain because of an acute 
injury and requiring an arthroscopic intervention. Exercise-induced muscle pain provoked acute shoulder pain in 
the healthy control group. In the healthy control group, CPM was compared before and after the pain induction. 
In the patient group, CPM values were compared before and after the surgical intervention. Although there are 
equivocal differences in baseline measurements between the patient group and the controls, the absolute 
difference in CPM response did not alter significantly after pain induction through exercise (p=0.778) or after 
pain reduction through surgery (p=0.186).  
In the study of Oono et al., (2012) the influence of an acute stimulus in the temporomanibular joint (TMJ) on 
CPM was examined. This experimental pain was induced by electrical stimulation. No significant differences in 
CPM values were found between the subjects who received electrical stimulation and the subjects who didn’t 
receive electrical stimulation (p>0.05). 
Based on these studies, there is moderate evidence that inducing or inhibiting (sub)acute pain does not change 
the CPM mechanism.   
 
4. DISCUSSION 
 
4.1. Results 
The main objective of this systematic review was to determine what is known thus far about the influence of 
clinical (acute or chronic) and experimentally induced pain or pain reduction on the CPM response in adults.  
The present study revealed that several drugs used for pain management might cause an inhibition of the CPM 
response. Each drug however, probably creates pain reduction through another working mechanism. Some 
medications work through inhibition of pain facilitating systems, others through activation of pain inhibiting 
systems. Although Pregabalin [7] is an analgesic medication, no effect on CPM could been found, suggesting it 
rather targets pain facilitating mechanisms. Tropisetron [20] as well is supposed to influence generalized 
hyperalgesia, what might be the reason why the researchers didn’t found any effect on CPM response.  
A lot of these medications have been tested on healthy controls [3,5,7,21,32] which might underline the 
influence of the drug itself, besides any confounding disease-related factors. Because a lot of chronic pain 
patients take all kinds of analgesic medication, a lower CPM response could be incorrectly interpreted as a 
reduced CPM mechanism due to the chronic disease, but can in fact be attributed to the intake of CPM inhibiting 
drugs [3]. Future research should take this into account when interpreting their results.  
Several researchers point at multiple systems that might contribute to pain inhibitory systems. Personal variables 
are one of those. Negative cognitive processing of pain might influence endogenous analgesia [13]. Also Nir et 
al., (2012) emphasized the relevance of cognitive mechanisms altering CPM characteristics. Moont et al., (2010) 
on the other hand experienced that modulation of CPM is not due to cognitive attention. Also the influence of 
gender is discussable. Although the majority of studies found no gender dependent differences on CPM 
[2,16,24,30], only men experienced a lower CPM response after opioid intake in the study of Ram et al. (2008). 
Until now it is difficult to make firm conclusions on these aspects. Future investigations might clarify these 
obscurities. 
Overall only one study for each medication was found instead of a series of studies for each intervention. More 
studies confirming the CPM effect of each analgesic drug is warranted to make a more robust conclusion 
concerning the influence of medication on the CPM response . 
The studies of Graven-Nielsen et al., (2012) and Kosek & Ordeberg (2000), pointed out that the CPM 
mechanism is less effective in OA patients before surgical intervention in comparison to the CPM response after 
surgery. According to the authors a reduced CPM mechanism is being maintained by peripheral pathology. Once 
the peripheral pathology is surgically approached, the CPM response is restored. Nevertheless the chronic 
peripheral pain itself might blur the CPM response as this acts as a third pain stimulus, besides the TS and CS. So 
before the CS is administered, the peripheral pain might work as CS and compass a pain-inhibits-pain mechanism, 
which will be abrogated when the real CS is administered in a CPM experiment. Another plausible explanation 
might be found in the use of analgesic medication in chronic pain patients which might affect the CPM response. 
A lot of patients might diminish the amount of medication after removal of the peripheral pain source which can 
influence subsequently the restoration of the CPM mechanism.  
Unlike in chronic diseases, removing clinical or experimental acute pain does not alter the CPM response. 
According to Valencia et al., (2012) this is due to the fact that the pain has not become chronic yet and therefore 
could not decrease CPM efficacy. So the CPM response needs to be decreased before it might improve after 
removal of this pain. Oono et al., (2012) concluded that CPM deficiencies in pain conditions are most likely more 
related to the duration of clinical pain than to the pain itself.   
Based on the preceding conclusions, one can assume that there is a difference between the effect of analgesic 
medication and pain relieving surgery in patients with chronic pain. Whereas medication mostly inhibits CPM, 
surgery rather restores a reduced CPM mechanism in chronic pain patients through the removal of the peripheral 
pathology. These results suggest that analgesic medication has a central and inhibiting effect on CPM, whereas 
surgery correcting peripheral pathology has a peripheral and stimulating effect on CPM.  
 
4.2. Limitations 
There were some limitations regarding to the included articles. In the studies of Baba et al. (2012), Chua et al. 
(2011), Le Bars et al. (1992) and Niesters et al. (2011) a rather small population size (only 9 or 10 subjects) was 
used. Therefore, these studies have less statistical power and undermine the reliability of their results. Moreover 
a proper control group was lacking in some articles. Le bars et al, (1992) for example compared a non-opioid 
group with an opioid taking group, although it would have been interesting to compare these two groups with a 
healthy control group to gain insight of the drugs on the CPM effect.  Besides this, studies examining the CPM 
response in some specific patient populations in which impaired endogenous pain modulation is expected, like 
patients with fibromyalgia, chronic fatigue syndrome, chronic whiplash associated disorders and other chronic 
diseases, are lacking.  
Two studies did not retest all patients within the same time frame after surgery. In the study of Graven-Nielsen 
et al. (2012) a wide postoperative time frame was used (5 to 28 weeks after surgery) to retest the patients. Also 
the study of Kosek & Ordeberg, (2000) used a time frame ranging from 6 to 14 months after surgery. The large 
differences in moment of retesting between various test subjects can lead to misinterpretation of the test results.  
A third arguable restriction could be the intensity of the CS. Some studies claim a CS needs to be painful enough 
to obtain a decent CPM response [5]. After administration of certain medications, the bottom up stimulus might 
be suppressed and might consequently result in an inadequate CPM response. Since not all studies examined the 
intensity sensation of CS and TS after administration of the medication, one cannot assume all stimuli were 
intense enough to arouse a decent CPM response, which might explain why some authors [7,20] did not find any 
changes at all in CPM response. 
In addition to these limitations, a lot of articles did not take into account confounders that might influence the 
CPM paradigm. Except for the article of Rezaii & Ernberg (2010), no other article mentioned the menstrual cycle 
phase of the female subjects in their study protocol although hormonal levels might influence the CPM paradigm 
[38]. Only 2 articles [20,32] mentioned the use of oral contraceptives during testing. Also other medication use 
was not prohibited for all participating populations [5,7,8,15,25,40]. Therefore interactions from other 
medication affecting the CPM mechanism cannot be excluded. Other personal factors like the psychological state 
of patients (anxiety, depression, emotional status, attention span), factors responsible for comorbidity (smoking 
or obesity) and ethnic origin were usually not mentioned. Kosek & Ordeberg (2000) did not even mention the 
sex ratio in the population or control group. The possible influence of these factors therefore cannot be ruled 
out.  Also patients’ expectations were not taken into account as a result of which placebo effects cannot be 
excluded.  
The fact that only a few studies examined the influence of an additional experimental stimulus (besides the test 
stimulus and the conditioning stimulus) on CPM, can also be seen as a limitation. Only 2 articles [25,40] examined 
the effect of introducing a third experimental and painful stimulus to the test protocol. 
Finally, a wide variety of test stimuli, conditioning stimuli, sites of administration, duration and intensity of the 
stimuli were included in this systematic review. No exclusion criteria were formulated to narrow down this 
variety. These differences in methodology can cause differences in the CPM effect [29] and can therefore 
influence the conclusions that were made by the present study.  
 
5. CONCLUSION 
 
The present study shows that modulations of pain might influence the efficacy of endogenous pain inhibition, 
measured by CPM. Analgesic medication and oral contraceptives might cause an inhibition of the CPM response. 
A possible explanation is that a lot of medication might have a central and inhibiting effect on the CPM 
mechanism by blocking the signal transition between the medulla oblongata and the periphery. Further research 
is needed to explain and interpret this hypothesis.  
On the other hand, removing the peripheral cause of chronic pain through surgery can ameliorate the CPM 
response in patients with osteoarthritis. However, the removal of acute pain through surgical interventions or 
the removal of acute, experimental induced pain does not alter the CPM response. These results suggest that 
disturbance of the CPM mechanism in patients may be time dependent: at first the CPM response should be 
decreased, like it is the case in chronic pain, before CPM can significantly improve again after (surgical) removal 
of this pain. 
  
APPENDIX 
Study 
Characteristics study 
population (patient 
population; control 
population; age) 
Intervention  
(patient population; control 
population) 
Study objective 
Test stimulus 
(type; site) 
Conditioning stimulus 
(type; site; duration) 
Outcome 
measure 
CPM Result 
Baba et al. 
(2012) 
 
PP: Healthy (n=10;  
M=5; F=5)  
CP: N/A 
A: 26-41 years 
[mean 29.6 ± SD 4.3 
years] 
PP: normal saline 
(0.095mL/kg/h); 
Dexmedetomidine (DEX) 
(0.38µg/kg/h & 0.75µg/kg/h) 
CP: N/A 
Effect of low / high 
dosage of DEX on CPM 
T: electrical  
S: tooth  
T: CO2-laser  
S: hand  
D: 60 pulses  
SEP +VAS  Low dosage of  DEX:  
CPM response (VAS 
p<0.05; SEP p<0.01) 
High dosage: CPM  
response (VAS 
p<0.001 en SEP 
p<0.001) 
Bouwense 
et al.  
(2012) 
 
PP: Chronic (n=64; 
M=40; F=24))  
CP: Healthy (n=15; 
M=8; F=7)  
A (PP): IQR 45-62 
years [mean 53.5 
years]  
A (CP): IQR 35-49 
years [mean 38 
years] 
PP: Pregabalin (75mg, 150 
mg & 300mg) or Placebo 
CP: N/A 
Effect of Pregabalin on 
CPM in patients with 
chronic pancreatitis 
T: pressure  
S: non-dominant knee 
(L4)  
T: CPT (1°C±3°C)  
S: dominant hand  
D: max. 120 s  
pPTT  Pregabalin: no effect on 
CPM response (p>0.05) 
Chua et al.  
(2011) 
 
PP: Cervical facet 
pain (n=9; M=7; F=2)  
CP: N/A 
A: 52-60 years 
[mean 58 years]  
PP: Diagnostic blocks 
(lidocaine or bupivacaine) 
CP: N/A 
Effect of diagnostic 
blocks (lidocaïne, 
bupivacaïne) on QST 
and CPM 
T: electrical  
S: non painful side, 
anterior thigh + face 
T: CPT (temp N/A) 
S: dominant hand  
D: max. 180 s/80 mm 
VAS  
EPTT  Diagnostic blocks:  CPM  
response  (DB1 thigh 
p=0.008; DB2 thigh 
p=0.021; DB1 face 
p=0.051; DB2 face 
p=0.015) 
Le Bars et 
al.  
(1992) 
 
PP: Healthy (n=9; 
M=4; F=5) 
CP: N/A 
A: 24-36 years [N/A] 
PP: Morfine (0.05mg/kg, 
5ml) & Naloxone 
(0.006mg/kg, 5ml) 
CP: N/A 
Effect of low dosage of 
Morfine / Naloxone on 
CPM (measured via RIII 
reflex) in healthy 
controls 
T: electrical (RIII reflex)  
S: L N. Suralis, ankle  
T: hot water bath 
(46°C) 
S: R hand up to 5 cm 
above wrist  
D: 120 s  
EMG RIII 
reflex  
Morfine: CPM response 
, reflex (p<0.001) 
Naloxone: CPM  
response , reflex 
(p<0.001) 
Neziri et al.  
(2012) 
 
PP: Chronic LBP 
(n=30;  M=15; F=15) 
CP: Chronic LBP  
A: 23-78 [mean 51 ± 
SD 15 years] 
PP: Tropisteron (2mg & 5mg) 
CP: Placebo (20ml, 0.9% 
saline) 
Effect of Tropisetron on 
CPM in chronic LBP 
T: pressure  
S: plantar tip of the 2nd 
toe (most painful side)   
T: CPT (0,1±0,7°C) 
S: ipsilat (most painful 
side) hand  
D: max. 120 s  
PPT  Tropisetron: no effect 
on CPM  response 
(p=0.016) 
Niesters et 
al.  
(2011) 
 
PP: Healthy (n=10;  
M=4; F=6) 
CP: Healthy  
A: range N/A [mean 
24.1 ±3.7 years] 
PP: Ketamine (40mg per 70 
kg) 
CP: Placebo 
Effect of Ketamine on 
CPM and Offset 
Analgesia 
T: heat (placebo 
46.1±2.5°C; ketamine 
45.9±2.9°C) 
S: L arm, ventral  
T: CPT (placebo 
10.3±3.9°C; ketamine 
10.7±3.8°C) 
S: foot + lower leg 
(side N/A) 
D: 55 s  
eVAS  Ketamine: CPM  
response  (p<0.01) 
No effect on Offset 
Analgesia.  
Ram et al.  
(2008) 
 
PP: Chronic pain 
(n=73; M=38;F=35)  
CP: Chronic pain 
(n=37; M=20;F=17) 
A: 19-76 years 
[49.5±16.5 years]  
PP: Opoid (OP)  
- Oxycodone (n=17; 20-
80mg/day) 
- Morphine (n=3; 10-360 
mg/day) 
- Tramadol (n=21; 50-
400mg/day) 
- Propoxyphene (n=18; 
40-200mg/day) 
- Fentanyl (n=13; 25-
375µg/h) 
- Codein (n=4; 15-
45mg/day 
CP: Non-Opioid (NOP) 
- Diclofenac (n=3; 50-
100mg/day) 
- Etodalac (n=18; 400-
1800mg/day) 
- Celecoxib (n=2; 200-
600mg/day) 
- Iboprofen (n=4; 400-
800mg/day) 
- Paracetamol (n=3; 500-
2000mg/day) 
- Dipyrone (n=4; 500-
1500mg/day) 
- Indometacine (n=1; 
200-600mg/day) 
- Etoricoxib (n=7; 60-
240mg/day) 
Effect of OP / NOP on 
CPM and on 
hyperalgesia in chronic 
pain 
T: heat (37±47°C) 
S: L thenar  
T: CPT (12°C) 
S: R hand  
D: max. 180 s  
NPS  CPM  response  in OP 
vs NOP (p=0.003) 
CPM  response  in OP 
vs NOP in men 
(p=0.001)  
Rezaii & 
Ernberg 
(2010) 
 
PP: Healthy (n=15; 
M=0; F=15) 
CP: Healthy (n=17; 
M=0; F=17)  
PP: Oral Contraceptives (OC) 
(different combinationas of 
hormones, but all containing 
ethinyl estradiol & gestagen) 
CP: no OC 
Influence of OC on CPM 
in healthy women 
T: pressure  
S: L or R, most 
prominent part of m. 
masseter + tip of the 
3rd finger  
T: CPT (3°C) 
S: contralat hand + 
wrist  
D: max. 300 s  
NRS  CPM  response  in OC 
vs non OC (p<0.05) 
A: range N/A [mean 
24.2 ± SD 3.2 years]  
Graven-
Nielsen et 
al.  
(2012) 
 
PP: Knee 
osteoarthritis (OA) 
(n=20; M=6; F=14)  
CP: Healthy (n=21; 
M=4; F=17)  
A (PP): 48-86 years 
[mean 68 years]  
A (CP): 40-81 years 
[mean 60 years] 
PP: knee replacement 
surgery 
CP: no intervention 
Influence of chronic 
tissue damage (caused 
by knee OA) on the 
maintaining of central 
sensitization measured 
by CPM 
T: pressure (cuff)  
S: bilat, knee: 7x 
peripatellar region  
T: ischem ex (TT)  
S: L arm, lower rim of 
cuff 3 cm proximal to 
the cubital fossa  
D: 4 cm VAS  
PPT  Preoperative: CPM 
response in OA (p<0.03) 
Postoperative: CPM 
response in OA 
(p<0.0002) 
Kosek & 
Ordeberg  
(2000) 
 
PP: Hip OA (n=15; 
M=?; F=?)  
CP: Healthy (n=15; 
M=?; F=?)  
A (PP): 29-66 years 
[mean 52 years] 
A (CP): 30-67 years 
[mean 50 years] 
PP: total hip replacement 
(n=11); osteonomy (n=2) 
CP: no intervention 
Influence of chronic 
pain (caused by hip OA) 
on CPM, measured 
before and after surgery 
T: pressure/ 
tactile/cold/ heat (temp 
N/A) 
S: contralat to the most 
painful hip, Trochanter 
Maior Femoris/thigh/lat 
side of the calf  
T: ischem ex (TT)  
S: ipsilat to most 
painful hip, just 
proximal to the 
cubital fossa  
D: max. 30 mm VAS  
PPT  Preoperative: CPM 
response in OA vs 
controls (p<0.02) 
Postoperative:  CPM 
response in OA (p<0.02 
Valencia et 
al.  
(2012) 
 
PP: Clinical shoulder 
pain (n=58: M=41; 
F=17)  
CP: Healthy  (n=56; 
M=40; F=16)  
A (M):  range N/A 
[mean 28.71 ±  8.44  
years]  
A (F):  range N/A 
[mean 32.34± 11.55 
years] 
PP: arthroscopic surgery of 
the shoulder 
CP: shoulder pain induction 
by exercise-induced muscle 
pain (by a isokinetic 
dynamometer) 
CPM in healthy 
population (pain 
induction via ischemic 
exercise) vs clinical 
shoulder pain (pre- and 
postoperative) 
T: heat (46,48,50°C) 
S: non-dominant/non-
surgical thenar  
T: CPT (8°C) 
S: dominant/surgical 
hand till wrist  
D: max. 60 s  
NRS  No difference in CPM 
response after pain 
induction (p=0.778) or 
surgery (p=0.186) 
Oono et al.  
(2012) 
 
PP: Healthy (n=40; 
M=20; F=20)  
CP: Healthy  
A (M): 20-38 years 
(mean 25.4 ± SEM 
0.9)   
A (F): 20-30 years 
(mean 24.9 ± SEM 
0.8) 
PP:  TMJ pain induction by el 
stim (5 Hz; 0.5 ms duration) 
CP:  without TMJ pain 
induction 
Influence of el stim (in 
TMJ) on CPM + effect of 
gender on CPM 
T: pressure  
S: R m. masseter + L 
forearm (Flexor Carpi 
Radialis)  
T: pressure  
S: pericranial muscles 
(vertex)  
D: ± 7 minutes  
VAS  No difference in CPM 
response with el stim vs 
without el stim (p>0.05) 
No sex differences 
Table 2: Evidence table. (PP=patient population; CP=control population; A=age; n=number of patients; M=male; F=female; T=type; S=site; D=duration; N/A=not applicable; SD=standard 
deviation; IQR=interquartile; SEM=standard error of the mean; L=left; R=right; SEP= Somatosensory evoked potentials; (e)VAS=(electronic) visual analogue scale; NPS=numeric pain scale; 
NRS=numeric rating scale; pPTT=pressure pain tolerance threshold; EPTT=electrical pain tolerance threshold; EMG=electromyography; RIII reflex=nociceptive flexion reflex; PPT=pressure pain 
tolerance; m=musculus; CPT=cold pressure test; QST=quantitative sensory testing; LBP=low back pain; vs=versus; OA=osteoarthritis; TT=tourniquet test; ischem ex=ischemic exercise; el  
stim=electrical stimulation; TMJ=temporomandibular joint; temp=temperature.) 
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ABSTRACT 
 
Background: The impairment in musculoskeletal structures in patients with low back pain is often 
disproportionate to their complaint. Therefore, the need arises for exploration of alternative 
mechanisms contributing to the origin and maintenance of non-specific LBP.  The recent focus has 
been on central nervous system phenomena in LBP and the pathophysiological mechanisms underlying 
the various symptoms and characteristics of chronic pain. Knowledge concerning changes in pain 
processing in low back pain remains ambiguous, partly due to the diversity in the low back pain 
population.  
Objective: The purpose of this study is therefore, to compare quantitative sensory assessment in 
different groups of low back pain patients with regard to chronicity. Recurrent low back pain (RLBP), 
mild chronic low back pain (CLBP) and severe CLBP are compared on the one hand with healthy 
controls (HC), and on the other hand with fibromyalgia (FM) patients, in which abnormal pain 
processing has previously been reported. 
Study design: cross-sectional study 
Setting: Department of rehabilitation sciences, University Ghent, Belgium.  
Methods: Twenty-three RLBP, 15 mild CLBP, 16 severe CLBP, 26 FM and 21 HC participated in this 
study. Quantitative sensory testing was conducted by manual pressure algometry and computer-
controlled cuff algometry. A manual algometer was used to evaluate hyperalgesia as well as temporal 
summation of pain and a cuff algometer was used to evaluate deep tissue hyperalgesia, the efficacy of 
the descending pain inhibitory system and spatial summation of pain.  
Results: Pressure pain thresholds by manual algometry were significantly lower in FM compared to 
HC, RLBP and severe CLBP. Temporal summation of pain was significantly higher in FM compared to 
HC and RLBP. Pain tolerance thresholds assessed by cuff algometry were significantly lower in FM 
compared to HC and RLBP and also in severe CLBP compared to RLBP. No significant differences 
between groups were found for spatial summation.  
Limitations: No psychosocial issues were taken into account for this study. 
Conclusion: The present results suggests normal pain sensitivity in RLBP, but future research is needed. 
In mild and severe CLBP some findings of altered pain processing are evident, although to a lesser 
extent compared to FM patients. In conclusion, mild and severe CLBP presents as a spectrum, 
somewhere between completely healthy persons and FM patients, characterized by pain 
augmentation.  
Key words: low back pain; fibromyalgia; pain assessment; quantitative sensory testing; central 
sensitization. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: “Mild” CLBP refers to “non-continuous” CLBP. “Severe” refers to “continuous” CLBP.  
1. INTRODUCTION 
 
The impairments in musculoskeletal structures in patients with low back pain (LBP) are often 
disproportionate to their complaints [1]. By consequence, the need arises to explore alternative 
mechanisms contributing to the origin and maintenance of non-specific LBP. In addition to potential 
peripheral mechanisms, the recent focus has been on central nervous system phenomena in LBP 
research and the pathophysiological mechanisms underlying the various symptoms and characteristics 
of chronic pain. Sensitized central pain mechanisms are the result of prolonged and strong activation 
of dorsal horn neurons which leads to increased neuronal responsiveness of pro-nociceptive 
mechanisms [2]. Moreover, an imbalance between enhanced pain facilitation and decreased 
endogenous pain inhibition is demonstrated in different chronic pain conditions, leading to widespread 
pain and hyperalgesia [3–5]. 
Sensitized central pain mechanisms may potentially be involved in the transition from acute to chronic 
widespread pain [6]. In whiplash patients, altered pain processing, rather than impaired motor control, 
has been identified as one of the prime prognostic factors for developing chronic whiplash complaints 
[7]. In fibromyalgia (FM) patients, it is suggested that central pain mechanisms can be dependent on 
abnormal peripheral input(s) for development and maintenance of the chronic condition [8]. Until 
now, only conflicting results for the involvement of sensitized central pain mechanisms in LBP are 
available in literature. Some studies found generalized hyperalgesia in patients with chronic low back 
pain (CLBP) [9–12], whereas others found no differences in pain perception or modulation in CLBP 
[13,14]. These inconsistent results might be the consequence of the heterogeneity within the LBP 
population as proposed by O’Sullivan et al [15]. In recurrent low back pain (RLBP), to our knowledge, 
no research on altered pain processing is performed. Besides, often there is no clear distinction 
between CLBP and RLBP. 
Consequently, the challenge is to compare subgroups of LBP with different levels of chronicity, for 
possible signs of malfunctioning in pain processing. Therefore, next to defining RLBP patients, 2 
subgroups of CLBP, based on the frequency of pain days in one week, were defined: a group with mild 
CLBP and a group with severe CLBP. In the current study, it is hypothesized that while RLBP may be 
mainly due to musculoskeletal dysfunctions (explaining the intermittent/fluctuating nature of the 
complaints), the transition to chronic pain may be complicated with sensitized pain processing 
mechanisms. Therefore, in contrast to RLBP and asymptomatic controls, severe CLBP patients and FM 
were hypothesized to have widespread hyperalgesia, facilitated spatial summation of pain (SS), 
facilitated temporal summation of pain (TS) and impaired conditioning pain modulation. 
Manifestations of pro- and anti-nociceptive mechanisms are examined by quantitative somatosensory 
testing. Handheld pressure algometry is a frequently used, valid and reliable method to evaluate 
subcutaneous pain sensitivity in the local area and in distant structures [16,17]. Alternatively, 
computer controlled cuff algometry is a standardized and examiner-independent tool to assess deep 
tissue pain sensitivity [18]. It is able to assess a larger tissue volume and is in that way less influenced 
by local pain sensitivity [6]. In this study, manual algometry is used to assess hyperalgesia and bottom 
up processing, while cuff algometry is used to assess deep tissue hyperalgesia, spatial summation and 
endogenous pain inhibition. 
 
 
2. METHODS 
 
Subjects 
All subjects were recruited through co-workers and students of the University hospital of Ghent. The 
recruitment occurred through announcements on social media (Facebook, twitter) and by 
advertisements (posters and flyers) in the different hospitals in Ghent and in private practices of the 
co-workers. Healthy controls (HC) are matched to the patient groups for gender. All in- and exclusion 
criteria can be found in table 1  [19–24].  
GROUP 
GENERAL IN- AND 
EXCLUSION CRITERIA 
SPECIFIC IN- AND EXCLUSION CRITERIA 
RLBP 
- males and females 
- 18-65 years old 
- ≥1 years post-natal 
- no neurological, respiratory, 
circulatory or severe 
orthopaedic diseases 
- no pregnancy 
- no back surgery 
- no previous cognitive exercise 
therapy for their low back pain 
- no use of antidepressants or 
analgesics (except for NSAID’s 
or paracetamol), taken two 
weeks prior to the testing 
- non-specific RLBP 
- ≥6 months 
- a frequency of ≥2 episodes in the past year [19] 
- a pain flare of ≥24 hours [20], characterized by an increase 
of ≥2 on a NRS scale and/or ≥5 on the Roland-Morris 
Disability Questionnaire [21] 
- followed by a pain free episode of ≥1 month, characterized 
by a 0/10 on an NRS scale and/or <2 on the Roland-Morris 
disability questionnaire [22] 
- applicate for medical help concerning low back complaints 
Mild CLBP 
- non-specific CLBP 
- ≥3 months [23] 
- 3 to 4 pain days a week 
Severe 
CLBP 
- non-specific CLBP 
- ≥3 months [23] 
- 7 pain days a week 
FM - diagnosed by the 2010 ACR-criteria for primary FM  [24] 
HC 
- healthy persons 
- no physical pain complaints 
- never asked for help or advice concerning low back pain 
Table 1: In- and exclusion criteria of all subjects. HC=healthy controls; RLBP=recurrent low back pain; CLBP=chronic low back 
pain; FM=fibromyalgia; NRS=numeric rating scale 
This cross-sectional study is part of a larger study. The complete study was approved by the local ethical 
committee (EC UZ 22012/791) and all subjects gave written informed consent to participate. 
 
Procedure 
An anamnesis was performed to control for all in- and exclusion criteria. To evaluate the LBP disability 
on the day of testing, all patient groups were asked to fill in the Roland-Morris Disability Questionnaire. 
The items in this questionnaire represent the execution of daily physical activities and functions that 
may be affected by LBP complaints [25]. Afterwards, the pain measurements were assessed.  
First, pressure pain thresholds (PPT) and TS were measured by manual algometry on the lower back, 
quadriceps, trapezius and hand. TS started 2 minutes after the PPT assessment and was provoked by 
10 consecutive pressure stimuli delivered at the previously determined PPT [26]. Next, the pressure 
pain detection threshold (cPDT) and the pressure pain tolerance threshold (cPTT) were measured by 
the cuff algometer. Spatial summation was assessed by recordings of cPDT and cPTT for 2 different 
stimulation areas (inflation of 1 and 2 chambers in the cuff). Afterwards 2 minutes of rest were 
inserted. Finally, to evaluate endogenous pain inhibition, conditioned pain modulation (CPM) was 
assessed. To assess a baseline for CPM, 15 repetitive cuff stimulation pulses were applied and the pain 
intensity was recorded, followed by 5 minutes of rest [27]. Afterwards this procedure was repeated, 
by adding the conditioning stimulus (immersion of the hand in a hot water bath of 46°C) for eliciting 
CPM. Standardized instructions were used for all subjects. An overview of all algometry parameters 
and the assigned abbreviations can be found in table 2.  
MEASURED 
BY 
ABBREVIATIO
N 
COMPLETE TERM CALCUATION 
Digital 
Algometer 
PPT Pressure pain threshold 
The moment of the first uncomfortable 
sensation 
TS 
Temporal summation of 
pain 
Area under the curve of pain sensation during 
pulse 1, 5, 10 when mean PPT was applied 10 
repetitive times 
Cuff Algometer 
cPDT 
Pressure pain detection 
threshold 
The moment when the visual analogue scale 
exceeds 0.5  
cPTT 
Pressure pain tolerance 
threshold 
The moment when the sensation gets 
unbearable 
SS 
Spatial summation of 
pain 
A lower PPDT and/or PPTol during inflation of 
both chambers compared to inflation of a single 
chamber  
CPM 
Conditioned pain 
modulation 
Area under the curve of the condition, in which a 
combination of a test stimulus and conditioning 
stimulus were applied, minus the earea under 
the curve of the condition, in which a singular 
test stimulus was applied 
Table 2: The elucidation of the used abbreviations of the algometry parameters. 
On the day of testing, all subjects were asked to refrain from alcohol, nicotine, caffeine and all 
medication, including NSAID’s and paracetamol. Subjects were also instructed not to perform 
exhausting physical activities the day before.  
 
Manual pressure algometry 
A hand held pressure algometer (Wagner Force Ten) with a circular probe of 1 cm diameter was used 
to assess PPTs. Pressure was applied perpendicular and at a constant rate (1kg/s) to the tissue surface, 
bilaterally at 4 spots: erector spinae muscle (lower back) at 5 cm laterally of the processus spinosus 
vertebrae at L3 [28]; quadriceps muscle (quadriceps) at the middle between anterior superior iliac 
spine and basis patella [26]; trapezius muscle (trapezius) at the middle between acromion and 
processus spinosus at C7 [29–31]; the web (hand) between index and thumb at the dorsal hand side 
[13,32]. For each site, 2 PPT measurements were taken with a 30 seconds interval [29] and the mean 
of both recordings was used for further analysis.  Lower back and quadriceps sites were measured in 
prone and supine position respectively (Figure 1A and 1B). Trapezius and hand sites were measured 
when sitting on a chair. For trapezius, both arms hung relaxed besides the trunk (Figure 1C) and for 
the hand site (Figure 1D), both hands were placed on a table. 
  
  
Figure 1. The assessment of pressure pain at 4 spots. A: lumbar erector spinae muscle (=lower back); B: quadriceps muscle 
(=leg); C: trapezius muscle (=neck); D: the web (=hand). 
A B 
C D 
 Pressure pain threshold: Subjects were instructed to say ‘stop’ when the sensation became 
‘uncomfortable’. The minimal amount of pressure that induces an ‘uncomfortable pain’, resembles 
PPT [15]. 
Temporal summation: TS was used to evaluate endogenous pain facilitation. The previous determined 
mean PPT intensity was applied 10 repetitive times at each assessment site and was maintained 1 
second before being released. Pressure was increased, during 1 second, until the previously 
determined mean PPT intensity was reached [27,31], followed by 1 second of rest. After the 1st, 5th and 
10th stimulus, a numeric rating score (NRS) of the pressure induced pain sensation was recorded.  
 
Cuff pressure algometry  
Computer controlled cuff algometry (Nocitech and Aalborg University, Denmark) was used to assess 
cPDT, cPTT, SS and CPM. The device consists of a computer controlled compressor, connected with a 
13-cm wide silicone tourniquet cuff (VBM Medizintechnik GmbH, Sulz, Germany) and an electronic VAS 
scale allowing continuous recording of the pain intensity [18]. The electronic VAS contains a ‘stop’-
button and a 10 cm bar, indicating the amount of experienced pain: 0 cm is ‘no pain’ and 10 cm 
represents ‘the worst pain imaginable’. The inflatable cuff was separated into 2 equal-sized chambers 
which were positioned directly onto the skin at the thickest point of the right calf (Figure 2A).  
Pressure pain detection threshold and pressure pain tolerance threshold: In order to evaluate cPDT and 
cPTT, the distal chamber of the cuff was gradually inflated (1kPa/s) until a maximum of 100kPa. 
Subjects constantly scored their sensation during inflation on the electronic VAS. They started shifting 
the bar at the point when feeling ‘uncomfortable’ and pushing the ‘stop’-button when the pressure 
stimulation got ‘intolerable’ (cPTT) after which immediate deflation was initiated. A VAS-values of 0.5 
cm was set as cPDT [18]. Inflation of 1 chamber and inflation of 2 chambers, respectively, were done. 
Assessments were repeated 3 times with 30 seconds rest in-between and the mean of the two last 
recordings was used for further analysis. 
Spatial summation: To assess SS, the cPDT and cPTT during inflation of the double-chamber cuff was 
compared by cPDT and cPTT during inflation of the singe-chambered cuff. The sequence of one or both 
chamber compressions was randomized and subjects were blinded for which condition was applied.   
Conditioned pain modulation: Fifteen repetitive cuff compressions of both chambers (1 second 
stimulation and 1 second pause) were used as a test stimulus [33], but only the 3rd pulse of both 
conditions were used for further analysis in this study. The intensity of the compression was set as the 
mean value of cPDT and cPTT [33,34]. As a painful conditioning stimulus, the subjects immersed their 
right hand in a hot water bath of 46°. Subjects were asked to immerse the hand in the water until 10 
cm above the wrist [35], 20 seconds prior to the administration of the test stimulus. Subjects scored 
the sensation of the cuff compressions on the electronic VAS and for each stimulus a VAS-score was 
extracted. They were instructed to focus on and rate the pain intensity of the leg and to ignore the 
sensation on the hand. CPM was quantified by calculating the amount of pain reduction in the test 
stimulus evoked by a painful conditioning stimulus [36]. (Figure 2B).  
 
  
Figure 2: The computerized cuff algometer assessment. A: a double chambered cuff around the calf 
and an electronic VAS in the hands of the patients. B: a hot water bath of 46° as conditioning 
stimulus. 
 
 
Data analysis and statistics 
Statistics were performed on Windows 10 software using IBM SPSS Statistics 22 (SPP Inc., Chicago, IL, 
USA). In all analysis by manual algometry, a mean value of left and right measurements was calculated 
and used.  
For TS, the area under the curve was calculated by summation of NRS during pulse 1, 5 and 10. For SS, 
the ratio of cPDT and cPTT, respectively were calculated: the threshold from the double-chamber cuff 
was divided by the threshold from the single-chamber cuff. For CPM a delta-value was calculated: the 
condition with conditioning stimulus minus the condition without conditioning stimulus resulted in 
CPM. The lower this CPM value, the less efficient the pain inhibition works. 
A B 
Since the data was observed to deviate from normally, a non-parametric Kruskal-Wallis analysis of 
variance test was performed to evaluate differences between groups in demographic variables, the 
Roland-Morris Disability Questionnaire, PPT by manual pressure algometer, and cPDT, cPTT, SS and 
CPM by cuff algometer. Mann-Whitney U tests were used post-hoc for group comparisons in case of a 
significant Kruskal-Wallis test. To evaluate the functionality of SS and CPM, a Wilcoxon Signed Ranks 
test was performed. A Chi-Square test was used to evaluate gender distribution between groups. TS 
measured by manual algometer, which was observed to be normally distributed, was examined using 
a general linear model (GLM) followed by post-hoc tests of which p-values and 95% confidence 
intervals are presented (Bonferroni corrected). Age and body mass index were initially used as 
covariates in GLM, but were observed to be of no influence in gathered data, so these covariates were 
no longer taken into account for further analysis. Homogeneity of variances was tested using the 
Levene’s test. In order to examine the influence of the applied pressure on TS and CPM respectively a 
Pearson and Spearman correlation was assessed for each group. Hence, in order to improve the 
interpretation of the results, a post hoc power analysis by the ‘GPower’ program (By Franz Faul, 
Universitat Kiel, Germany, Version 3.1.9.2) was performed. A P-value of 0.05 was considered 
significant. 
 
 
3. RESULTS 
 
Demographics 
A total of 101 subjects between 20 and 64 years of age participated in this study (Table 3). No 
difference in gender was seen between groups (Chi-Square: p>0.05). The mean age was significantly 
lower in RLBP compared to respectively severe CLBP and FM (Mann-Whitney U: p=0.002; p<0.05). The 
mean age was also significantly lower in mild CLBP compared to respectively severe CLBP and FM 
(Mann-Whitney U: p=0.021; p=0.002). The body mass index was significantly higher in FM compared 
to HC and RLBP (Mann-Whitney U: p=0.027; p=0.018) and in severe CLBP compared to respectively HC, 
RLBP and mild CLBP (Mann-Whitney U: p=0.029; p=0.020; p=0.041). The score on the Roland-Morris 
Disability Questionnaire was significantly lower in RLBP compared to mild CLBP, severe CLBP and FM 
(p<0.05) and higher in FM compared to severe CLBP (p=0.002) and to mild CLBP (p=0.001). None of the 
subjects used alcohol, nicotine, caffeine or any medication (including NSAID’s and paracetamol) on the 
day of testing.  
 HC (n=21) RLBP (n=23) CLBP mild (n=15) CLBP severe (n=16) FM (n=26) Total (n= 
101) 
GENDER 9 m; 12 f 9 m; 14 f 7 m; 8 f 8 m; 8 f 7 m; 19 f 40 m; 61 f 
SYMPTOMATIC 
SIDE 
/ - L: 2  
- R: 4 
- bilat: 17 
- R: 1 
- bilat: 14 
- L: 2 
- R: 2 
- bilat: 12 
- R: 1 
- bilat: 18 
- centr: 5 
- no LBP: 2 
- L: 4   
- R: 8 
- bilat: 61 
- centr: 4 
- no LBP: 23 
 mean 
(SD) 
median 
(IQR) 
min-
max 
mean 
(SD) 
median 
(IQR) 
min-
max 
mean 
(SD) 
median 
(IQR) 
min-
max 
mean 
(SD) 
median 
(IQR) 
min-
max 
mean 
(SD) 
median 
(IQR) 
min-
max 
mean 
(SD) 
median 
(IQR) 
AGE (years) 38 (13) 40 (29) 20 - 55 31 (10) 27 (12) 21 – 53  34 
(10) 
31 (14) 20 - 
54 
46 
(14) 
50 (28) 23 - 
64 
45 (9) 46; 
(11) 
22 - 
58 
39 
(13) 
39 (24) 
BMI 23.00 
(3.02) 
22.46 
(4.06) 
18.25-
30.22 
22.88 
(2.33) 
22.80 
(2.59) 
18.59-
28.83 
23.29 
(1.60) 
23.07 
(1.13) 
 25.00 
(3.07) 
24.07 
(3.53) 
19.66-
31.74 
26.14 
(5.07) 
24.99 
(6.70) 
19.49-
37.84 
24.14 
(3.62) 
23.30 
(4.12) 
SYMPTOME 
DURATION 
(months) 
/ / / 112 
(81) 
84 (120) 24 - 
300 
104 
(74) 
78 
(138) 
24 - 
240 
199 
(169) 
156 
(213) 
30 - 
552 
159 
(124) 
150 
(144) 
20 - 
508 
141 
(118) 
102 
(132) 
RMDQ (max 24) / / / 1.52 
(1.44) 
1.00 (1) 0 - 6 4.93 
(2.69) 
5.00 
(3) 
1 - 
11 
5.56 
(2.90) 
5.00 
(5) 
1 – 12  10.19 
(4.77) 
10.50 
(7) 
1 - 21 4.63 
(4.79) 
3.00 
(6) 
Table 3: Subject characteristics (SD=standard deviation; IQR=interquartile range; n=number of subjects included; m=male; f=female; L=left; R=right; 
bilat=bilateral; centr=central; no LBP=no low back pain; RMDQ=Roland-Morris disability questionnaire; HC=healthy controls; RLBP=recurrent low back pain; 
CLBP=chronic low back pain; FM=fibromyalgia. 
 
 
 
Manual pressure algometry 
Significant differences between groups were found for PPT in quadriceps and lower back and a border 
significant difference was found for trapezius (Kruskal-Wallis: p=0.044; p.0.035; p=0.052). Mean values 
for PPT were significantly lower in FM compared to respectively HC, RLBP and severe CLBP for 
quadriceps (Mann-Whitney U: p=0.004; p=0.029; p=0.049), lower back (Mann-Whitney U: p=0.011; 
p=0.005; p=0.038) and trapezius (Mann-Whitney U: p=0.006; p=0.026; p=0.039).  
Significant differences between groups were found for VAS scores to repeated pressure stimulation in 
quadriceps, lower back, trapezius and first web (ANOVA: p=0.001; p=0.006; p<0.05; p=0.003). TS was 
significantly higher in FM compared with HC and RLBP for quadriceps (Bonferroni: p=0.047, [0.21, 
10.12]; p<0.05, [2.95, 12.49]) and trapezius (Bonferroni: p=0.023, [0.45, 9.31]; p<0.05, [3.08, 11.72]). 
The mean TS was also significantly higher in FM compared to RLBP for lower back and hand 
(Bonferroni: p=0.002, [2.01, 11.92]; p=0.001, [2.12, 11.68]). No correlations were found between TS 
and the intensity of the applied pressure (Pearson: p>0.05).  
Cuff algometry 
Significant differences between groups were found for cPTT (Kruskal-Wallis: p=0.006) but not for cPDT 
(Kruskal-Wallis: p=0.496) when assessing 1 chamber. The mean cPTT was significantly lower in FM 
compared with HC and RLBP (Mann-Whitney U: p=0.005; p=0.041) and in severe CLBP compared to 
RLBP (Mann-Whitney U: p=0.041). 
Significant lower cPTT (Wilcoxon Signed Ranks test: p<0.012) was found in all groups when 
compression in both chambers was applied compared to compression in one chamber, resembling a 
well-functioning SS. Also significant lower cPDT were found in all groups (Wilcoxon Signed Ranks test: 
p<0.042) when inflation in both chambers was applied, except in severe CLBP (p>0.05). The SS-ratio 
although, was not significantly different between groups for cPDT or cPTT (Kruskal-Wallis: p>0.05; 
p>0.05) (Figure 3A and 3B).  
 
Figure 3A and 3B. Spatial Summation of cPDT and cPTT: VAS-values for inflation of 1 chamber versus VAS-values for inflation 
of 2 chambers. 
  
For CPM, mean values when the conditioning stimulus was applied were lower compared to the 
condition when no conditioning stimulus was applied, although not significant (Wilcoxon Signed Ranks 
test p>0.05). Also no significant differences between groups were established for CPM nor for the 
baseline condition without conditioning stimulus (Kruskal-Wallis: p=0.683; p=0.478). No correlations 
were found between CPM and the intensity of the applied pressure (Spearman: p>0.05). Post hoc 
power analysis demonstrated a power of 0.29 for the difference between HC and severe CLBP 
(expected effect size=0.5; p=0.05).  
A summary of all presented data can be found in table 4.  
 HC RLBP Mild CLBP Severe CLBP FM 
mean 
(SD) 
median 
(IQR) 
min-
max 
mean 
(SD) 
median 
(IQR) 
min-
max 
mean 
(SD) 
median 
(IQR) 
min-
max 
mean 
(SD) 
median 
(IQR) 
min-
max 
mean 
(SD) 
median 
(IQR) 
min-
max 
MANUAL PPT 
quadriceps 7.48 
(4.68) 
6.24 
(4.19) 
2.63 – 
24.70 
6.46 
(3.15) 
5.00 
(3.41) 
2.89 – 
16.38 
6.19 
(3.08) 
5.58 
(4.22) 
2.20 – 
14.00 
6.25 
(2.53) 
6.09 
(4.32) 
1.24 – 
10.05 
4.70 
(2.54) 
4.46 
(3.03) 
1.32 – 
12.00 
lower back 7.30 
(4.42) 
5.83 
(4.23) 
2.36 – 
19.76 
6.89 
(3.32) 
5.57 
(3.82) 
2.91 – 
16.94 
6.14 
(3.07) 
5.16 
(3.84) 
1.94 – 
14.27 
6.36 
(3.47)  
5.31 
(3.79) 
0.86 – 
13.87 
4.44 
(2.12) 
4.26 
(2.99) 
1.16 – 
8.70 
trapezius 5.22 
(3.76) 
4.27 
(3.15) 
1.29 – 
19.54 
4.27 
(1.84) 
3.55 
(2.55) 
1.67 – 
7.74 
4.33 
(2.18) 
3.94 
(1.43) 
0.95 – 
9.43 
4.04 
(1.71) 
3.69 
(2.05) 
1.00 – 
7.78 
3.18 
(1.57) 
2.87 
(2.15) 
1.07 – 
6.93 
hand 5.79 
(4.16) 
4.59 
(4.21) 
1.78 – 
19.26 
4.87 
(2.49) 
3.90 
(3.45) 
2.01 – 
10.42 
4.78 
(3.04) 
4.20 
(3.10) 
1.45 – 
13.88 
4.56 
(2.28) 
4.54 
(2.60) 
1.27 – 
10.44 
3.77 
(1.48) 
3.71 
(2.03) 
0.98 – 
6.66 
MANUAL TS                
quadriceps 11.30 
(6.17)  
10.25 
(11.25) 
2.50 – 
22.50  
8.74 
(6.35) 
6.00 
(8.00) 
0.50 – 
24.00 
12.13 
(6.23) 
13.00 
(7.50) 
1.50 – 
22.50 
12.5 
(5.48) 
13.75 
(9.00) 
4.00 – 
21.00 
16.45 
(5.73) 
16.75 
(9.75) 
7.00 – 
27.00 
lower back 11.13 
(6.38) 
9.25 
(11.00) 
3.00 – 
23.50 
8.15 
(6.77) 
6.50 
(10.50) 
0.50 – 
22.00 
12.53 
(6.19) 
11.50 
(10.00) 
3.00 – 
24.00 
12.46 
(5.57) 
10.25 
(10.00) 
5.50 – 
23.00 
15.12 
(6.08) 
14.75 
(9.25) 
3.00 – 
27.50 
trapezius 11.35 
(5.10) 
10.75 
(8.63) 
4.50 – 
21.00 
8.70 
(4.48) 
7.50 
(8.50) 
0.50 – 
15.50 
13.50 
(6.92)  
14.50 
(10.00) 
2.50 – 
24.00 
12.79 
(5.58) 
12.75 
(9.38) 
3.50 – 
22.00 
16.10 
(5.50) 
16.75 
(9.13) 
7.00 – 
25.50 
hand 11.98 
(5.38) 
10.25 
(8.75) 
3.00 – 
23.50 
8.02 
(5.91) 
7.00 
(8.50) 
0.00 – 
22.00 
13.40 
(7.13) 
13.00 
(10.50) 
1.50 – 
27.00 
12.29 
(6.88) 
12.25 
(12.75) 
1.50 – 
25.00 
14.92 
(5.32) 
16.25 
(9.00) 
6.00 – 
22.50 
CUFF 
cPDT  35.94 
(18.31) 
40.01 
(30.68) 
7.27 – 
68.46 
34.17 
(18.36) 
29.70 
(20.43) 
9.96 – 
76.68 
31.23 
(17.85) 
25.58 
(20.54) 
12.65 – 
71.97 
27.25 
(11.25) 
25.98 
(18.29) 
12.23 – 
52.43 
29.64 
(12.89) 
27.24 
(15.08) 
9.09 – 
58.07 
cPTT  75.87 
(20.64) 
70.13 
(40.88) 
40.24 – 
100 
78.61 
(20.51) 
80.30 
(32.08) 
25.61 - 
100 
66.09 
(23.05) 
60.43 
(51.84) 
35.49 - 
100 
68.39 
(17.67) 
67.31 
(20.02) 
40.82 - 
100 
56.92 
(23.36) 
52.46 
(34.47) 
22.68 - 
100 
SS (cPDT) 0.89 
(0.33) 
0.82 
(0.55) 
0.44 – 
1.70 
0.85 
(0.37) 
0.78 
(0.38) 
0.26 – 
2.12 
0.83 
(0.30) 
0.84 
(0.48) 
0.39 – 
1.42 
0.97 
(0.26) 
0.92 
(0.32) 
0.53 – 
1.58 
0.74 
(0.19) 
0.74 
(0.32) 
0.46 – 
1.13 
SS (cPTT) 0.88 
(0.21) 
0.91 
(0.25) 
0.52 – 
1.32 
0.84 
(0.16) 
0.87 
(0.26) 
0.48 – 
1.09 
0.80 
(0.12) 
0.81 
(0.14) 
0.59 – 
1.01 
0.85 
(0.19) 
0.85 
(0.26) 
0.60 – 
1.35 
0.77 
(0.16) 
0.74 
(0.29) 
0.50 – 
1.03 
CPM (no CS) 1.11 
(1.61) 
0.00 
(20.13) 
0.00 – 
6.32 
0.30 
(0.48) 
0.00 
(0.37) 
0.00 – 
1.76 
0.93 
(1.24) 
0.55 
(1.58) 
0.00 – 
4.51 
0.58 
(0.93) 
0.00 
(1.11) 
0.00 – 
3.26 
0.43 
(0.75) 
0.00 
(0.62) 
0.00 – 
2.76 
CPM (no CS 
minus CS) 
0.32 
(0.72) 
0.00 
(0.74) 
-0.47 – 
1.90 
-0.03 
(0.25) 
0.00 
(0.17) 
-0.83 – 
0.37 
-0.09 
(1.01) 
0.00 
(0.45) 
-3.44 – 
0.94 
0.01 
(0.35) 
0.00 
(0.15) 
0.72 – 
1.36 
-0.01 
(0.34) 
0.00 
(0.20) 
-0.57 – 
0.86 
Table 4. Summary statistics of PPT and TS by manual algometer and outcome variables by cuff algometer. SD= standard deviation; IQR= interquartile range; mini=minimum; max=maximum; 
HC=healthy controls; RLBP=recurrent low back pain; CLBP=chronic low back pain; FM=fibromyalgia; PPT=pressure pain threshold; TS=temporal summation; cPDT=pressure pain detection 
threshold by cuff algometer; cPTT=pressure pain tolerance threshold by cuff algometer; SS=spatial summation; CPM=conditioned pain modulation (the delta value of the condition without 
conditioning stimulus minus with the condition with conditioning stimulus). 
4. DISCUSSION 
 
The current study aimed at evaluating pain processing mechanisms in 3 LBP groups, compared to FM 
and HC. To our knowledge, this is the first study that aimed at investigating pain processing in RLBP 
and in different CLBP populations with defined degrees of chronicity, in comparison to the two 
extremes of the musculoskeletal pain spectrum with HC suffering from no pain and FM characterized 
by widespread pain and hyperalgesia. This study hypothesized altered pain processing in severe CLBP, 
but not in RLBP.  Mild CLBP were expected to float between RLBP and severe CLBP.  
PPT measured by manual pressure algometry is significantly lower in FM compared to HC, RLBP and 
severe CLBP at the quadriceps, lower back and trapezius, indicating widespread hyperalgesia in FM. 
These results confirm the generally widespread hypersensitivity in FM [8,37,38]. In the LBP groups, no 
clear primary hypersensitivity at the lower back is found. Because of standardization, PPT was 
measured at level L3, which might be different from the exact pain location. Also PPT values localized 
in distant structures in RLBP, mild CLBP and severe CLBP appear not different from HC. Thus, localized 
and widespread hyperalgesia is found in FM, but cannot be establish in RLBP, mild CLBP and severe 
CLBP. 
Cuff pressure algometry reveals significant lower cPTT in FM compared to HC and RLBP and in severe 
CLBP compared to RLBP. These results indicate deep tissue hypersensitivity at the leg, away from the 
pain location, and are suggestive for maladaptive pain processing in both FM and severe CLBP, but 
not in RLBP. These results are in line with another study, which found generalized and localized 
hyperalgesia in participants with long-lasting LBP (>30 days pain in the previous year), but not in 
patients with recent LBP (pain within the last 7 days) [10]. These findings supports the hypothesis that 
generalized hyperalgesia develops over time, as a consequence of long lasting pain [6]. In the current 
study, severe CLBP are older compared to RLBP. Previous research by cuff algometer established 
enhanced pain sensitivity in older healthy subjects compared to younger persons. Therefore, age might 
contribute to the differences between severe CLBP and RLBP [39].  
In the current study, RLBP scores better on the Roland-Morris Disability Questionnaire compared to 
mild and severe CLBP indicating that the perceived disability because of LBP is lower in RLBP compared 
to mild and severe CLBP. Other psychosocial factors, e.g. the ability to cope, self-efficacy, social 
support, sense of control, etc. might also differ between recurrent and chronic pain patients and 
influence local and global pain perception and pain expression [9]. It can be hypothesised that 
psychosocial characteristics might help RLBP to recover after a pain episode and prevent of becoming 
chronic, whereas psychosocial factors in CLBP might be related to the maintenance of physical 
symptoms. As far as we know, no extensive studies examined psychosocial factors in RLBP versus CLBP 
yet. 
Results on cPDT are not different between groups. Similar results were established in an earlier study 
between HC and patients with chronic whiplash associated disorders with differences in cPTT but not 
in cPDT [34]. In the current study, the cuff pressure algometer was unable to detect difference between 
groups in cPDT, whereas PPT by manual pressure algometer established differences between FM and 
HC, RLBP and severe CLBP. This inconsistency can be explained by differences in procedure: cPDT is 
defined as the pressure associated with the first increase on the VAS, while the PPT is defined as the 
pressure at which the patient indicates a feeling of discomfort. So the pain intensity at cPDT is probably 
lower compared to the PPT. Consequently, 2 different constructs are measured by cPDT by cuff 
algometer and PPT by manual algometer. Cuff pressure algometry was, however, able to reveal 
differences in cPTT between severe CLBP and RLBP. Therefore, cPTT by the computerized cuff 
algometer might be a sensitive tool to evaluate secondary hyperalgesia in LBP patients.  
Repetitive noxious stimulation at the same intensity, also known as TS, is experienced as increased 
pain and is a proxy for the level of central sensitization [6]. TS is facilitated in FM compared to HC for 
quadriceps and trapezius and compared to RLBP for quadriceps, trapezius, lower back and hand. These 
results confirm results in earlier studies [3,40]. TS in mild and severe CLBP was more provocative 
compared to HC and RLBP, however not significant, and less provocative compared to FM. As indicated 
in previous research, a shorter interstimulus interval evokes a higher pain sensation [41]. Since the 
pressure pain threshold was the lowest in FM, the aimed intensity at which TS is applied, is reached 
sooner. As a consequence, the interstimulus interval in theory is shorter in FM compared to the other 
groups and might influence the TS result. The applied intensity itself, was of no influence on TS.  As a 
consequence, these results suggest enhanced pain facilitation in CLBP groups, but not as clearly as in 
FM. These results should be confirmed in future studies. Conclusively, the results of the present study 
show clear enhanced temporal summation of pain in FM patients, but could not establish TS in CLBP 
groups.  
Interestingly, although not significant, RLBP in remission demonstrate less TS and a higher mean cPTT 
compared to HC. Besides, no local hyperalgesia is established in RLBP and TS in RLBP is significantly 
lower compared to FM. All these results illustrate a properly working pain processing in RLBP. Possibly, 
pain processing in RLBP works in very efficient way, maybe even more efficient compared to HC. This 
efficiency might help them to recover after every pain episode instead of developing chronicity. In 
general, little research has been done on pain processing in RLBP. A single study applying pain 
assessment on female workers with and without RLBP indicated no significant differences in pressure 
pain thresholds between subjects with RLBP and HC [42] confirming the results of the present study. 
The results of the current study suggest normal pain sensitivity in the RLBP group.  
Besides TS, also SS is an important mechanism to represent altered pain processing [43]. Doubling the 
tissue volume under the cuff evokes pain earlier and faster during constant compression [34,44]. In 
the present study, lowered cPDT and cPTT is seen when the surface is doubled, indicating SS is working 
properly. No differences are however found between groups. Although, these results confirm earlier 
research [34]. These results indicate no clear enhanced spatial summation in FM or LBP-groups, 
however a larger study is warranted to reconsider these results. 
Reduced descending pain inhibition contributes to maintaining pain conditions and are seen in 
different chronic pain populations [29,45,46]. In FM, a deficiency in pain inhibition is well recognized 
[45,47,48]. In the current study, the experienced pain intensity from the test stimulus is decreased 
when a conditioning stimulus is applied compared to baseline, although not significantly. This might 
indicate that the CPM assessment paradigm did not work properly. Possibly, the applied intensity 
during the baseline measurement might be too weak to elicit pain or likewise the conditioning 
stimulation was insufficient.  
The current study divided the non-specific CLBP group into a mild CLBP and a severe CLBP based on 
the amount of pain days in one week. This division between mild and severe CLBP is based on the 
amount of pain days per week. Other criteria might also be appropriate to define both groups and are 
warranted to subdivide the heterogeneous CLBP group. Future research should look for other 
parameters characterizing the different CLBP groups more accurately. By this classification however, a 
whole spectrum of subjects is created: starting from completely healthy persons, to RLBP suffering 
from pain episodes altered by pain free episodes, to mild CLBP suffering of LBP for 3-4 days a week, to 
severe CLBP suffering every day of LBP, to FM patients who are known to have generalized pain 
hypersensitivity. This study established differences between RLBP and severe CLBP for cPTT by cuff 
algometry. By manual pressure algometry, differences were seen between FM and RLBP and severe 
CLBP, but not with mild CLBP. As a matter of fact, mild CLBP didn’t differ from HC nor FM for PPT by 
manual pressure algometer. These results might indicate that mild CLBP floats between the 2 extremes 
of the spectrum and underline the diversity in pain sensitivity within the LBP population.  
The results of the current study must be seen in the light of some statistical limitations. Since this study 
did not correct for multiple comparison, statistical type-I errors cannot be excluded for the 
measurements analysed by non-parametric tests. After correction, differences remain for PPT in the 
quadriceps and trapezius and for cPTT between FM and HC, as well as for PPT in the lower back 
between FM and RLBP. Also the lack of statistical power might influence the results of this study: to 
detect an expected effect of medium size, only a power of 0.29 was found. As a consequence, true 
differences between groups might be missed. A larger study exploring pain processing in CLBP patients 
is therefore needed. For RLBP, results are promising and point in the direction of normal pain 
processing, but further research is warranted to confirm these results. 
 
 
5. CONCLUSION 
 
Generalized hyperalgesia, deep-tissue hypersensitivity and enhanced pain facilitation was seen clearly 
in FM. In both mild and severe CLBP some indications of altered pain processing were evident, although 
not in the extent of FM patients. The present results also suggest that normal pain sensitivity is 
observed in RLBP, but future research is needed. In conclusion, we propose that both mild and severe 
CLBP are situated in a spectrum, somewhere between completely healthy persons, with no altered 
pain processing and FM patients, which are established to have altered pain processing. Further 
research should unravel at which extent pain processing deficiencies are present in CLBP. 
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ABSTRACT 
Objectives 
Some LBP patients recover after every pain episode whereas others develop chronicity. The amount 
of atrophy and fat infiltration differs between patients with low back pain (LBP). Also enhanced pain 
sensitivity is present only in a subgroup of LBP patients. The relationship between pain sensitivity and 
muscular deformations is however unexplored. This study examined the association between pressure 
pain thresholds and cross-sectional area of the lumbar muscles in different groups of LBP  
Methods 
Total cross-sectional area, fat cross-sectional area, muscle cross-sectional area and muscle fat index of 
the multifidus and erector spinae were examined in 54 LBP patients (23 recurrent LBP patients, 15 non-
continuous chronic LBP patients and 16 continuous chronic LBP patients). Pressure pain thresholds 
were measured at 4 locations (lower back, neck, hand and leg). The associations between pressure 
pain thresholds and muscle structure characteristics were examined. 
Results 
A positive association was found between pressure pain thresholds and the total cross-sectional area 
of the erector spinae on the one hand and muscle cross-sectional area of the erector spinae on the 
other hand, irrespective of the LBP group. No such association was found in the multifidus muscle. 
Furthermore, no association was found between pressure pain thresholds and fat cross-sectional area 
or muscle fat index. 
Discussion 
A higher pain sensitivity is associated with a smaller total and muscle cross-sectional area in the erector 
spinae muscle, but not in the multifidus muscle. No association between lumbar muscle fat and pain 
sensitivity is found. Furthermore, all results were independent from the LBP subgroup. 
Key words: recurrent; chronic; pressure pain thresholds; cross-sectional area; magnetic resonance 
imaging  
1. INTRODUCTION 
 
Low back pain (LBP) is one of the most common complaints world wide. Up to 85% of all adults will 
deal with LBP at one point in their lives 1,2. Recurrence rates are high (44-78%) 3 and are related to a 
large amount of health care costs and reduced productivity 2. Up to 10% of all low back pain patients 
suffering from an acute episode of LBP develop chronic and disabling LBP 4,5. To date, it is unknown 
why some people recover after an episode of LBP whereas others develop chronic low back pain 
(CLBP). Research on the pathogenic mechanisms that trigger, underpin and maintain LBP complaints, 
is quintessential to prevent recurrence of LBP and the progression to chronicity. 
Alterations in lumbar muscle structures are associated with the recurrence and chronicity of LBP, but 
differ among subgroups of LBP. However not consistent, previous research presents lumbar muscle 
degeneration, such as atrophy and fat infiltration, in patients with CLBP 6. In recurrent low back pain 
(RLBP) patients, an increased muscle fat index (MFI) is present, representing a microscopically 
enhanced amount of fat content in lean muscle cross-sectional area (CSA), in the absence of atrophy 
and/or fat infiltration 6,7. These alterations in muscle structure do not resolve when RLBP patients are 
in a state of remission 7,8.  
Apart from established alterations in low back muscle morphology, a relationship between muscle 
characteristics in LBP and the experience of pain is assumed. Previous experimental pain research in 
healthy persons and RLBP patients in remission established changes in motor output of the lumbar 
muscles during movement9–11. These alterations in motor output in response to pain have been 
postulated as an adaptive protection strategy to avoid further pain or injury 12 and point at a direct 
association between pain and motor output. Furthermore, it is hypothesized that an alteration in 
muscle function due to pain might also be related to peripheral adaptations 13. Consequently, a relation 
between pain and muscle structure can be assumed. An experimental study in pigs established a 
reduction of CSA and histological changes in the multifidus (MF) a few days after injury induction 14. 
These findings confirm muscle CSA changes occur after injury (and assumed pain) and indicate an 
association between pain and muscle structural alterations. The mechanisms for the reduced muscle 
mass are yet unknown. The authors suggest a reduction in neural drive, but the basis for the change 
of this neural drive however remains unclear.  
It can be hypothesized that these changes in neural drive are influenced by pain processing 
mechanisms. In some pain patients, the responsiveness of the central neurons seems increased and 
pain processing mechanisms are disordered 15. It is shown that excitability and hypersensitivity of the 
peripheral nociceptors occurs in acute LBP 16. In case of sustained LBP however, noxious input persists, 
leading to an enhanced responsiveness of the neurons system, termed as central sensitization. These 
changes in the central nervous system in some cases persist, even when the noxious input has 
disappeared and the initial injury is healed 16. Central sensitization is characterized by an imbalance 
between enhanced pain facilitation and impaired pain inhibition 17–19. A possible indicator of enhanced 
pain facilitation is widespread hyperalgesia or a generalized increased response to a (painful) stimulus 
resulting in a lowered pain threshold 16,20. Altered pain processing is established in several chronic pain 
populations like whiplash associated disorders 21, fibromyalgia 22,23 and chronic fatigue syndrome 24. In 
CLBP however, contradicting results concerning widespread hyperalgesia are reported. Some studies 
found segmental/widespread hyperalgesia 25–28 whereas others did not 29,30, resulting in the 
assumption that altered pain processing might be only present in a subgroup of CLBP patients. No 
aberrant pain processing is present in RLBP28.  
Time aspects seem to be involved in the relationship between pain and structural muscle alterations 
in LBP. One study found a relation between “the time elapsed since the last pain episode” and lean 
muscle CSA and total CSA in lumbar muscle tissue of RLBP patients. Recovery from atrophy might 
therefore occur during pain remission periods 7. Moreover, deterioration in muscle quality seems 
related to the frequency of previous pain episodes in RLBP 7. As a result, the time period of pain 
resolution, as well as the frequency of pain episodes, might play an important role in the alteration 
process of lumbar muscle structure in recurrent patients.   
As far as we know, the association between the pain processing and muscular alterations in LBP is an 
unexplored issue. Nevertheless, understanding of this relationship might provide insight in the 
recurrence and chronicity of LBP. Therefore, this explorative study examined to investigate the 
association between pressure pain thresholds on the one hand and alterations in CSA and MFI of the 
lumbar erector spinae (ES) and MF muscle on the other hand, in LBP patients. Since the relationship 
between muscle structure and pain processing might be influenced by the frequency of pain episodes, 
we investigated three subgroups, namely patients with RLBP in remission, CLBP with non-continuous 
LBP complaints and CLBP with continuous LBP complaints. It is hypothesized that an association 
between pressure pain thresholds and muscle structure is found in the LBP population. Besides, it is 
hypothesized that belonging to a subgroup of LBP might influence the association between pain 
processing and muscle structure alterations.  
  
2. METHODS 
 
a. Participants 
Males and females between 18 and 65 years old, with non-specific recurrent or chronic LBP were 
recruited through advertisement in hospitals in Ghent, in private practices for physiotherapy and 
through social media. 
The RLBP subjects are characterized by pain episodes alternated by pain free periods. According to the 
definition of a LBP episode, launched by De Vet et al., an episode of LBP is defined as a pain flare of at 
least 24 hours, followed by a pain free episode of at least 1 month 31. Because this definition is not 
based on quantitative evidence, concomitant parameters of LBP recurrence were added: a pain flair is 
characterized by an increase of at least 2 on a NRS scale for pain and/or at least 5 on the Roland Morris 
Disability Questionnaire 32, and a pain free episode is characterized by a 0/10 on an NRS scale for pain 
and/or a score of less than 2 on the Roland Morris Disability Questionnaire 33. Subjects in the RLBP 
group suffered from non-specific recurrent LBP during at least 6 months, with a frequency of at least 
2 episodes in the past year 34. In addition, subjects in the RLBP group are currently in a state of 
remission.  
According the definition of CLBP, subjects in the CLBP group are characterized by LBP complaints for 
at least 3 months 35. Because a large heterogeneity exists within the CLBP population and the frequency 
of pain flares might influence the association between muscle morphology and pain processing, the 
CLBP population was subdivided into a non-continuous CLBP subgroup and a continuous CLBP 
subgroup. Subjects in the continuous CLBP subgroup suffered daily from LBP complaints, whereas 
those in the non-continuous CLBP subgroup suffered from LBP for 3-4 days a week.  
On the day of testing all subjects were asked to refrain from alcohol, nicotine, caffeine and all 
medication (including NSAID’s and paracetamol). Subjects were also instructed not to perform 
exhausting physical activities the day before. All subjects were provided with MRI-safety instruction 
and gave written informed consent prior to participation. All in- and exclusion criteria for RLBP, non-
continuous CLBP and continuous CLBP are summarized in table 1.  
This cross-sectional study took place at the University hospital of Ghent between September 2013 and 
November 2014 and was approved by the local ethical committee (EC UZ 22012/791). All subjects give 
written informed consent prior to participation. 
 
GROUP 
GENERAL INCLUSION 
CRITERIA 
GENERAL EXCLUSION CRITERIA 
SPECIFIC IN- AND EXCLUSION CRITERIA 
RLBP 
- males and 
females 
- 18-65 years old 
- ≥1 years post-
natal 
- Non-specific LBP 
- no neurological, respiratory, 
circulatory or continuous 
orthopaedic diseases  
- no use of antidepressants or 
analgesics (except for NSAID’s or 
paracetamol), taken two weeks prior 
to the testing 
- no pregnancy 
- no back surgery 
- no previous cognitive exercise 
therapy 
- ≥6 months 
- a frequency of ≥2 episodes in the 
past year  
- a pain flare of ≥24 hours, 
characterized by an increase of ≥2 on 
a NRS scale and/or ≥5 on RMDQ 
- followed by a pain free episode of ≥1 
month, characterized by a 0/10 on an 
NRS scale and/or <2 on RMDQ 
- applicate for medical help 
concerning low back complaints 
NON-
CONTINUOUS 
CLBP 
- ≥3 months 
- 3 - 4 pain days a week 
CONTINUOUS 
CLBP 
- ≥3 months  
- 7 pain days a week 
Table 1: In- and exclusion criteria for subject selection.RLBP=recurrent low back pain; CLBP=chronic low back pain; 
NSAID’=nonsteroidal anti-inflammatory drugs; NRS=numeric rating scale; RMDQ=Roland-Morris Disability Questionnaire.  
 
b. Pain characteristics, psychosocial characteristics and sociodemographic data  
Sociodemographic information (age, gender, body mass index (BMI) and symptom characteristics) was 
obtained during an anamnesis prior to the testing. To evaluate the impact of the LBP intensity on the 
day of testing, all subjects were asked to fill in the Roland-Morris Disability Questionnaire, with scores 
ranging from 0 to 24 36. Greater levels of disability are reflected by higher scores. Also the current LBP 
intensity was recorded at the start of the experiment by use of a NRS in which ‘0=no pain’ and ‘10=the 
worst pain imaginable’. To evaluate fear and anxiety in the subjects, the Dutch version of the Hospital 
Anxiety and Depression Scale (HADS) was assessed, providing a score on anxiety and a score on 
depression. A score above 11 to a maximum of 21, indicates an enhanced chance of anxiety and 
depression 37. The Dutch version of the Pain Catastrophizing Scale (PCS) was used to evaluate 
catastrophizing thoughts concerning pain. Besides a total score on the PCS (with a maximum score of 
53), this questionnaire encompasses 3 subscales and provides measures on rumination, magnification 
and helplessness. The individual does not need to be in a pain-flare to fulfill this questionnaire 38,39.    
 
 
 
 
c. Pain measurements 
A hand held manual algometer (Wagner Force Ten, in kgF) with a probe of 1 cm diameter was used to 
assess pressure pain thresholds. Therefore, pressure was applied 2 times, perpendicular and at a 
constant rate (1kg/s) onto the tissue surface, bilaterally at 4 spots: lumbar erector spinae muscle 
(=lower back) at 5 cm laterally of the spinous process at L3 height 40; quadriceps muscle (=leg) at the 
middle between anterior superior iliac spine and basis patella 41; trapezius muscle (=neck) at the middle 
between acromion and spinous process at C7 height 42–44; the web (=hand) between index and thumb 
at the dorsal hand side29,45. Lower back represented local pain area, whereas neck, leg and hand 
represented distant areas. Lower back and leg were measured respectively in prone and supine 
position. The pressure pain threshold at the neck and hand were measured when sitting on a chair: for 
the neck pressure measurement, both arms hung relaxed besides the trunk and for the hand pressure 
measurement, both hands were placed on a table (Figure 1). The minimal amount of pressure that 
induces an ‘uncomfortable sensation’, resembles the pressure pain threshold 46. Therefore, pressure 
pain thresholds were obtained by instructing the subjects to say ‘stop’ when the sensation became 
‘uncomfortable’. The mean of both measurements was calculated and used. Furthermore, the mean 
value of the left and right mean pressure was calculated and used in further analysis.   
  
  
Figure 1. The assessment of pressure pain at 4 spots: quadriceps muscle (=leg); lumbar erector spinae muscle (=lower back); trapezius 
muscle (=neck); the web (=hand). 
d. Structural muscle measurements 
A 3-Tesla Siemens Trio-Tim whole-body MRI system (Siemens AG ®, Erlangen Germany) was used to 
acquire a T1-weighted 2-point DIXON scan, which was assessed to evaluate the CSA of MF and ES. 
Patients were installed supine on the MRI table, knees supported by a cushion, through which the hips 
were slightly flexed (30°). A flexible 6-element body-matrix coil, centred ventrally at L4 height, coved 
the complete lumbar region. A dorsal standard phased-array spine coil, acted as a receiver coil 7.  
On a sagittal localizing MRI scan, a slap group of 36 slices, (3mm slice thickness and 22.2% 
oversampling) was positioned at the upper endplate of L4. Measurement parameters for this two-
point DIXON fat/water separation were: 320mm FOV read, 6.59ms TR, 2.45ms TE1, 3.675ms TE2 with 
5m 01s acquisition time and a 0.7x0.7matrix. The DIXON scan resulted in a fat image and water image. 
Total CSA, muscle CSA and fat CSA of ES and MF were calculated from these images. Signal intensities 
of the MRI data were obtained in the Siemens environment. All data was processed by the same 
researcher who was blinded for the participant’s LBP status. 
To estimate the total CSA of the ES and MF, the region of interest (ROI) of each muscle was drawn on 
the fat image, which was automatically copied onto the water image (figure 2B). ES and MF were 
bilaterally outlined on 2 slices at the height of L4. The total CSA of each muscle was calculated as the 
number of voxels in the respective ROI, multiplied by voxel size. A mean value of both slices was 
calculated respectively for right and left ES and MF. The signal intensity for fat (SIfat) and the signal 
intensity for water (SIwater) of both ES and MF were also obtained on these particular ROIs. To 
estimate total fat index, the following formula was applied: “SIfat*100/(SIfat + SIwater)” 47,48. The CSA 
of lean muscle tissue (muscle CSA) was calculated by the formula: “total CSA*(1-total fat index)” 49. To 
calculate the CSA of fat tissue in the spinal muscles (fat CSA), muscle CSA was distracted from total 
CSA. 
To estimate the amount of fat in lean muscle tissue (lean MFI), the fat fraction in homogenous muscle 
tissue was estimated (Figure 2B). Therefore, the procedure above was repeated but in a homogenous 
muscle region instead of the total muscle region.  
Since there were no differences in CSA between the left and right MF and ES and the majority of 
subjects suffered from central or bilateral LBP complaints, a mean value of left and right measurements 
was used in all analyses. 
 Figure 2A and 2B. Illustration of a DIXON fat and water image. 2A illustrates the ROI to define total muscle CSA and the belonging fat index. 
2B illustrates the ROI to define lean muscle fat index.  
 
e. Statistical analyses  
Statistics were performed using IBM SPSS Statistics 22 (SPP Inc., Chicago, IL, USA). Normality of the 
data was assessed visually and through the Shapiro-Wilk test. Comparability of the groups was studied 
with a Pearson Chi-Square test for gender distribution and symptom site. Since most of the data were 
not normally distributed, a non-parametric Kruskal-Wallis test was used to compare groups for age, 
BMI, symptom duration, disability, current LBP intensity, HADS and PCS, whereas a Mann-Whitney U 
test was used for post-hoc pairwise comparison. Significance was set at  < 0.05. To summarize and 
reduce the original pain pressure threshold variables into fewer composite variables without loss of 
information, principal component analysis was performed (pressure pain thresholds at the back, leg, 
neck and hand), aiming at reducing all variables into one ‘pain sensitivity’-variable (=pain processing) 
which was used in further analysis. 
Multiple general linear regression models were performed with pain processing as independent 
variable, muscle structure parameters as dependent variables, patient-group as fixed factor, and age 
and BMI as covariates. After building these models, all models were individually checked via residual-
analyses, analyzing the following assumptions: linearity between variables, homoscedasticity and 
randomness of error terms. In addition, the cook’s distance for each observation was calculated to 
assess the influence of potential outliers on the estimated model. The significance level for the multiple 
general linear regression model was set at  < 0.01 to counteract multiple comparison. 
  
3. RESULTS 
 
a. Demographic variables 
A total of 54 LBP patients (23 RLBP, 15 non-continuous CLBP, 16 continuous CLBP) between 20 and 64 
years old were included. RLBP were younger (p=0.002) and had a lower BMI (p=0.020) compared to 
continuous CLBP. RLBP experienced less disability (p<0.001) and current pain (p<0.001) compared to 
both continuous and non-continuous CLBP. Furthermore, RLBP patients experienced less anxiety and 
depression compared to non-continuous CLBP patients (respectively p=0.005; p=0.011). No significant 
differences between groups were found for gender, symptom site, symptom duration and all subscales 
of PCS (p>0.05). All demographic variables are represented in table 2.  
b. Association between pressure pain thresholds and muscle structure  
A significant association was found between pain processing and the total CSA of ES (p=0.001) and the 
muscle CSA of ES (p=0.001), controlled for age and BMI and irrespective of the LBP group. Furthermore, 
in MF, no association was found between pain processing and muscle CSA (p=0.030) or total CSA 
(p=0.034). No association was found between pain processing on the one hand and fat CSA of MF 
(p=0.876), fat CSA of ES (p=0.142), MFI of MF (p=0.274) or MFI of ES (p=0.231) on the other hand.  
BMI was associated with fat CSA of MF (p=0.004), fat CSA of ES (p=0.006), MFI of ES (p=0.003) and MFI 
of MF (p<0.010). Age was associated with fat CSA of MF (p=0.008) but not with MFI ES (p=0.037), fat 
CSA of ES (p=0.115) or MFI ES (p=0.167). All associations can be found in table 3.  
 
  
 
RLBP (N=23) NON-CONTINUOUS CLBP (N=15) CONTINUOUS CLBP (N=16) TOTAL (N= 54) 
GENDER 9 m; 14 f 7 m; 8 f 8 m; 8 f 24 m; 30 f 
SYMPTOM SITE - L: 2  
- R: 4 
- bilateral: 17 
- R: 1 
- bilateral: 14 
- L: 2 
- R: 2 
- bilateral: 12 
- L: 4 
- R: 7 
- bilateral: 43 
 mean (SD) median (IQR) min-max mean (SD) median (IQR) min-max mean (SD) median (IQR) min-max mean (SD) median (IQR) 
AGE (years) 31 (10) 27 (12) 21-53 34 (10) 31 (14) 20-54 46 (14) 50 (28) 23-64 36 (13) 32 (24) 
BMI 22.88 
(2.33) 
22.80 
(2.59) 
18.59-
28.83 
23.29 
(1.60) 
23.07 
(1.13) 
19.83-
26.13 
25.00 
(9.45) 
24.07 (3.53) 
19.66-
31.74 
23.62 
(2.54) 
23.28 
(2.86) 
SYMPTOM DURATION 
(months) 
112 (81) 84 (120) 24-300 104 (74) 78 (138) 24 - 240 199 (169) 156 (213) 30-552 135 (117) 90 (141) 
RMDQ (max 24) 1.52 (1.44) 1.00 (1.00) 0- 6 4.93 (2.69) 5.00 (3.00) 1-11 5.56 (2.90) 5.00 (5.00) 1-12 3.67 (2.95) 3.00 (5.00) 
HADS - anxiety 5.30 (3.18) 5.00 (3.00) 1-15 8.33 (3.09) 8.00 (2.00) 4-16 5.67 (2.58) 6.00 (4.00) 1-9 6.26 (3.22) 6.00 (4.50) 
HADS - depression 2.78 (3.20) 1.00 (3.00) 0-11 5.27 (3.47) 4.00 (7.00) 1-11 3.20 (3.80) 2.00 (4.00) 0-15 3.60 (3.55) 2.00 (4.50) 
PCS - rumination 7.17 (2.96 7.00 (4.00) 1-13 7.20 (2.27) 8.00 (4.00) 3-10 5.93 (3.35) 6.00 (5.00) 1-12 6.83 (2.91) 7.00 (4.00) 
PCS - magnification 2.04 (1.61) 2.00 (2.00) 0-6 2.60 (1.84) 2.00 (3.00) 0-6 1.93 (1.58) 1.00 (3.00) 0-4 2.17 (1.66) 2.00 (2.00) 
PCS - helplessness 5.00 (3.20) 5.00 (5.00) 2-12 7.40 (2.32) 7.00 (3.00) 4-12 7.13 (4.66) 7.00 (9.00) 0-18 6.59 (3.50) 6.00 (4.50) 
PCS total 14.91 
(6.11) 
15.00 
(8.00) 
4-27 
17.20 
(3.12) 
17.00 
(5.00) 
12-22 
15.00 
(8.49) 
17.00 
(14.00) 
2-31 
15.59 
(6.23) 
16.00 
(8.00) 
Current LBP (NRS) 0.09 (0.43) 0.00 (0.00) 0-2 2.36 (2.02) 2.00 (1.5) 0-8 2.40 (1.93) 2.00 (2) 0-7 1.41 (1.88) 0.25 (2.00) 
Table 2: Subject Characteristics (SD=standard deviation; IQR=interquartile range; n=number of subjects included; m=male; f=female; L=left; R=right; no LBP=no low back pain; BMI=body mass 
index RMDQ=Roland-Morris disability questionnaire; HADS=Hospital Anxiety and Depression Scale; PCS=Pain Catastrophizing Scale; NRS=numeric rating scale; RLBP=recurrent low back pain; 
CLBP=chronic low back pain). 
 
  
MODEL df 
R2-
adjusted 
Sig. 
PARAMETER 
ESTIMATES 
 t (sig) 
95%-CI 
Lower 
B 
Upper 
B 
To
ta
l C
SA
 M
F df1 = 5 
df2 = 
46 
14% 0.034 
(intercept) 2.826 1.490 (0.143) -0.991 6.644 
RLBP 0.463 1.106 (0.275) -0.380 1.306 
Continuous CLBP 0.624 1.244 (0.220) -0.386 1.635 
BMI 0.142 1.687 (0.098) -0.027 0.311 
Age -0.021 -1.228 (0.226) -0.055 0.013 
Pain Processing 0.525 2.862 (0.006)* 0.156 0.895 
M
u
sc
le
 C
SA
 M
F 
df1 = 5 
df2 = 
46 
15.5% 0.030 
(intercept) 3.319 1.899 (0.064) -0.199 6.837 
RLBP 0.374 0.968 (0.338) -0.403 1.151 
Continuous CLBP 0.479 1.035 (0.306) -0.453 1.410 
BMI 0.099 1.280 (0.207) -0.057 0.255 
Age -0.028 -1.831 (0.074) -0.060 0.003 
Pain Processing 0.530 3.134 (0.003)* 0.190 0.871 
Fa
t 
C
SA
 M
F df1 = 5 
df2 = 
46 
41.9% <0.001* 
(intercept) -0.493 -1.556 (0.126) -1.130 0.144 
RLBP 0.090 1.281 (0.206) -0.051 0.230 
Continuous CLBP 0.146 1.739 (0.089) -0.023 0.314 
BMI 0.043 3.042 (0.004)* 0.014 0.071 
Age 0.008 2.756 (0.008)* 0.002 0.013 
Pain Processing -0.005 -0.157 (0.876) -0.066 0.057 
M
FI
 M
F 
df1 = 5 
df2 = 
47 
44.3% <0.001* 
(intercept) -0.024 -0.915 (0.365) -0.077 0.029 
RLBP -0.005 -0.755 (0.454) -0.017 0.008 
Continuous CLBP 0.009 1.233 (0.224) -0.006 0.024 
BMI 0.004 3.149 (0.003)* 0.001 0.006 
Age 0.001 2.152 (0.037) 0.0001 0.001 
Pain Processing -0.003 -1.107 (0.274) -0.009 0.002 
To
ta
l C
SA
 E
S df1 = 5 
df2 = 
44 
20.4% 0.009* 
(intercept) 9.274 1.879 (0.067) -0.675 19.224 
RLBP 1.257 1.174 (0.274) -0.901 3.415 
Continuous CLBP 1.081 0.857 (0.396) -1.461 3.622 
BMI 0.307 1.404 (0.167) -0.134 0.749 
Age -0.041 -0.971 (0.337) -0.127 0.045 
Pain Processing 1.685 3.599 (0.001)* 0.742 2.629 
M
u
sc
le
 C
SA
 E
S 
df1 = 5 
df2 = 
44 
20.5% 0.009* 
(intercept) 10.606 2.397(0.021) 1.689 19.522 
RLBP 1.008 1.050 (0.299) -0.926 2.941 
Continuous CLBP 0.478 0.423 (0.674) -1.799 2.756 
BMI 0.177 0.901 (0.372) -0.219 0.573 
Age -0.059 -1.552 (0.128) -0.136 0.018 
Pain Processing 1.531 3.650 (0.001)* 0.686 2.377 
Fa
t 
C
SA
 
ES
 
df1 = 5 36.2% <0.001* 
(intercept) -1.959 -1.581 (0.121) -4.453 0.536 
RLBP 0.179 0.654 (0.516) -0.372 0.730 
df2 = 
46 
Continuous CLBP 0.571 1.739 (0.089) -0.090 1.231 
BMI 0.158 2.869 (0.006)* 0.047 0.268 
Age 0.017 1.605 (0.115) -0.004 0.040 
Pain Processing 0.179 1.493 (0.142) -0.062 0.421 
M
FI
 E
S 
df1 = 5 
df2 = 
46 
56.6% <0.001* 
(intercept) -0.073 -2.550 (0.014) -0.130 -0.015 
RLBP -0.005 -0.782 (0.438) -0.019 0.008 
Continuous CLBP 0.015 1.804 (0.078) -0.002 0.031 
BMI 0.006 4.964 (p<0.001)* 0.004 0.009 
Age 0.000 1.403 (0.167) 0.000 0.001 
Pain Processing -0.004 -1.214 (0.231) -0.010 0.002 
Table 3: Model characteristics and parameter estimates Multiple general linear regression models for different muscle 
structure outcome parameters with pain processing as predictor, corrected for patient group, BMI and Age. The model 
characteristics are situated on the left side, the parameter estimates on the right side. Non-continuous CLBP is the 
reference group. *p<0.010 is significant. (df=degrees of freedom; CI=confidence interval; B=bound; MF=multifidus; 
ES=erector spinae; CSA=cross-sectional area; MFI=muscle fat index). 
 
 
4. DISCUSSION 
 
This study is the first to discuss the association between pain processing and structural changes in the 
lumbar muscles in patients with LBP.  
Associations were found between pressure pain thresholds on the one hand and the total and muscle 
CSA ES on the other hand in LBP patients, when controlled for age and BMI. This implies that higher 
pressure pain thresholds, indicative for a better pain processing, are associated with a larger lumbar 
CSA in ES among all LBP patients. As a consequence, one can hypothesize that patients with LBP who 
are generally more sensitive for pain (lower pressure pain thresholds in general), might also have 
smaller lumbar ES muscles and vice versa. It can be speculated that those smaller muscles, might be 
less resilient for daily impact, contributing to the recurrence and/or chronicity of LBP complaints.  
To date limited evidence suggests pain results in alterations in muscle structure and muscle function 
10,14,50, but the opposite can not be ruled out. On the one hand, an altered control strategy, induced by 
nociceptive input, might contribute to muscle overload or disuse and thus induce adaptations at the 
muscle level. On the other hand, pain might also be the consequence of alterations in muscle 
structures and/or muscle activity 13. A longitudinal design is needed to examine this question more 
closely. Follow-up studies, starting before the onset of LBP, might reveal more valuable information 
on the influence of the relationship between muscular deformations and pain processing mechanisms 
on occurrence and recurrence of LBP.  
Furthermore, no associations between pressure pain thresholds and fat CSA in MF or ES were 
established. Also no association with the quality of muscle tissue (MFI) was observed. Possibly other 
factors besides pain processing are determined for the amount of fat infiltration and muscle quality 
deterioration in the lumbar muscles. Several personal factors are related with muscular characteristics 
51,52. Aging processes are related to a declined total muscle CSA 53 as the consequence of a loss of motor 
units and muscle fiber degeneration 54. In addition, this gradual decrease in muscle size is accompanied 
by a replacement by fat and connective tissue 54,55. In the current study, a significant influence of age 
on fat CSA in MF, and a borderline significant influence of age on MFI in MF, also point in that direction. 
However, no association with age was found in the ES muscle. These results are in concordance with 
recent findings of Crawford and colleagues, who established age-related muscle degeneration was 
more pronounced in the MF compared to the ES in asymptomatic subjects 56. Also BMI is known as an 
influencing factor for muscle thickness 53,57,58. An association between BMI and fat CSA and MFI of both 
the MF and ES in the current study confirms previous research reporting an influence of BMI on muscle 
atrophy and fat infiltration 59,60.  
Remarkable, no association was found between pain processing and total/muscle CSA in MF since the 
significant association did not survive the multiple comparison correction. Beside personal factors, 
such as age and BMI, other characteristics, such as psychosocial factors, might interfere in the 
association between pain processing and muscle characteristics. As opposed by Hodges and Smeets 
(2015), motor output, whether accompanied by alterations in muscle structure or not, is associated 
with pain. This association however, is complex and seems to be influenced by several mechanisms 61. 
Cognitive-emotional issues, like pain catastrophizing and fear of pain/injury/movement and 
hypervigilance might play an essential role in the association between pain and peripheral muscle 
adaptations. In the current study, patients with non-continuous CLBP were characterized by a higher 
degree of anxiety and depression compared to RLBP patients. It is possible that the psychological state 
influences the association between pain processing and muscle characteristics. As described in the 
model characteristics of the performed statistics for total and muscle CSA in MF, only a small part of 
the variance is explained by the current included factors (age, BMI, LBP groups and pain processing). 
Including additional personal and psychosocial characteristics in the analysis are therefore worth 
considering in further research.  
Differences between RLBP and CLBP exist in muscle morphology and are suggested in pain processing 
mechanisms. This study did not find an association between muscle characteristics and the LBP-
subpopulations. The groups in which the LBP patients were allocated, or in other words the frequency 
of pain, was therefore of no importance on the association between pressure pain thresholds and 
muscle morphology in the models included in this manuscript. Given the rather small sample sizes per 
group, small effect sizes might have been missed. Moreover, other statistical models, based on 
additional personal and/or psychosocial variables, might provide more insight on the influence of the 
type of LBP on the potential association between pain processing and muscle structure.  
 
Clinical implications 
Due to the observation that some associations between morphological changes and pressure pain 
thresholds exists in LBP patients, one can speculate that improvement of pain sensitivity eventually 
might positively affect muscle characteristics. Therapy focusing on decreasing pain sensitivity, might 
therefore also positively influence muscle characteristics in LBP in the longer term and contribute to 
the recovery of LBP.  
Also the opposite might work in therapy. Previous studies found enhanced muscle characteristics and 
a decrease in pain experience after exercise treatments 62,63. Reconditioning muscular tissues might 
positively affect the pressure pain thresholds of LBP patients and therefore decrease the pain 
sensitivity of those patients. Future research should assess the association between muscle 
characteristics and pain processing in therapy context in more detail. 
 
Limitations 
The average reported pain intensity and disability in both CLBP is rather situated in the lower spectrum 
of pain and disability. Moreover, scores on the HADS and PCS were overall relatively low, indicating 
that the LBP subgroups were not characterized by overall enhanced anxiety, depression or pain 
catastrophizing. It is however opposed that at least a subgroup of CLBP is characterized by emotional 
distress interfering with pain and disability64–67. These findings implicate that the included subject 
sample in this study might not represent the complete CLBP population.  
Furthermore, in this study, pain processing was only assessed by pressure pain thresholds using 
manual algometry. Future research should incorporate additional quantitative sensory testing to fully 
record pain processing, amongst which temporal summation of pain, spatial summation of pain, 
conditioned pain modulation and deep tissue hyperalgesia.  
 
  
5. CONCLUSION 
 
Associations between pain sensitivity and total and muscle CSA in the lumbar ES seem to exist, 
independent from the frequency of pain complaints. No such association was found in MF.  
Furthermore, no association was found between pain processing and fat CSA or MFI in any lumbar 
muscle. These novel and preliminary findings need further investigation. Longitudinal studies including 
more variables are necessary to address the influence of an individual’s pain sensitivity on muscle 
morphology and vice versa in LBP patients.  
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 General Discussion  
1. SUMMARY OF STUDY RESULTS 
 
This dissertation intended to provide an innovative perspective on differences and similarities between 
recurrent, non-continuous and continuous chronic low back pain (LBP) by studying the concepts of 
peripheral muscle dysfunctions on the one hand and pain mechanisms on the other hand. Through 
this, we aimed at contributing to an explanation for the question why some patients have recurrent 
episodes of back pain but recover after every pain flare and others move further in this downward 
spiral. Table 1 provides a schematic overview of the study findings in this dissertation. 
 
1.1.Muscle characteristics [Chapter 1]  
 
1.1.1. Overview of the current knowledge on structural alteratio ns in low back 
pain [Chapter 1, Part 1] 
 
To gain an overview of the current existing literature on macro- and/or microscopic structural 
alterations in the lumbar muscles in non-specific acute, recurrent and chronic LBP patients, a 
systematic review was performed. This review revealed atrophy of the multifidus muscle in chronic 
low back pain (CLBP) patients [1]. After pain onset, a combination of reflex inhibition and coordination 
disturbance occurs changes in the multifidus muscle [2,3]. The atrophy in the multifidus is situated 
mainly at the lower levels, possibly because the multifidus surface increases as the level goes more 
distal and is therefore more vulnerable for more atrophy [4]. Atrophy of the paraspinal and erector 
spinae muscles in CLBP is less univocal [1]. This research confirms previous findings that multifidus is 
more susceptible to atrophy compared to other lumbar muscles [5]. The multifidus muscle is 
exclusively innervated by the medial ramus of the dorsal root of the spinal nerve without segmental 
nerve supply, which is indeed present in other the spinal muscles [5]. This phenomenon might 
therefore declare why atrophy is mainly found in the multifidus and not in the other spinal muscles. It 
is however striking that most current research focusses on the multifidus rather than the isolated 
erector spinae or complete paraspinal muscle, by which firm conclusion concerning atrophy in the 
erector spinae and the total paraspinal muscles are not appropriate.  
Results concerning fat infiltration in CLBP patients are scarce and inconsistent. This systematic review 
suggests that other factors such as age [6,7], body mass index (BMI) [8] and physical (in)activity [9] 
might be more related to the amount of muscular fat, rather than the LBP complaints it selves [1]. Only 
a single study evaluated fiber type distribution and did not establish alterations in fiber type in the 
paraspinal muscles in CLBP. Taken together, these inconsistent results concerning muscle 
characteristics in CLBP might suggest that muscle alterations might only be present in a subgroup of 
CLBP patients and enhance the need for further research in this field.  
In recurrent low back pain (RLBP) patients, no atrophy and visible fat infiltration is established. 
Possibly, no macroscopic changes occur in this LBP population, due to several possible reasons. First 
of all, in general, RLBP patients seem to be younger compared to patients with chronic pain complaints 
[10]. This way, large muscle degeneration attributed to age [7] is excluded. Furthermore, RLBP is 
characterized by prolonged pain free episodes. Consequently these patients might be at lower risk to 
become physically inactive compared to the CLBP population, which are possibly more physically 
disabled because of their continuous LBP complaints. It is also possible that the episodes of LBP are 
not long and intense enough to trigger muscle alterations. This is however disputable since a study in 
pigs established early muscle alterations after inducing experimental pain and/or injury [11]. It is also 
possible that a reduction in muscle mass resolves during remission. This explanation is supported by a 
correlation found between cross-sectional area (CSA) and “the time elapsed since the last episode of 
LBP” in previous research [12]. In the current dissertation however, no similar correlation was found 
(unpublished data). As a result, we were not able to confirm this rationale. In RLBP patients, the muscle 
fat index seems enhanced, reflecting increased relative amounts of intramuscular lipids, in lean muscle 
tissue. This way, contractile muscle tissue is replaced by non-contractile tissue, which compromises 
proper functioning of the lumbar muscles. So, despite the presence of clear atrophy and fat 
infiltrations, the quality of the muscle tissue seems deteriorated in remission periods. This muscle 
degeneration might be involved in the recurrence of LBP complaints in RLBP. Evidence in RLBP is 
however very limited and needs extension. 
In acute LBP, no studies investigated fat infiltration of fiber type distribution. One study established 
atrophy in the multifidus at the symptomatic side and level in acute LBP, suggesting inhibition due to 
perceived pain via a long-loop reflex in order to protect the local tissues [13]. This study however was 
considered as high risk of bias. As a consequence, firm conclusion concerning muscle atrophy in acute 
LBP can not be made at this point. In conclusion, further research concerning muscle structure in acute 
LBP is needed to establish whether or not muscle alterations are present in acute phases of LBP [1]. 
  
Atrophy of the multifidus muscle, mainly at the lower lumbar levels is present in CLBP patients, 
whereas atrophy of the erector spinae muscles is less established. Results on fat infiltration in the 
lumbar muscles are contradicting but a possible increase in fat infiltration in CLBP seems more likely to 
be due to personal factors, rather than to LBP itself. In RLBP, no clear signs of muscle changes are 
characterizing the lumbar musculature, but more important is a suggested deterioration in muscle 
quality of the lumbar muscles. Muscle alterations in acute LBP and fiber type distribution in  all LBP 
groups need more investigation to draw firm conclusions. 
 
 
1.1.2. Experimental research on muscle alterations in low back pain  [Chapter 1, 
Part 2] 
 
Knowledge concerning muscle characteristics of LBP-subpopulations contributes to the insight in the 
recurrence and chronicity of LBP. Differences in lumbar muscle structure between RLBP and CLBP are 
rarely studied in literature. In an experimental investigation, the characteristics of muscle structure 
and muscle activity between patients in different stages of LBP are examined. A DIXON (T1-image) 
magnetic resonance imaging (MRI) scan measured the spinal muscle CSA, fat infiltration and muscle 
fat index and a muscle functional MRI (mfMRI) (T2-estimated image) evaluated the lumbar muscle 
metabolic activity after a lumbar extension exercise [10].  
This dissertation revealed an enlarged presence of fat CSA and muscle fat index in the lumbar 
multifidus and erector spinae in continuous CLBP compared to non-continuous CLBP and RLBP [10]. 
These results are in line with some data establishing fat infiltration in lumbar muscles [14,15], but as 
mentioned above, few studies are available. It is striking that no general decrease in muscle or total 
CSA in the multifidus nor erector spinae was found in the continuous CLBP group compared to the 
RLBP group. Based on theses results, one could conclude that total and muscle CSA is not different 
between RLBP, non-continuous CLBP and continuous CLBP. This is however questionable, since our 
systematic review established atrophy in the multifidus muscles in CLBP patients [1] and an absence 
of atrophy in RLBP patients compared to healthy controls [12]. Therefore, adjustments within the 
lumbar muscles might mask a loss of general muscle mass. Recent research revealed structural 
remodelling of muscle tissue, rather than general muscle atrophy [16]. So possibly, muscle CSA is 
replaced by other tissues, such as fat tissue or connective tissue, masking general atrophy of the 
lumbar muscles. This explanation is confirmed by the established differences in lumbar fat infiltration 
in the current dissertation [10]. As a consequence, also differences between groups for muscle CSA are 
expected, but were not found in this dissertation. A lack of power in this study cannot be ruled out.  
This dissertation also shows an increased T2-shift in the lumbar muscles of continuous and non-
continuous CLBP patients after a standardized lumbar exercise [10]. These findings confirm one 
previous study evaluating metabolic activity in CLBP [17]. A higher T2-shift, caused by a standardized 
activity, resembles an enhanced metabolic activity of the lumbar muscles. The increase in T2-signal 
due to exercise, indicates physiological changes within the muscle fiber, caused by osmotic changes in 
intracellular fluid volumes and pH, resulting in the accumulation of metabolites [18]. Consequently, 
the T2-shift provides an indication of the efficiency of muscle recruitment, and the muscle fiber 
endurance capacity and therefore the efficiency of muscle work during a performed activity. This 
increased metabolic activity, replicates a relatively higher intensity in contractions performed by the 
lumbar muscles. As described before, redistribution of activity within and between muscles might 
occur due to pain and nociception [19]. The enhanced muscle activity in the lumbar stabilizing muscles 
might be initiated as a protection mechanism [20]. Ongoing impaired muscle activation however, might 
make the spine susceptible to strain and further injuries or pain. As a result, this process might be a 
contributing factor why non-continuous and continuous CLBP patients, unlike RLBP patients, don’t 
recover after every pain episode. 
Another possible reason for enhanced muscle activity seen in continuous CLBP is the underlying change 
in muscle structure to compensate for the lost muscular integrity. Deterioration in muscle structure 
(resembled by an enhanced muscle fat index) and increased fat CSA is accompanied by a decrease in 
contractile ability in the muscles due to replacement of contractile tissue with non-contractile tissue 
[16]. It could be speculated that the remaining healthy muscle tissue, carries higher workload, resulting 
in a potential faster acidification and a higher T2-shift. Due to this maladaptive strategy the lumbar 
muscles, stabilizing performance capabilities of the lumbar muscles might be compromised.  
Finally, cognitive-emotional processes might contribute to the changes in muscle activity. It is shown 
that anticipated threat to tissues results in motor control changes. Previous research in healthy 
volunteers established a similar change in motor output during anticipation of pain as during pain 
stimulation. The alterations in motor output do not diminish once the threat of pain is ceased [21]. 
Other research found a delayed activation of the deep trunk muscles during a single arm movements 
when anticipating experimental back pain and an augmentation of the superficial trunk muscles [22]. 
These findings are in line with the established enhanced muscle activity in RLBP patients despite a state 
of remission [23]. Consequently, it can be hypothesized that changes in muscle activity are also 
influenced by pain related descending inputs. In the long-term, this initially protective strategy might 
be associated with a reduction in fine control, enhance the load on spinal structures and might 
therefore contribute to recurrence or chronicity of LBP.  
In non-continuous CLBP, fat CSA and muscle fat index in the lumbar multifidus and erector spinae is 
lower compared to continuous CLBP. No differences in fat CSA and muscle fat index between non-
continuous CLBP and RLBP are found. Furthermore, no differences in total CSA and muscle CSA is found 
with RLBP or continuous CLBP. These results on muscle structure in continuous and non-continuous 
CLBP might explain why many inconsistencies concerning CSA area and fat infiltration in the CLBP 
population exist in literature [1]. On the other hand, the metabolic activity in non-continuous CLBP is 
enhanced compared to RLBP, whereas no differences in metabolic activity in the lumbar muscle 
between non-continuous and continuous CLBP are found. The enhanced metabolic activity in the non-
continuous CLBP group can be explained by all the above mentioned theories, but one. Since an 
enhanced T2-shift is established in non-continuous CLBP in the absence of enhanced fat infiltration, 
other muscle characteristics besides fat infiltration might be involved. Skeletal muscles with large 
portions of type I fibers are characterized by a greater capacity for fatty acid metabolism compared to 
muscles with a greater portion of type II fibers, which rely more on the glycolytic metabolism [24]. In 
case of fiber type alterations in the favor of type-II fibers, more metabolic substances are produced 
during contractions. Furthermore, the remaining type I fibers are therefore supposed to work harder, 
resulting in muscle fatigue [25]. This association between muscle structural changes and muscle 
activation is underpinned by correlations found between T2-rest with muscle fat index on the one hand 
and fat CSA on the other hand [10].  The mean values of T2-rest in the non-continuous CLBP group 
indeed intend to confirm this hypothesis. Unfortunately, this dissertation established no sginificant 
post-hoc differences in T2-rest between groups. It is however possible that the sample size of LBP-
subgroups in this dissertation was to small to detect differences between groups.  
Fat CSA and muscle fat index in multifidus and erector spinae in RLBP is lower compared to continuous 
CLBP, but not compared to non-continuous CLBP. One single previous study already established lower 
fat density in muscles in RLBP compared to CLBP patients [15] and are in line with the current findings. 
The T2-shift in the RLBP patients was however lower compared to continuous CLBP patients and to 
non-continuous CLBP patients, resembling a lower metabolic activity in RLBP patients in comparison 
with the muscles in non-continuous and continuous CLBP. These observations might seem obvious 
since RLBP patients were in remission. The ongoing presence of pain is however not necessary for 
motor control changes to persist [23]. Psychosocial factors, such as fear of movement have a similar 
effect and can explain changes in motor output in patients with musculoskeletal pain even when in 
remission [26]. Previous research already examined alterations in muscle activity in RLBP in a state of 
remission compared to healthy persons [23,27–29]. For that reason, it is assumable that the muscle 
activity in the RLBP in this dissertation is also deviant from muscle activity in normal situations. Due to 
lack of comparison to a healthy control group, this was not confirmed in the present dissertation. For 
T2-rest no differences between the 3 LBP groups are found. Previous research established lower T2-
rest values in the multifidus muscle in RLBP compared to healthy persons, indicating higher proportions 
of glycolitic (type II) fibers [23]. As a consequence, enhanced type-II fibers might be present in all three 
groups compared to healthy controls, implying that fiber type composition is shifted towards the 
glycolytic side, despite the amount of aerobic (type I) fibers. To establish whether this shift is more 
pronounced in one group or another, more research is needed.  
In the current study, no healthy subjects are included. Previous research however established an 
increased muscle fat index in the absence of clear atrophy [12] and alterations in muscle activity 
[23,27–29] in patients with RLBP in remission compared to HC. As a result, deterioration of the lumbar 
muscle quality of the RLBP population might be present in the absence of clear atrophy. The results of 
the current study point out that enhanced fat infiltration and more deterioration in muscle quality is 
present in the continuous CLBP group compared to the RLBP and that metabolic activity is enhanced 
in both the continuous and non-continuous CLBP group. Taken together, it could be hypothesized that 
deterioration in muscle quality and alterations in muscle performance occur in RLBP and decline 
further as a patient has back pain more frequently or more continuously. More research is however 
needed to confirm or decline this hypothesis. 
 
The lumbar muscles in continuous CLBP patients are characterized with more fat tissue and a 
higher muscle fat index in the absence of lean muscle atrophy and total atrophy. This means a 
devaluation in quality, rather than decrease in overall muscle mass in continuous CLBP patients. This 
muscle degeneration accompanied by less efficient muscle work, established by enhanced T2-shift 
values, might compromise proper biomechanics and motion of the spinal units. In non-continuous CLBP, 
the change in metabolic activity in the absence of atrophy, fat infiltration and enhanced muscle fat 
index are possibly due to a shift in fiber type distribution towards the glycolitic fiber type. Furthermore, 
it seems that the amount of metabolic activity and the amount of structural alterations in RLBP is less 
present compared to the chronic groups. It is therefore possible that these muscle characteristics in 
RLBP are an important feature in the recovery of RLBP. The more favorable muscle condition of RLBP 
might provide a good environment to recover after a pain episode and prevent RLBP patients from 
becoming chronic. Taken together with previous research, establishing deterioration of the lumbar 
muscle quality and persisting alterations in muscle performance in RLBP patients in remission compared 
to healthy persons, one could hypothesize that LBP presents as a continuum: muscle quality starts to 
deteriorate in RLBP and declines further as a patient has back pain more frequently or more 
continuously. The non-continuous CLBP population is a LBP group situated in the continuum between 
the RLBP patients and continuous-CLBP patients. 
 
1.2.Pain processing [Chapter 2] 
 
1.2.1. The effect of pain on conditioned pain modulation [Chapter 2, Part 1] 
 
To evaluate whether present clinical pain, pain reduction or experimental pain induction influences 
the efficacy of endogenous pain inhibition, measured by conditioned pain modulation (CPM), a 
systematic literature study was conducted. This review provided an overview of the current knowledge 
on the effects of clinical pain, experimental pain induction and pain reduction on CPM in adults. In total 
12 eligible articles are found, investigating the effect of medication (in healthy persons and chronic 
pain patients), the effect of surgery (in chronic pain patients) and the effect of acute or experimental 
pain on CPM. Pain medication, frequently applied in chronic pain patients (dexmedetomidine, 
lidocaine, bupivacaine, morphine, ketamine, opioids) and oral contraceptive seem to negatively 
influence CPM. Naloxone (=opioid antagonist) on the other hand is able to increase pain inhibition 
again after the pain inhibition was experimentally reduced. Only 2 studies were unable to establish the 
influence of pain medication on CPM (pregabalin and tropisteron), probably because both analgesic 
medications influence other pain pathways besides the diffuse noxious inhibitory control pathway, as 
measured with the CPM paradigm. Surgery is also able to reinstall normal pain inhibition in patients 
with osteoarthritis in which CPM was decreased before the surgical intervention. In contrast, pain 
induction in healthy persons or acute clinical pain did not influence CPM [30]. In this systematic review 
it became clear that the administration of the test- and conditioning stimulus is very different among 
studies, complicating the generalizability of results. Besides, little research specifically targets the LBP 
population. Drawing firm conclusions for this population is therefore difficult. Furthermore, it remains 
unclear whether pain is mainly the consequence of impaired CPM or the mediator for impaired pain 
inhibition.  
 
This review concludes that pain medication negatively influences the CPM effect. As a 
consequence, clinicians should take into account that chronic pain patients, might respond different to 
therapies than expected, mediated by the presence of pain and/or medication. Moreover, removing 
the peripheral structural cause of chronic pain, repairs abnormal pain inhibition. In contradiction, an 
acute pain source does not affect CPM. Therefore, possibly also in RLBP, CPM might work properly 
 
1.2.2. Experimental research on pain processing in low back pain [Chapter 2, 
Part 2] 
 
Because the impairment in musculoskeletal structures in patients with LBP is often disproportionate 
to their complaints, alternative mechanisms might contribute to the origin, recurrence and 
maintenance of non-specific LBP. A possible contributing mechanism is central sensitization, which is 
suggested in a subgroup of CLBP [31]. To evaluate the contribution of altered pain processing, 2 extra 
subject populations were needed in this research. The three LBP groups are compared with healthy 
controls characterized by normal pain processing mechanisms and with patients with fibromyalgia, 
characterized by altered pain processing mechanisms (predominant central sensitization pain) [32]. 
This way, a complete spectrum was created with healthy subjects on the one end, sensitized patients 
on the other and the three LBP groups in between.  
At both the lower back and remote sides, pressure pain thresholds by manual algometry are decreased 
in patients with fibromyalgia compared to healthy controls, RLBP and continuous CLBP. Pressure pain 
tolerance thresholds assessed by cuff algometry are decreased in fibromyalgia compared to healthy 
controls and RLBP. In conclusion, widespread hyperalgesia seems present in FM patients. This research 
confirms previous results indicating general widespread hyperalgesia in FM [33–36].  
In all LBP groups no primary or secondary hyperalgesia was found by manual algometry. Since RLBP 
were in remission, the absence of primary hyperalgesia in the lower back region in this group is 
expected. In addition, pressure is applied at L3-level, which might be different from the exact pain 
location. Interestingly, pain assessment by cuff algometry revealed lowered pressure pain tolerance 
thresholds in continuous CLBP compared to RLBP [32]. These results indicate alterations in pain 
processing in continuous CLBP but not in RLBP and confirm previous research establishing localized 
and generalized hyperalgesia in long-lasting LBP but not in recent LBP [37]. One could hypothesize, 
that alterations in pain processing develop over time, as a consequence of long-lasting pain [38]. 
Another influencing factor in pain processing is age [38]. Since the continuous CLBP population is older 
compared to the RLBP patients, contribution of age can therefore not be excluded. In fibromyalgia, 
temporal summation (TS) of pain is enhanced at the lower back and remote sides compared to healthy 
persons and RLBP. No significant differences in TS are established between RLBP and non-continuous 
or continuous CLBP, although mean values in the 3 LBP groups picture an image of enhanced pain 
sensitivity for TS for pain in the CLBP groups. Possibly, a lack of power or the known heterogeneity 
within the chronic back population is responsible for this finding [32]. Taken together the reported 
differences in pressure pain thresholds and TS of pain between fibromyalgia patients and RLBP, this 
dissertation establishes a proper working pain processing mechanism in RLBP. Possibly, the efficient 
pain modulation, might explain why RLBP recover after every pain episode and are characterized by 
prolonged pain free periods. It might even protect them from sliding down the downwards spiral to 
chronicity. 
In all groups, pressure pain (detection and tolerance) thresholds are lower when 2 chambers are 
inflated compared to the inflation of a single chamber, resembling the pain inhibition is properly 
activated in response to spatial summation (SS) of pain in all test groups. No significant differences 
between groups are found [32]. Previous studies also failed in establishing differences in SS of pain in 
patients with fibromyalgia [39,40] or chronic whiplash associated disorders [41] and are therefore in 
line with the current results. Other studies, however, established enhanced SS in patients with knee 
osteo-arthritis [42] and fibromyalgia [43], but not in CLBP [43]. In conclusion, one can say SS of pain 
remains unclear and demands further research.  
Also for CPM, no differences between groups are established, however, previous research clearly 
indicate CPM is impaired in patients with fibromyalgia compared to healthy persons [43–45]. A lack of 
power might be responsible for not detecting differences. Another possibility is that the CPM paradigm 
was not sufficient to activate pain inhibition. In this dissertation, the baseline measurement of the CPM 
paradigm consisted of a TS of pain measurement. Whereas TS measured by manual algometry is 
enhanced in FM compared to healthy persons and RLBP, no differences in baseline between groups 
are established by cuff algometry. The reliability and sensitivity of cuff algometry are however 
comparable with manual algometry for pain assessment and cuff algometry seems sensitive for CPM 
[46]. Baseline measurements for TS used to evaluate the sensitivity for CPM was equal to the pressure 
pain tolerance threshold of the subjects. According to previous studies evaluating CPM by cuff 
algometry in clinical populations, in this dissertation the baseline measurement was set at the mean 
of the individual pressure pain detection threshold and pressure pain tolerance threshold [41,47]. 
According to previous research, “mild to moderate” pain levels should suffice to induce an inhibitory 
effect [48]. It is however possible that the baseline measurement did not reach the “mild to moderate” 
level and was not sufficient to evoke TS and that therefore the CPM paradigm was insufficient. Another 
possibility is that the conditioning stimulus was incapable of inducing pain inhibition. Future research 
intending to assess CPM, could take into account the recent expert-opinion-based recommendations 
for practice on CPM testing [48]. In summary, CPM assessment should contain the following:  
(1) Inclusion of two types of test stimuli, e.g. thermal or mechanical stimuli;  
(2) The stimulation paradigm should be performed either at an ascending intensity (and to be 
discontinued at a pain level of 40/100) or at a fixed intensity (at a predetermined pain level of 
40/100); 
(3) Test-stimuli should be performed twice, with at least 10-min interstimulus interval, at two 
different skin sites; 
(4) The same conditioning stimulus should be used for both types of test-stimuli; 
(5) A standard additional full CPM protocol: two successive mechanical pressure transients as test 
stimulus (either ascending or fixed), at a pain level of 40/100 and a conditioning stimulus of a 
1-min cold water immersion of the hand to the wrist; 
(6) Preferably performance of the “conditioned” test stimulus immediately after the conditioning 
stimulus, rather than parallel. 
In conclusion, in continuous CLBP some findings of altered pain processing are evident, but not to the 
extent as in chronic pain conditions such as fibromyalgia. 
 
Overall, these pain results indicate generalized hyperalgesia, deep-tissue hypersensitivity and 
enhanced pain facilitation in patients with fibromyalgia whereas RLBP are characterized by normal pain 
processing. In non-continuous and continuous CLBP, some signs of pain processing alterations are 
present, although not at the extent of fibromyalgia. The groups of non-continuous and continuous CLBP 
are considered within the spectrum, somewhere between completely healthy persons and fibromyalgia 
patients, characterized by pain augmentation.  
 
 
1.3.The association between muscle characteristics and pain processing 
[Chapter 3] 
 
To gain insight in the mechanisms behind recurrence and chronicity of LBP, the relation between 
muscular alterations [Chapter 1, Part 2] and pain processing alterations [Chapter 2, Part 2] is 
investigated. This explorative research establishes a positive association between pain sensitivity and 
total CSA and muscle CSA in the erector spinae muscle, controlled for age and BMI. Consequently, 
patients who are more sensitive to pain, and therefore have lower pressure pain thresholds in general, 
are more likely to have smaller erector spinae muscles and vice versa. Possibly, patients with smaller 
muscles and a higher pain sensitivity are less resilient to daily impact. In that case, this feature in 
general, might contribute to the recurrence or chronicity of LBP complaints. Previous evidence 
suggests that alterations in muscle structure and muscle function are the consequence of pain. An 
altered control strategy, induced by nociceptive input, might contribute to muscle overload and/or 
disuse and result in muscular adaptations [49–51]. The chronicity based classification of the LBP-
subgroups used in this dissertation, however, is of no importance to the association between pressure 
pain thresholds and muscle morphology [52]. Still it is also possible that small effect sizes in this 
explorative study are missed due to the small sample sizes of the study populations.  
This dissertation found no association between pain sensitivity and fat CSA or muscle fat index, when 
corrected for age and BMI [52]. Rather than pain processing mechanisms, age and BMI might influence 
muscle characteristics. Aging processes seem to be related to a declined total muscle CSA [8] as the 
result of a loss of motor units and muscle fiber degeneration on one hand [7] and a replacement of 
muscle tissue by fat and connective tissue on the other hand [7,53]. In the current study, a significant 
influence of age on fat CSA and a borderline significant influence on the muscle fat index in the 
multifidus, confirmed those previous results. No association was found in the erector spinae muscle, 
which is in accordance with recent findings in healthy persons establishing more pronounced muscle 
degeneration in multifidus compared to erector spinae [54]. Another influencing factor for muscle 
thickness is BMI [8,55,56]. The association between fat CSA, muscle fat index and BMI in the current 
study confirms previous research reporting BMI influences muscle structures [57,58]. 
Furthermore, this dissertation found no association between total and muscle CSA of the multifidus 
muscle and pain processing. Both age and BMI did not seem to influence the association. The 
relationship between motor output, whether accompanied by alterations in muscle structure or not, 
and pain is however complex and seems to be influenced by several mechanisms. Cognitive-emotional 
issues, like pain catastrophizing, fear of pain/injury/movement and hypervigilance might play a role in 
the association between pain and peripheral muscle adaptations. [20]. Including additional personal 
and psychosocial characteristics are therefore worth considering in further analysis concerning this 
topic. 
 
Consequently, LBP patients with generally increased pain sensitivity are more likely to have 
smaller lumbar erector spinae muscles and vice versa. No association between pain processing and fat 
infiltration in the lumbar muscles, muscle quality of the lumbar muscles or atrophy in the multifidus 
muscles are found. These finding seem independent from the recurrent or chronic nature of the LBP 
complaints, but further research is needed.  
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 HC RLBP CLBP FM 
Total CSA Normal Normal ↓↓ in MF, normal in ES  
Muscle CSA Normal Normal unknown  
Fat CSA Normal Normal conflicting  
MFI Normal ↑ unknown  
Fiber type  Normal unknown conflicting  
Metabolic activity Normal ↑ ↑  
Pain processing Normal Normal ↓(subgoup) ↓↓ 
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 HC  RLBP  nc-CLBP  c-CLBP  FM 
Total CSA    =  =    
Muscle CSA    =  =    
Fat CSA    =  <<    
MFI    =  <<    
Fiber type (in favor 
of glycolitic fibers) 
   Unclear (<)  Unclear (>)    
Metabolic activity    <<  =    
Pain processing 
 =  =  
< 
(subgroup?) 
 <<  
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 HC RLBP nc-CLBP c-CLBP FM 
Total CSA Normal Normal Normal unclear  
Muscle CSA Normal Normal Normal unclear  
Fat CSA Normal Normal Normal ↑↑  
MFI Normal ↑ Normal ↑↑  
Fiber type (in favor of 
glycolitic fibers) 
Normal ↑(?) ↑↑ (?) ↑(?)  
Metabolic activity Normal ↑  ↑ ↑ ↑ ↑  
Pain processing Normal Normal Normal ↓ (subgroup) ↓↓ 
Table 1: An overview of the results found in this dissertation for healthy persons, recurrent low back pain patients, non-
continuous chronic low back pain patients, continuous chronic low back pain patients and patients with fibromyalgia 
(HC=healthy controls; RLBP=recurrent low back pain; nc=non-continuous; c=continuous; CLBP=chronic low back pain; 
FM=fibromyalgia; CSA=cross-sectional area; MFI=muscle fat index)  
2. CLINICAL IMPLICATIONS 
 
2.1.Lumbar muscles 
 
Lumbar muscles in patients with continuous CLBP are characterized by an increased metabolic activity, 
deterioration of muscle quality and increased fat infiltration in the lumbar multifidus and erector 
spinae. Also non-continuous CLBP are characterized by improper muscle activity during exercise 
[Chapter 2]. These muscle alterations compromise the performance of the lumbar muscles in CLBP. 
The multifidus and erector spinae play an important role in the static-dynamic control of the lumbar 
spine [59]. It is possible that inefficient muscle work leads to increased stress and load on the 
musculoskeletal structures of the spine. This unfavorable condition might eventually result in 
premature fatigue and hamper proper motor control [60,61]. Treatments aiming to restore this 
inefficiency in muscle work are therefore warranted in all LBP patients with altered muscle activity 
patterns. Exercise therapy (e.g. stabilization exercises, balance training, coordination exercises, 
exercises addressing neuromuscular motor control and aerobic exercises) is the most widely used type 
of conservative treatment in non-specific CLBP and seems effective in reducing pain and improving 
function in CLBP. No evidence however exists that one particular type of exercise is more effective 
compared to others. It is even suggested that any kind of physical activity might provide an equivalent 
clinical benefit to a supervised low back exercise program [62–68]. Based on the findings of this 
dissertation, exercise to restore muscle activity is especially advised in non-continuous and continuous 
CLBP.  
Up to date, research concerning specific treatment methods to decrease the amount of fat in muscles, 
is restricted. Nevertheless, results following resistance training are promising. A recent study of Welch 
et al. established a significant reduction in fat infiltration accompanied by an increase in fat free CSA 
at the lumbar level of L3-L4 and L4-L5 after a 16-week, progressive free-weight resistance training 
intervention in patients presenting LBP complaints for more than 3 months. Besides improvement in 
muscle structure characteristics, resistance training improved pain and disability, quality of life and 
strength endurance [69]. Another study investigated the effects of a resistance training program for 
upper and lower body muscle groups, involving a 24-week resistance training followed by 24 weeks of 
detraining, followed by 12 weeks of retraining in older healthy individuals. Cessation of resistance 
exercise in trained older persons was found to increase fat infiltration of muscle while resumption of 
exercise was found to decrease it [70]. More research concerning modalities of exercise therapy and 
their effect on muscle structure characteristics is however needed to formulate firm 
recommendations. Furthermore, as an interrelationship exist between muscle structure and muscle 
function, it is possible that muscle structure characteristics might also benefit from functional exercise 
[25]. Based on our results, exercises focussing on reduction of fat infiltration is advised in continuous 
CLBP. 
According to the management of acute LBP, a customized treatment program with focus on current 
pain relief and enhancement of disability might be recommended in RLBP in a pain elapse. 
Disagreement on the exact content of pain relief however exists [65,71]. In this dissertation, RLBP 
patients are in remission. At this particular moment, no immediate medical intervention for these 
patients is needed. Preventive measures are however advisable, in order to limit (re)occurrence and 
possible evolution to chronicity. Firm recommendations on prevention of pain flares in RLBP patients 
in remission are currently lacking. There is moderate quality evidence that post-treatment exercise 
programs can prevent recurrences of LBP [68]. Furthermore, it is established in previous research in 
RLBP, that despite their state of remission, muscle quality is deteriorated [12] and muscle function is 
altered [23,28,29,72]. Consequently, it is plausible that exercises with focus on functionality might 
improve the muscle characteristics in these RLBP patients and limit pain flares.  
 
2.2.Pain processing 
 
As described before, repetitive noxious stimulation with the same intensity results in an increase in 
pain perception (=wind-up) [73,74]. The application of certain treatment methods, might elicit a similar 
repetitive stimulation to the skin, muscles and joints, and result in enhanced pain sensation. Hands-on 
techniques such as mobilizations [75,76] or repetitive exercises eliciting some nociception, might 
replicate the wind-up phenomenon and result in excessive pain flares after treatment. This should be 
taken into account when treating CLBP patients, since alterations in pain processing might be present 
in a subgroup of CLBP. Also a dysfunction of endogenous nociceptive inhibition during exercise is 
reported in chronic pain populations, e.g. in patients with chronic fatigue syndrome [77], chronic 
whiplash associated disorders [78] and patients with fibromyalgia [44]. In normal situations, pain 
thresholds increase during physical activity because of the release of substances (e.g. opioids) 
orchestrated by the central nervous system [79]. In case of an impaired endogenous nociceptive 
inhibition during exercise, patients report lowered pain thresholds [77]. In CLBP, research was not able 
to establish impairments in endogenous inhibition during exercise [80,81]. As previously remarked, it 
is possible that endogenous inhibition is disturbed in only a subgroup of patients with CLBP. It is 
therefore advised for physical therapist to bear in mind that some CLBP patients are possibly 
characterized by altered pain processing including impaired pain inhibition (during exercise) and might 
experience excessive pain flares after exercise.  
The main focus and treatment goal of a physical therapist is to identify and approach the cause of the 
pain. This disease oriented diagnostic approach works well in the assessment and management of 
acute episodes of LBP but seems to fail in persistent pain [82]. As a result, in a subpopulation of non-
continuous and continuous CLBP, other approaches are urged. A more cognitive-behavioral approach 
is known to prevent LBP from becoming a chronic condition, can reduce pain and improve or maintain 
function in CLBP patients [20,83]. Therefore, a comprehensive rehabilitation program which involves 
pain neuroscience education followed by a custom-made, cognition targeted training program for 
chronic spinal pain is suggested by Nijs et al. This approach intends to address peripheral muscle 
dysfunctions in a biopsychosocial framework. A first phase in this program contains education on pain 
systems intending to change misbeliefs on pain. In a second phase, exercises are performed to improve 
specific function of the spinal muscles and to ameliorate overall control of posture and movement. In 
a third phase, the learned skills are incorporated in dynamic tasks and functional positions. This way, 
this approach intends to limit the disabling effect of back pain in LBP patients. Preliminary data on this 
approach demonstrates promising results [84,85]. In a subgroup of patients with continuous CLBP, 
characterized by centralized sensitization, this approach is advised. Moreover, continuous CLBP 
patients without centralized sensitization and non-continuous CLBP patients with misconceptions 
concerning pain might also benefit from this approach. Patients with a negative mind set might evolve 
into catastrophizing thoughts such as fear of pain, injury and movement in the long-term, these 
adaptation can result in disuse and complete avoidance of pain and movement [20,83–85]. This 
cognitive based exercises approach might reduce pain and disability in these CLBP patients.  
In RLBP, pain processing is assumed to be normal. Consequently, hand-on techniques and exercises 
can be applied quite safely in this population. It need to be stressed out that these RLBP patients are 
in remission and this dissertation does not provide data concerning alterations of pain processing in 
RLBP during a pain flare. As indicated above, the main treatment goal for RLBP patients in remission 
might be prevention of recurrence of a pain flare. Besides exercises as a preventive measure, a 
cognitive-behavioral approach, anticipating for erroneous thoughts on pain might be useful as well in 
certain RLBP patients. Education on beliefs and behaviors concerning pain might prevent RLBP patients 
from sliding down this downward spiral and becoming chronic  
 
 
 
2.3. The associations between muscle characteristics and pain processing  
 
The current research established a relationship between pain mechanisms and muscle structures in all 
LBP groups [Chapter 3]. This observation implies that therapy focusing on absolute improvement of 
pain sensitivity might positively affect muscle characteristics and as a consequence improve LBP 
complaints. Also the opposite might work. Previous research already revealed that peripheral input 
plays an important role in maintaining central sensitization in chronic pain syndromes [86]. Exercise 
treatment addressing muscle characteristics might decrease pain experience and influence pain 
processing mechanisms and therefore positively affect LBP [69,87].  
In addition, generalized hyperalgesia and impaired endogenous pain inhibition is modifiable by 
alleviating the noxious peripheral stimulus [30,88,89]. Clinically, this implies that removing the noxious 
input in patients belonging to the subgroup of CLBP patients with altered pain processing, might also 
relieve LBP complaints. In idiopathic pain, an apparent musculoskeletal pain source is lacking. 
Modification of noxious input in non-specific LBP is however possible by some forms of medication 
[30]. Medication might be able to erupt the vicious circle of altering pain processing in CLBP. In 
addition, other forms of pain control might have this effect. If the noxious peripheral stimulus is 
suppressed, normalization in pain processing might follow and consequently the enhancement in 
muscular structures and functions.  
General recommendations on treatment approaches in RLBP, non-continuous CLBP and 
continuous CLBP are currently unavailable. Based on the current available guidelines, one can say 
moderate to high intensity exercises are suitable for CLBP without generalized pain, whereas 
progressive, low intensity sub maximal fitness and endurance activities are recommended into the pain 
management and health promotion strategies for CLBP with generalized pain [90]. A general improved 
condition of the lumbar muscle tissue, consisting of decreased fat infiltration combined with a 
restoration in muscle quality, might result in more efficient muscle work and increase in load tolerance 
[91]. A cognitive targeted approach is needed in continuous CLBP and advised in non-continuous CLBP 
and RLBP whom might benefit from this approach.  
It must however be stressed out that it is undesirable to pigeon hole LBP patients with eye on 
rehabilitation. Every individual has a different history, environment, psychosocial condition and 
medical need. Consequently, two persons cannot exactly fit into one box. This innovative perspective 
on differences in pain processing and muscle structures between recurrent and CLBP patients should 
always be situated in its bio-psychosocial environment. The treatment approaches of all LBP patients 
should be custom made and tailored to the individual’s profile within its on psychosocial environment.  
3. STRENGTHS AND LIMITATIONS  
 
3.1.Combined investigation of pain processing and peripheral characteristics  
 
Since LBP is the most commonly reported complaint in the National Health survey in Belgium (2010) 
and therapies do not always offer satisfactory results concerning pain and disability [65,92], a domain 
exceeding approach is warranted in order to provide more insight in the clinical picture of LBP. This 
dissertation united two divergent fields, leading to an innovative perspective on the clinical picture of 
recurrent and chronic LBP patients. On the one hand, peripheral lumbar structures were examined in 
different LBP populations, whereas on the other hand also pain processing mechanisms were 
investigated between those populations. In addition, psychosocial characteristics within groups were 
explored post hoc (see below in 3.6) to picture a more holistic image. Together, a multidimensional 
profile of the individual RLBP patient, non-continuous CLBP and continuous CLBP is generated, which 
is clearly a strength of this dissertation. This comprehensive depiction of those three LBP groups are a 
valuable piece in the understanding of recurrence and chronicity of LBP. Only understanding of a 
pathology implies a proper framing for treatments. 
 
3.2.mfMRI versus EMG as evaluation techniques 
 
The dissertation evaluated muscle activity with mfMRI, registering the change in metabolic activity 
after exercise [Chapter 1, Part 2]. Fine wire and surface EMG are alternative methods to evaluate 
muscle activity. Whereas mfMRI represents the metabolic activity in muscles, EMG represents the 
electrical activity of muscle work [93]. Fine wire EMG enables to record deep muscles such as the 
lumbar multifidus, but the technique is invasive and records only a small muscle volume. Surface EMG 
is a non-invasive method but might encounter crosstalk of neighboring muscles and inaccessibility of 
the deeper located muscles. The main advantage of mfMRI compared to the other techniques 
measuring muscle activity, is its superior spatial resolution, which permits imaging of multiple 
superficial and deep muscles at multiple levels from one single scan. Furthermore, the mfMRI 
technique is non-invasive [94]. mfMRI is therefore a convenient solution to overcome these 
shortcomings of the EMG method and a strength of this dissertation.  
On the other hand, evaluating muscle activity by mfMRI also has some disadvantages. The muscle 
activity detection threshold for EMG is lower compared to mfMRI. Moreover, EMG is able to 
investigate the amount and timing of activity in real time, whereas mfMRI can only measure the 
amount of activity after the exercise [93,94]. Because the lumbar exercise in this dissertation is 
performed outside the MRI scanner, a delay between the imaging and the exercise itself, exist. The 
latency effect on the T2-shift due to the delay between completion of the exercise and the start of the 
scan is still not fully understood [94]. Furthermore, distinguishing between concentric, isometric and 
eccentric phase of the Biering-Sörensen exercises is impossible by solely mfMRI evaluation.  
Therefore, a combination of mfMRI results with EMG data in patients performing a lumbar exercise 
would provide a more complete image of the differences in muscle activity patterns between LBP 
groups. Surface EMG data during the modified Bering Sorensen test at 40% of 1RM is also investigated 
in this investigation protocol of this project. Data is available and can be processed in the near future 
to provide more insight in the muscle activity mechanisms of the different LBP-groups. The 
combination of data provided by mfMRI and surface EMG is a strength of the protocol in this 
dissertation. 
 
3.3.DIXON-MRI as a semi-quantitative evaluation technique 
 
All muscle structure characteristics are evaluated by use of a DIXON MRI scan. This relatively new 
method provides an objective measurement of fat fraction in the lumbar muscles, which is a strength 
of this dissertation. The multi-point DIXON fat mapping MRI technique works through the chemical 
shift-based water-fat separation. This method uses the phase difference between water and fat to 
separate these two components, resulting in a quantitative measurement of the fat fraction [95–97]. 
This way, the fat CSA in the current dissertation also took into account non-visual fat droplets. As a 
consequence, the method provides a very accurate representation of visual and non-visual fat content 
in the lumbar muscles.  
 
3.4.Non-continuous and continuous chronic low back pain 
 
Another strength in this dissertation is the subdivision of the CLBP population. CLBP patients are 
defined as persons suffering from back pain persisting for more than three months. According to some, 
this definition is somewhat arbitrarily: “The natural course of LBP consists of fluctuating symptoms 
with intermittent periods of exacerbations followed by less continuous periods and a simple cut off 
point does not take this into account” [98]. In clinical practices, the division between RLBP and CLBP is 
gradually adopted. It is however suggested that the group of CLBP is still heterogeneous [99,100]. 
Altered pain processing is suggested only in a subgroup of CLBP [31,101]. Also general disuse and 
deconditioning might be present only in a subgroup of CLBP, illustrating that some patients with CLBP 
are able to cope with pain and maintain a certain level of daily physical activity, whereas others do not 
cope sufficiently and decline to a state of general disuse and deconditioning [102]. Moreover, 
adaptations of motor output due to pain in pain populations, range from subtle redistribution within 
and between muscles to complete avoidance of tasks and movements [20]. To understand why some 
people recover after every pain episode, whereas other do not and why some are able to function 
normally despite LBP and others don’t, it is vital to unravel this heterogeneity. Ideally, research should 
take into account all personal factors possibly influencing patients’ LBP manifestation. However, this 
is not feasible. Therefore, it is a challenge to discover the most influencing factors of LBP and optimally 
refine the subgroups of LBP. Creating a division between non-continuous and continuous CLBP in this 
dissertation was a first move in order to define a chronicity dependent classification.  
Looking at the pain severity and disability scores, the non-continuous group and continuous CLBP 
group are situated rather on the lower spectrum of pain and disability. A subpopulation of CLBP 
patients, characterized by higher degrees of pain and disability might not be represented by this study 
sample, which is a shortcoming this dissertation. The assessment protocol of the overall study was 
time-consuming. Besides, the exercise protocol with MRI assessment and pain assessment might have 
terrified patients in severe pain for participation in the study. Moreover, highly disabled patients might 
have been unable to come over since all assessments were performed in a laboratory setting. Inclusion 
of CLBP subjects with higher levels of pain severity and disability might influence the study results on 
pain processing and muscle characteristics. Future research could look into this.  
 
3.5.Similarities between recurrent low back pain, non -continuous and 
continuous chronic low back pain  
 
According to fat infiltration and deterioration in muscle quality, RLBP and non-continuous CLBP differs 
from continuous CLBP, whereas according to muscle function, RLBP differs from both non-continuous 
and continuous CLBP. These results also suggest similarities between RLBP and non-continuous CLBP 
for muscle structure and between non-continuous and continuous CLBP for muscle function. 
Furthermore, no differences between LBP-groups could been found for TS, SS or CPM. Statistically it is 
however incorrect to assume similarities between subject groups because no differences were 
established. Possibly, the constructs to measure the differences between groups were insufficient. 
Another explanation for the absence of these differences is the possible lack of power. A priori power 
calculations indicated 24 subjects in each group were needed to reach a power of 0.80. Due to the 
complexity of the test protocol, this postulated amount was not reached, which is a shortcoming of 
this dissertation.  
 
3.6.Psychosocial characteristics in different groups of low back pain  
 
In the experimental chapters of this dissertation, the lack of psychosocial correlates is several times 
discussed as a shortcoming. The results of this dissertation and their clinical implications should always 
be seen in the light of a patients’ individual psychosocial environment. As an interplay between pain 
and psychosocial factors is assumed, psychosocial factors have a strong influence on the perception 
and expression of pain [103]. It is established that mood and emotions modulates pain through the 
descending pain modulatory pathways [104]. Fear and anxiety are emotional states which modulate 
human pain reactivity [105]. Emotional distress is one of the most important constructs influencing 
pain intensity and pain disability in LBP [106]. Also pain behavior and coping, job dissatisfaction, work 
relations and social support are possible risk factors for occurrence and chronicity of non-specific LBP 
[107]. On the other hand, recurrent and chronic pain affect the psychological function. After 
experimental nerve injury, a subpopulation of rats presents disturbances of sleep and social interaction 
caused by pain [108]. Also fear avoidance as a consequence of LBP is commonly reported in overall LBP 
patients [109]. Those psychosocial factors might contribute to the transition from acute to chronic LBP 
[107,110,111]. If not properly addressed, these psychosocial factors in combination with LBP might 
facilitate loss of employment, stress in relationships and even suicidal behavior [82]. 
The relationship between biological, psychological and social factors in LBP is complex. As far as we 
know, differences or similarities in psychosocial factors between RLBP, non-continuous CLBP and 
continuous CLBP are yet unexplored. In this dissertation, all subjects underwent psychosocial 
investigations based on standardized questionnaires: 
To evaluate self-reported fatigue and strength, the Checklist of Individual Strength (CIS) is 
assessed. The CIS consists of 20 items measuring 4 dimensions of fatigue: subjective fatigue 
severity, reduced concentration, reduced motivation and reduced physical activity level. 
Respondents indicate on a 7-point Likert scale to which degree each item was true in the past 
2 weeks preceding to the examination. High scores indicate a high level of fatigue and lower 
levels of concentration, motivation and physical activity. The total score ranges from 20-140. 
A total score > 76 is interpreted in employees as problematic fatigue and at risk for long-term 
drop out. The validity and internal consistency of the CIS is good [112–114].  
The Hospital Anxiety and Depression Scale (HADS) recorded the degree of anxiety and 
depression. It is a 14-item self-report screening scale, developed to indicate the possible 
presence of anxiety and depressive states. The HADS contains two 7-item scales: one for 
anxiety and one for depression both with a score range between 0–21. A score of 11 or higher 
implicates supposed anxiety or depression. The HADS has a good reliability and validity as 
screening instrument [115].  
The daily influence of pain is recorded by the Multidimensional Pain Inventory – section 1 
(MPI-I). This section contains subscales on interference of pain in daily life (=“interference”), 
social support (=“support”), “life control”, “pain severity” and “affective distress”. Each item is 
rated on a 7-point scale ranging from 0-6. Scale scores are computed by summing all items and 
then the mean is composed based on the number of scale items. A higher score on social 
support and life control represents a better perceived social support and perceived life control. 
A higher score on interference in daily life, pain severity and affective distress represents a less 
favorable perceived interference in daily life, perceived pain severity and perceived affective 
distress. The total score is not used [116].  
The Pain Catastrophizing Scale (PCS) is a 13-item questionnaire  used to evaluate 
catastrophizing on pain in pain patients and healthy persons. Each item has a 5-point rating 
scale ranging from 0 (=“not at all) to 4 (=all the time) and scores provide a total score for the 
PCS (between 0-52) and subscale scores for rumination (between 0-16), magnification 
(between 0-12), and helplessness (between 0-24). The 75th percentile cut-off scores replicate 
clinical relevant levels of catastrophizing and respectively are a score of 30 on the total PCS, a 
score of 11 on the rumination subscale, a score of 5 on the magnification subscale and a score 
of 13 on the subscale for helplessness. The PCS is a valid and reliable measure of 
catastrophizing [117,118]. 
The Pain Disability Index (PDI) evaluates the degree of interruption of life due to pain. This 
measure evaluates the impact of pain on the ability of a person to participate in essential life 
activities through 7 items: (1) activities related to family and home (2) hobbies, sports and 
other leisure time activities, (3) participation with friends and acquaintance other than family 
members, (4) activities partly or directly related to working, housework and volunteering, (5) 
frequency and quality of sex life, (6) self care, (7) basic life-support behaviors (e.g. eating, 
sleeping, breathing,…). All items are scored between 0 (=”no disability at all”) and 10 (=”all 
activities in which a responder would normally be involved have been totally disrupted or 
prevented by their pain”). A total score on a maximum of 70 is calculated to report on disability. 
A study in 425 CLBP and 178 acute LBP established a mean PDI of respectively 36.5 and 38.0 
on a maximum of 70 [119]. The Dutch version in valid and reliable [119,120].  
Finally, the Survey Of Pain Attitudes (SOPA) is assessed to evaluate believes on pain. It 
contains 57 items, assessing 7 pain related beliefs: (1) perceived control over pain (=“control”), 
(2) belief in the effects of emotions on pain experience (=“emotion”), (3) belief in oneself as 
disabled by pain (=”disability”), (4) belief in a medical cure for the pain problem and that it is 
the responsibility of the medical profession to reduce of cure the pain problem (=”medical 
cure”), (5) belief that pain will lead to physical damage and the need to avoid exercise 
(=”harm”), (6) belief that medication is an appropriate treatment (=”medication”), (7) believes 
that others, specially family members, should be solicitous in response to the experience of 
pain (=”solicitude”). All items are scored on a scale ranging from 0 (=”agree not at all”) to 4 
(=”completely agree”). Items (1) and (2) measure adaptive beliefs, whereas items (3) to (7) 
evaluate maladaptive beliefs. A higher score on item (1) and (2) are therefore measures for 
adaptive behavior, whereas higher scores on items (3) to (7) are measures for maladaptive 
behavior. Scores of < 3 on control; < 1 on emotion; ≥ 38 on disability;  > 28 on medical cure; ≥ 
26 on harm; > 23 on medication or ≥ 20 on solicitude are considered as maladaptive believes. 
The Validity and reliability is good [121,122].  
 
Because it is important in clinical practice to approach LBP patients within their own psychosocial 
situation, an overview of the results on psychosocial characteristics in each group included in this 
dissertation is represented below: 
 
- Compared to RLBP, LBP complaints are associated with more disability in continuous CLBP. 
Also the impact of LBP on daily living is experienced higher and the severity of pain is 
considered worse.  
- Non-continuous CLBP patients experience more subjective fatigue, concentration problems, 
motivation problems and disability caused by their LBP complaints compared to RLBP patients. 
They are also less physically active and are more anxious and depressed. Non-continuous CLBP 
experience their pain as more continuous compared to RLBP.  
- Few differences between non-continuous and continuous CLBP patients were seen. Non-
continuous CLBP only suffered more concentration problems compared to continuous CLBP. 
- No differences between groups were found for social factors such as civil state, education 
level, job status or job characteristics. 
These preliminary analyses confirm the differences between the 3 LBP groups in this dissertation. The 
psychosocial state and degree of disability of RLBP seems to be more favorable in comparison with 
non-continuous and continuous CLBP and might consequently be influential on the occurrence of LBP 
and evolution to chronicity [83]. It can be hypothesized that patients with RLBP are less likely to 
develop misbelieves on pain and maladaptive behavior due to pain, because they only experience short 
episodes of pain flares alternated with longer pain free periods. On the other hand, also the opposite 
is possible. A more positive mindset of RLBP patients compared to chronic patients might help them 
to recover after every pain episode and prevent them from lingering in a pain flare. Although 
differences between RLBP, non-continuous and continuous CLBP patients are established, the overall 
cognitive and emotional state in the LBP patients is not dramatic. Total scores and scores on subscales 
in non-continuous and continuous CLBP are not in the range of (available) normative data for pain 
patients. This implicates that despite the less favorable scores in non-continuous and continuous CLBP 
compared to RLBP on individual strength, anxiety and depression, pain severity, interference of pain 
in daily life and disability due to pain, explicit erroneous thoughts in the 3 patient groups cannot be 
established. Notably, the ranges reported in table 2 [Addendum], indicate some individuals do tend 
towards an adverse cognitive-emotional state. Identification of these individuals in clinical practice and 
addressing these issues is advised in order to prevent reoccurrence and chronicity. Furthermore, it is 
striking that the 3 LBP groups report very low scores on rumination, magnification, helplessness and 
the total PCS questionnaire. However, pain catastrophizing is seen as an important related construct 
of pain [123], these results point out that no pain catastrophizing is present in this subject population. 
These overall moderate results on pain believes might confirm our previous remark that the group of 
continuous CLBP possibly lacks a subgroup of patients experiencing high levels of pain, disability and 
maladaptive believes. Finally, it must be noted that despite the general positive cognitive-emotional 
state of the 3 LBP groups, scores on adaptive believes (SOPA for control and SOPA for emotion) are 
low, indicating that besides the absence of clear maladaptive believes, also adaptive believes might be 
lacking. Further research on this is however needed.  
 
More details on the differences in psychosocial factors between LBP population can be found in table 
2 and in the abstract in the addendum of this dissertation [Addendum]. These data need further 
exploration and will be published in the future. 
  
4. FUTURE RESEARCH 
 
4.1.Peripheral alterations in patients with fibromyalgia  
 
FM patients, in which altered central pain processing is established, are in this doctoral thesis seen as 
a reference group to detect sings of enhanced pain facilitation or reduced pain inhibition in the LBP 
groups [Chapter 2, Part 2]. Although it was not the main scope of this dissertation, it would be 
interesting to evaluate peripheral abnormalities concerning muscle structure and metabolic activity 
underlying the FM pathology based on the data available in this dissertation. A peripheral contribution, 
both bottom-up as top-down, to the occurrence and maintenance of central sensitization in chronic 
pain patients is often suggested [35,124–126]. Histochemical and metabolic changes, alterations in 
muscle fibers, vascular abnormalities and mitochondrial functioning resulting in muscular ischemia are 
already established in patients with fibromyalgia [35]. It is therefore possible that metabolic activity, 
fiber type distribution, atrophy and fat infiltrations are also altered features in those patients.  
Furthermore, it would be valuable to investigate whether a relation between altered pain processing 
mechanisms and muscular characteristics exist within the fibromyalgia population.  
 
4.2.Differences in fiber type distribution in different groups of low back pain  
 
This research was not able to establish differences in T2-rest values, reflecting fiber type distributions, 
between the three LBP subpopulations. Previous research however, established a lower T2-rest, 
indicating a possible enhanced portion of type II fibers in RLBP patients compared to HC [23]. It is 
therefore possible that alterations in fiber type distributions occur in all three groups. The ANCOVA 
statistics, indicated a border significant group differences. It is therefore possible that due to a low 
statistical power, differences between the three LBP subpopulations are missed. Future work focussing 
on differences in fiber type distribution might clarify this issue.   
 
4.3.Subjectivity of pain & psychosocial influences  
 
Even though chronic pain is described as continuous, it comes and goes and fluctuates in intensity [35]. 
Individual differences in reported pain are a major issue in pain assessment. An interplay between pain 
and psychosocial factors is assumed [82,103,104,107,108]. Per definition, the ‘pressure pain threshold’ 
refers to the smallest stimulus intensity perceived as painful by the subject, whereas ‘pressure pain 
tolerance threshold’ refers to the maximum pain intensity the subject is willing to endure. This implies 
that the pressure pain tolerance threshold depends partly on the willingness of the subject and might 
be influenced by motivation and psychosocial factors [127]. Other methods to investigate pain 
processing, might overcome this issue. Brain imaging techniques e.g., allow visualization of brain 
structures and function involved in pain processing and provide objective evidence of augmented 
responses to pressure stimuli [128,129]. In the last decades, brain imaging improved the insight in pain 
perception, pain modulation and chronicity of pain [130,131]. In CLBP patients indicating enhanced 
pain sensation, fMRI was able to establish more extensive patterns of neuronal activation in pain 
related cortical areas when compared to HC [128,132,133]. Also the nociceptive flexion reflex, which 
is a physiological correlate of spinal excitability, gains interest in research [134–137]. Given that 
nociceptive flexion reflex is a spinal reflex, implicates the outcome of this technique is not dependent 
on subjective report and supraspinal modulation [138]. Future work with this innovative paradigm is 
needed.  
 
4.4.Recurrent low back pain in a pain flare versus remission 
 
In this dissertation, no alterations in pain processing are established in RLBP in remission [Chapter 2, 
Part 2]. Currently, no results concerning pain processing in RLBP patients in a pain flare are reported. 
The influence of a clinical pain source on these characteristics however, might be interesting. The 
systematic review on the influence of pain on CPM, established that a present pain source might 
influence the endogenous pain working mechanism, but only when the CPM mechanism is impaired, 
like in chronic pain conditions, and not in acute pain [Chapter 2, Part 1]. No knowledge concerning 
RLBP is obtained. Comparing CPM in RLBP in a pain flare and in remission might contribute to the 
expertise on pain processing in this patients population. Also other pain processing parameters could 
be investigated in both pain states. Besides pain processing, expertise concerning muscle 
characteristics in RLBP in a pain flare is limited. Experimental pain induction in RLBP in remission 
established a generalized, widespread inhibitory response in lumbar muscle activity during trunk 
extension [139]. Remarkably, this response is opposite to the increase in multifidus activity, shown 
during remission [23], suggesting a possible role for pain in the modification of motor alterations along 
the course of recurrent LBP [139]. As a consequence, clinical/experimental pain might also interfere 
with muscle structure characteristics in RLBP. As Hodges et al. (2006) [11] established, rapid atrophy 
occurs after experimentally induced injury in pigs. We are however not familiar with such research in 
subjects with RLBP. Investigating the differences in muscle characteristics between RLBP patients in a 
pain flare and a pain free episode might therefore be an interesting topic to record characteristics of 
the RLBP pathomechanisms.  
Initially, this dissertation intended to evaluate pain processing, muscle characteristics and psychosocial 
factors in RLBP during a pain flare and during a pain free episode. Patients with RLBP during a pain 
episode were however hard to recruit for assessments. This patient group was quite young and 
reported a busy schedule. Moreover, the total amount of assessment hours was up to 5 hours, divided 
over 2 days, with a maximum of 10 days between both assessments. Planning the assessment during 
a pain free episode was feasible, because arrangement could been made weeks or months before. A 
pain flare however, only lasts for a couple of days. The courtesy to be investigated on such short notice 
was for most RLBP patients not attainable. Consequently, only patients who were accidentally in a pain 
flare at the scheduled time were assessed during a pain episode and reassessed afterwards in a pain 
free period. In total, 8 patients in a pain flare were assed for pain, of which 7 also for MRI. Only 5 
patients fulfilled the complete protocol of 2 pain assessments and 2 MRI assessments (both once 
during a pain flare and once during a pain free episode). Research focusing mainly on RLBP might 
however be able to recruit sufficient subjects in both episodes. Another option is to experimentally 
induce pain in RLBP patients in remission and perform all assessment during pain flare due to 
experimentally induced pain.  
 
4.5.The association between peripheral changes and pain processing  
 
In this dissertation the influence of pain processing on muscle structure characteristics is investigated. 
Contribution of peripheral mechanisms to the occurrence and maintenance of central sensitization are 
previously assumed [35,126] but until now identification of a central source of sensitizing input to pain 
pathways has failed in chronic pain patients [35]. The association between pain sensitivity and muscle 
structure in LBP, might indeed ratify the contribution of peripheral mechanisms in central sensitization. 
However, to evaluate whether alteration in pain processing working mechanisms are cause or result 
of muscle alterations, a longitudinal study is needed. Follow-up studies, starting before the onset of 
LBP, might reveal more valuable information on the influence of the relationship between muscular 
deformations and pain processing mechanisms on occurrence and recurrence of LBP.  
An interplay between pain, muscle function and muscle structure seems to exist [140]. Therefore, one 
can speculate that muscle activity might also be related to pain processing. Altered muscle activity has 
been observed in patients with LBP. Those alterations in the short term are functional after tissue 
injury to prevent further injury. Changes in recruitment which remain after the normal tissue healing 
are however possibly harmful [140] and might be related to neural processes influenced by pain 
modulating mechanisms and cognitive-emotional processes [141]. Future research could investigate 
this track.  
 
 
 
 
     
 
Figure 1A & 1B: A. Theoretical model concerning the interrelationship between muscle function affected by pain and 
muscle structure in neck pain patients. Adopted from Falla and Farina [25]. B. A modified theoretical model concerning the 
interrelationship between muscle characteristics and pain and the possible role of psychosocial factors in this association. 
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4.6.Prevention  
 
Because of the increasing age of the population, along with high rates of obesity and sedentary 
lifestyles, the prevalence and incidence of CLBP enhances [83].  Rather than treating chronic spinal 
pain patients, prevention of future episodes and chronicity would provide more potential benefit in 
health gaining [90]. It is established that psychological factors such as distress and depressive mood, 
are contributing to the transition from acute to chronic LBP [107,111]. Also job related psychosocial 
factors and social support might influence the occurrence of LBP [142]. Furthermore, relationships 
between obesity [143–145], alcohol abuse [145] and smoking [145,146] and the 
occurrence/recurrence of LBP are suggested. Prevention by healthy life style promotion might reduce 
the prevalence of LBP and its disabilities and socio-economic costs. Also investigations concerning 
strategies to adapt pain behavior and pain beliefs about LBP are needed as a method in prevention for 
recurrence and chronicity [83]. It is established that exercise in combination with education is likely to 
reduce the risk of LBP in the longer term [147]. These ‘yellow flags’, which are recognized warning signs 
for the vulnerability to develop chronicity, are well-known and discussed in literature [107]. Screening 
for treatable risk factors and assessment of these yellow flags might be the most promising and cost-
effective move to anticipate on people becoming chronic. Until now, little research focusses on the 
development and validation of prevention programs. A paradigm shift from treatment programs for 
RLBP and CLBP to prevention programs is needed in research.   
5. GENERAL CONCLUSION 
 
This dissertation intended to investigate differences in peripheral back muscle characteristics and pain 
processing in patients with LBP. Differences and similarities are established between RLBP patients in 
remission, non-continuous CLBP patients suffering 3 to 4 days per week from pain complaints and 
continuous CLBP patients experiencing LBP every day.  
 
5.1.Recurrent low back pain  
 
The lumbar muscles of RLBP patients in remission are characterized by a lower degree of fat 
infiltration, less deterioration in muscle quality and fewer metabolic residuals after lumbar muscle 
activity, compared to persons suffering daily from LBP. Furthermore, metabolic activity in RLBP 
patients in remission is lower compared to non-continuous CLBP patients. Atrophy of the total lumbar 
muscle mass or the lean muscle mass seems not different in RLBP patients compared to any of the 
CLBP groups. RLBP patients in remission are characterized by better pain processing mechanisms 
compared to patients with fibromyalgia, in which altered pain processing was seen. Also the pain 
tolerance threshold, measured by cuff algometer, revealed a better pain processing in RLBP compared 
to the continuous CLBP group. These results suggest a properly working pain processing mechanism 
in RLBP in remission, but additional research on pain systems in RLBP patients in a pain flare is 
warranted. Moreover, explorative data establishes a positive association between pressure pain 
thresholds with the total and lean muscle mass in the erector spinae, but not in the multifidus. Finally, 
RLBP patients in remission are characterized by a more favorable mental state and a lower degree of 
disability and interference of pain in daily life, compared to the CLBP groups.  
 
5.2.Non-continuous chronic low back pain 
 
The amount of fat infiltration and quality deterioration in the lumbar muscles is smaller in non-
continuous CLBP patients, compared to continuous CLBP patients, whereas these muscle structural 
characteristics do not alter between non-continuous CLBP patients and RLBP patients. On the other 
hand, enhanced metabolic residuals are indeed more present in non-continuous CLBP patients 
compared to RLBP patients, but not compared to continuous CLBP patients. Moreover, no difference 
in total muscle mass or lean muscle mass exists between the three LBP groups.  
In pain processing, no differences were found between non-continuous CLBP patients and healthy 
persons on the one hand or patients with fibromyalgia on the other hand. Also no differences with 
RLBP or continuous CLBP patients could have been established. Based on the above mentioned results, 
one can suggest that LBP seems to present as a continuum, in which the non-continuous CLBP patients 
turn out to float between RLBP patients and continuous CLBP patients. Furthermore, explorative data 
establishes a positive association between pressure pain thresholds with the total and lean muscle 
mass in the erector spinae, but not in the multifidus. Finally, non-continuous CLBP patients are 
characterized by a higher degree of subjective fatigue, concentration problems, motivation problems, 
anxiety, depression, pain and disability and a lower level of physical activity compared to RLBP 
patients. No apparent psychosocial differences between non-continuous and continuous CLBP patients 
are however present.  
 
5.3.Continuous chronic low back pain 
 
Increased fat infiltration and decreased muscle quality of the multifidus and erector spinae in the 
absence of clear enhanced total muscle or lean muscle atrophy, is a feature in continuous CLBP 
compared to RLBP in remission or non-continuous CLBP. Furthermore, enhanced metabolic residuals 
after muscle activation are present in the lumbar muscles of continuous CLBP compared to the RLBP 
patients. Also signs of altered pain processing in the continuous CLBP group are established in this 
dissertation, however not at the extent as seen in other chronic pain patients, such as patients with 
fibromyalgia. It is therefore expected that impaired pain processing might be present in only a 
subgroup of the continuous CLBP patients. Moreover, explorative data establishes a positive 
association between pressure pain thresholds with the total and lean muscle mass in the erector 
spinae, but not in the multifidus. Finally, continuous CLBP indicate a higher pain severity and 
interference of pain in daily life and are feeling more disabled compared to RLBP. Few differences 
between continuous CLBP and non-continuous CLBP are however present.  
 
 
 
 
 Figure 2: A musculoskeletal  LBP continuum 
 
RLBP, non-continuous CLBP and continuous CLBP differ on several levels. In conclusion for muscle 
characteristics, we suggest a continuum within the complete LBP population. The lumbar muscles of 
continuous CLBP are characterized by the largest amount of muscle deterioration, fat infiltration and 
muscle inefficiencies, whereas the lumbar muscles of RLBP in remission are characterized the smallest 
amount of muscle alterations. Since the non-continuous CLBP patients also present inefficient muscle 
performance but less muscle structure alterations, this group is assumed to float in between the RLBP 
and continuous CLBP group. Also for pain processing a continuum is proposed. RLBP patients are 
assumed to have proper pain processing, in conformity with healthy persons. Some signs of altered 
pain processing are seen in continuous CLBP patients, but definitely not as clear as in patients with 
generalized pain processing impairments, such as patients with fibromyalgia. Non-continuous CLBP 
patients did not differ from fibromyalgia patients, continuous CLBP patients, RLBP patients nor the 
healthy subjects and is therefore hypothesized to be situated somewhere in between (Figure 2). 
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Summary in English 
  
Background and aim 
Even though low back pain (LBP) can be seen as a normal feature of the aging process, for some LBP 
evolves into a disabling chronic pain condition prohibiting daily activities, work and relationships. Some 
patients seem to recover after every pain episode, whereas others develop a chronic pain state. Two 
types of LBP are frequently reported: recurrent low back pain (RLBP) and chronic low back pain (CLBP). 
RLBP is characterized by pain flares of at least 24 hours followed by a pain free period of at least 1 
month, whereas the CLBP patients are characterized by LBP for at least 3 months. To date it is still 
unknown why some patients develop recurrent or chronic LBP. Little research even distinguishes 
between RLBP and CLBP. Furthermore, a large heterogeneity within the CLBP group exists, e.g. some 
patients suffer from LBP on a daily basis, whereas others alternate pain days with days of being pain 
free. This heterogeneity within the LBP population might arise due to different working mechanisms, 
which in their turn might contribute to the typical characteristics of each group. Insight in the working 
mechanisms of different LBP groups might clarify why some patients recover and others do not, and 
could eventually lead to specialized treatments for each LBP group. 
This dissertation intends to provide an innovative perspective on the differences and similarities 
between RLBP patients, non-continuous CLBP patients and continuous CLBP patients by studying the 
concepts of peripheral muscle dysfunctions and pain mechanisms. Through this, we aim to contribute 
to the knowledge of the characteristics of different LBP groups. Insight in these characteristics might 
provide understanding why some patients recover after every pain flare and others proceed further in 
this downward spiral. 
 
 Muscle characteristics 
A systematic review concerning the changes in cross-sectional area (CSA), fat infiltration and muscle 
fiber type illustrates the gaps in the current knowledge concerning muscle structure alterations in LBP 
[Chapter 1, Part 1]. A second manuscript outlines experimental research, which evaluates the muscle 
structure and muscle activity of the lumbar erector spinae muscle and multifidus muscle in RLBP, non-
continuous CLBP and continuous CLBP. A T1-weighted DIXON scan measured the spinal muscle CSA, 
fat infiltration and muscle fat index in lean muscle tissue, whereas an estimated T2-weighted muscle 
functional MRI scan evaluated the metabolic activity after a lumbar extension exercise [Chapter 1, Part 
2]. 
 
 
 Pain processing 
A systematic literature study is conducted to evaluate whether the presence of pain influences the 
efficacy of endogenous pain inhibition when measured by conditioned pain modulation (CPM). This 
manuscript provides an overview of the current knowledge of the effects of clinical pain, experimental 
pain induction and pain reduction on CPM in adults [Chapter 2, Part 1]. The experimental research on 
pain measurements in RLBP, non-continuous CLBP and continuous CLBP is outlined in a second 
manuscript. To accurately investigate pain processing in the three LBP populations, results are 
compared to 2 additional groups: healthy persons and fibromyalgia patients. Hereby, a complete 
spectrum is created with healthy subjects, representing a population with normal pain processing on 
the one end and fibromyalgia patients, representing a population with altered pain processing on the 
other end. The 3 LBP groups are expected to be situated in between those 2 ends [Chapter 2, Part 2]. 
 
The association between muscle characteristics and pain processing 
To gain insight in the mechanisms behind recurrence and chronicity of LBP, the association between 
muscular alterations and pain processing alterations is investigated [Chapter 3, Part 1]. 
 
Results and clinical implications  
 Muscle characteristics 
A systematic review reveals atrophy of the multifidus muscle in CLBP, mainly at the lower lumbar 
levels, whereas atrophy of the erector spinae muscle is less established. An increase of fat infiltration 
in CLBP seems to be due to personal factors, rather than to LBP itself. Besides a deterioration of muscle 
quality (represented by an enhanced muscle fat index) in RLBP in remission, no clear signs structural 
changes of the lumbar musculature are seen in RLBP. More research is needed on acute LBP and fiber 
type characteristics [Chapter 1, Part 1]. 
Experimental research in muscle characteristics reveals an increased presence of fat and a decreased 
muscle quality in the lumbar multifidus and erector spinae in continuous CLBP compared to non-
continuous CLBP and RLBP. However, no general atrophy is however seen indicating that muscle tissue 
is possibly replaced by fat tissue and hereby masking an overall atrophy of the lumbar muscles in 
continuous CLBP patients. Fat infiltration and loss of muscle quality is not different in RLBP when 
compared to non-continuous CLBP. In addition, an increased T2-shift is found in continuous CLBP and 
non-continuous CLBP compared to RLBP, indicating more metabolic residuals due to less efficient 
muscle work in both CLBP groups.  
In conclusion, the non-continuous CLBP seems not different from RLBP for lumbar muscle structure 
and from continuous CLBP for lumbar muscle function. Therefore, clear differences between the 3 LBP 
populations exist. These results indicate that LBP presents as a spectrum in which muscle 
characteristics start to deteriorate in RLBP and decline further as chronicity worsens. Clinically, these 
results underline the importance of back exercises as patients become more chronic. [Chapter 1, Part 
2]. 
 
 Pain processing 
The systematic review establishes that pain inhibitory medication and oral contraceptives inhibit the 
CPM mechanism, whereas surgery removing a chronic pain source, improves the CPM mechanism. 
Inducing or inhibiting (sub)acute pain does not alter the CPM mechanism. We can conclude that 
medication and surgical removal of a chronic pain source indeed influences the efficacy of CPM. 
Research should therefore take into account that pain medication might influence outcome results. 
Furthermore, eliminating a chronic pain source might be a promising treatment goal in rehabilitation, 
in order to interrupt the vicious circle [Chapter 2, Part 1].  
In the experimental pain research, pressure pain thresholds by manual algometry are shown to 
decrease in patients with fibromyalgia when compared to healthy persons, RLBP and continuous CLBP. 
Temporal summation of pain is enhanced in patients with fibromyalgia compared to healthy persons 
and RLBP. Pain tolerance thresholds assessed by cuff algometry are decreased in fibromyalgia patients 
when compared to healthy controls and RLBP. Interestingly, pain tolerance thresholds in continuous 
CLBP are decreased when compared to RLBP. No significant differences between groups are found for 
spatial summation of pain or CPM. In conclusion, these results suggest normal pain sensitivity in RLBP. 
In continuous CLBP, some findings of altered pain processing seem evident, but not at the extent of 
chronic pain conditions such as fibromyalgia. Altered pain processing possibly occurs only in a 
subgroup of continuous CLBP. Clinicians should take this into account when treating those patients. 
Proper detection, assessment and treatment of altered pain processing mechanisms in continuous 
CLBP is quintessential in clinical practices. The non-continuous CLBP group seems to be situated 
between healthy persons/RLBP and continuous CLBP. [Chapter 2, Part 2].  
 
 
The association between muscle characteristics and pain processing 
No association is found between pain processing and fat tissue in the lumbar muscles. However, a 
positive association is established between pain sensitivity, total CSA and muscle CSA in the lumbar 
erector spinae, but not in the multifidus. The classification of subgroups seems of no importance to 
the association. As a consequence, LBP patients who are generally more sensitive to pain, are more 
likely to have smaller lumbar erector spinae muscles and vice versa. Smaller muscles might be less 
resilient to daily impact, contributing to the recurrence and/or chronicity of LBP complaints. Clinically, 
one can speculate that removing the noxious input in patients with altered pain processing, might also 
relieve LBP complains. Eliminating the pain might erupt the vicious circle of alterations in pain 
processing leading to improvement of muscular structures and functions [Chapter 3, Part 1].  
 
Conclusion 
Regarding muscle characteristics, one can speak of a continuum in the LBP population. Deterioration 
of fat infiltration and muscle activity is less present in RLBP when compared to continuous CLBP. The 
continuous CLBP is characterized by more fat infiltration and more muscle deterioration compared to 
RLBP and non-continuous CLBP, and a less efficient muscle work compared to only RLBP. The non-
continuous CLBP is assumed to be situated in between the RLBP and continuous CLBP group.  
For pain processing a continuum is also proposed. RLBP is assumed to have proper pain processing, in 
conformity with healthy persons. Some signs of altered pain processing are seen in continuous CLBP, 
but not as clear as in patients with fibromyalgia. Non-continuous CLBP patients do not differ from 
fibromyalgia patients, RLBP nor the healthy subjects and is therefore hypothesized to be situated in 
between RLBP and continuous CLBP. 
Finally, only an association between total and muscle CSA of the erector spinae and pain processing is 
established. LBP patients who are generally more sensitive to pain, are more likely to have smaller 
lumbar erector spinae muscles and vice versa. Smaller muscles might be less resilient to daily impact, 
contributing to the recurrence and/or chronicity of LBP complaints. 
  
Samenvatting in het 
Nederlands 
  
Achtergrond en doel van het doctoraat  
Lage rugpijn is een veel voorkomend probleem in onze maatschappij. In principe is het verloop van 
acute lage rugpijn een goedaardig proces wat zichzelf oplost. In sommige gevallen echter evolueert 
een acute opstoot van lage rugpijn naar langdurige klachten. Deze langdurige klachten kunnen 
gekenmerkt zijn door herhaaldelijke opstoten afgewisseld met lange pijnvrije periodes (= patiënten 
met recurrente lage rugpijn) of zelfs voortdurende rugpijnklachten (= patiënten met chronische lage 
rugpijn). Tot op heden is het een mysterie waarom sommige mensen evolueren naar een toestand 
waarin ze na een opstoot telkens weer herstellen en andere evolueren naar een toestand van 
chronische klachten. Het is waarschijnlijk dat de mechanismen onderliggend aan deze beide soorten 
van lage rugpijn, onderling verschillen. Om te begrijpen waarom sommige mensen vervallen in 
chronische klachten en anderen herstellen na elke pijnopstoot, is het dan ook noodzakelijk om meer 
inzicht te krijgen in die onderliggende mechanismen.  
Dit doctoraat schetst daarom een innovatief beeld omtrent de gelijkenissen en verschillen tussen de 
soorten lage rugpijn. Naast het verschil tussen recurrente en chronische lage rugpijn, blijkt de groep 
van chronische lage rugpijnpatiënten bovendien erg heterogeen te zijn. Daarom werd de chronische 
groep nog verder onderverdeeld in een groep met dagelijkse lage rugpijnklachten (= patiënten met 
continue chronische lage rugpijn) en een groep met 3 à 4 dagen per week klachten van lage rugpijn (= 
patiënten met niet-continue chronische lage rugpijn). Door de karakteristieken van deze 3 groepen in 
kaart te brengen, willen we proberen begrijpen waarom sommige mensen herstellen na elke opstoot 
van lage rugpijn en andere chronische klachten ontwikkelen. Op langere termijn kan inzicht in de 
verschillende karakteristieken de effectiviteit van behandelingen voor de verschillende subgroepen 
van lage rugpijn verhogen. 
 
Spierkarakteristieken 
Als eerste stap is een systematisch literatuuronderzoek verricht om de lacunes in de huidige 
wetenschappelijke literatuur inzake spierstructuur in lage rugpijnpatiënten bloot te leggen [Chapter 1, 
Part 1]. Vervolgens is een experimenteel onderzoek opgezet waarin de spierstructuur en spierfunctie 
van de 3 groepen met lage rugpijn werden onderzocht. Met een MRI-toestel is er gekeken naar de 
grootte van de rugspieren, de mate van vetinfiltratie in de rugspieren, de veranderingen in 
spierkwaliteit en de veranderingen in spieractiviteit bij beweging. 
 
 
 Pijnkarakteristieken 
Ook het onderzoek naar pijnkarakteristieken is gestart met een systematisch literatuuronderzoek. 
Deze keer om te onderzoeken of de “aanwezigheid van klinische pijn”, “het induceren van 
experimentele pijn” of “het wegnemen van pijn” een invloed heeft op endogene pijninhibitie [Chapter 
2, Part 1]. Vervolgens is er een experimenteel onderzoek verricht waarin de 
pijnverwerkingsmechanismen in de 3 groepen van lage rugpijn worden onderzocht. Hierin wordt 
gekeken naar hun pijndrempels, temporele summatie van pijn, spatiële summatie van pijn en de 
werking van hun endogene pijninhibitiesysteem. Om dit onderzoek te kunnen doen, worden 2 
referentiegroepen toegevoegd: gezonde personen (= zij hebben een normaal pijnverwerkingssysteem) 
en patiënten met fibromyalgie (= zij zijn gekenmerkt door afwijkingen in hun pijnverwerkingssysteem). 
Er wordt verondersteld dat de 3 lage rugpijngroepen zich tussen deze 2 referentiegroepen bevinden 
[Chapter 2, Part 2]. 
 
De relatie tussen spierkarakteristieken en pijnkarakteristieken 
Als laatste onderdeel wordt de relatie tussen de 2 voorgaande hoofdstukken onderzocht [Chapter 3, 
Part 1].  
 
Bevindingen en klinische implicaties 
 Spierkarakteristieken 
Een systematisch literatuuronderzoek toont aan dat chronische lage rugpijnpatiënten gekenmerkt zijn 
door voornamelijk atrofie van de multifidus spier en niet zozeer door atrofie van de erector spinae. 
Ook vetinfiltratie is kenmerkend voor chronische patiënten, al is dit eerder te wijten aan persoonlijke 
factoren zoals leeftijd en body mass index, dan aan de lage rugpijnklachten zelf. Bij recurrente lage 
rugpijnpatiënten is er enkel een achteruitgang in de kwaliteit van de spier te zien, maar geen globale 
atrofie of vetinfiltratie [Chapter 1, Part 1].  
Experimenteel onderzoek toont aan dat er meer vet en achteruitgang in de spierkwaliteit te vinden is 
bij continue chronische lage rugpijnpatiënten, in vergelijking met de andere 2 groepen. Voorts is er 
geen verschil gevonden tussen de 3 groepen inzake de totale oppervlakte van de rugspieren en de 
zuivere spieroppervlakte. Concreet betekent dit dat het spierweefsel van de continue chronische lage 
rugpijnpatiënten mogelijks vervangen wordt door vetweefsel, waardoor de totale spieroppervlakte 
niet lijkt af te nemen, maar de kwaliteit van de spier wel achteruit gaat.   
Verder zijn er meer afvalstoffen te vinden in de spieren van de continue én niet-continue chronische 
lage rugpijnpatiënten na het uitvoeren van een rugspieroefening, in vergelijking met de recurrente 
lage rugpijnpatiënten. Dit inefficiënte spiergebruik in beide chronische groepen leidt mogelijks tot 
snellere vermoeidheid wat nefast is voor alle structuren in de wervelkolom en kan leiden tot verdere 
klachten. Algemeen gesteld kunnen we dus zeggen dat de niet-continue lage rugpijnpatiënten niet 
verschillen van de recurrente patiënten wat spierstructuur betreft, en niet verschillen van de continue 
lage rugpijnpatiënten wat spieractiviteit betreft. We kunnen dus concluderen dat lage rugpijn zich 
presenteert als een continuüm waarin de niet-continue lage rugpijnpatiënten zweven tussen de 
recurrente lage rugpijnpatiënten enerzijds en de patiënten die dagdagelijks last hebben van lage 
rugpijn anderzijds [Chapter 1, Part 2].  
 
 Pijnkarakteristieken 
Medicatie en orale contraceptiva onderdrukken het pijninhibitiemechanisme. Ook chirurgie heeft zijn 
effect op het inhibitiemechanisme. Met name het wegnemen van een pijnbron, kan de verstoorde 
werking van het inhibitiemechanisme herstellen, op voorwaarde dat de werking reeds verstoord was 
door de aanwezigheid van een chronische pijnbron. Wetenschappelijk onderzoek moet dus aandacht 
hebben voor de invloed die medicatie heeft op dit pijninhibitiesysteem. Ook benadrukt deze bevinding 
dat het pijnverwerkingssysteem wel degelijk moduleerbaar is en dat therapie een gunstige invloed kan 
hebben [Chapter 2, Part 1].  
Het experimenteel onderzoek heeft ontdekt dat drukpijndrempels bij patiënten met fibromyalgie lager 
zijn dan die bij gezonde personen, recurrente lage rugpijnpatiënten en continue lage rugpijnpatiënten. 
Ook temporele summatie van pijn en pijntolerantiedrempels zijn afwijkend bij patiënten met 
fibromyalgie ten opzichte van gezonde mensen en recurrente lage rugpijnpatiënten. Opmerkelijk is dat 
patiënten met continue lage rugpijn bovendien verlaagde pijntolerantie vertonen in vergelijking met 
patiënten met recurrente lage rugpijn. Als conclusie kunnen we stellen dat de recurrente lage 
rugpijnpatiënten een gezonde pijnverwerking hebben. Voorts vertonen de continue lage 
rugpijnpatiënten lichte afwijkingen in hun pijnverwerkingssystemen maar niet in dezelfde mate als de 
patiënten met fibromyalgie. Mogelijks is slechts een klein deeltje van deze continue lage rugpijngroep 
echt gekenmerkt door een slecht werkend pijnsysteem. Als gevolg van storingen in de pijnverwerking 
kunnen pijndempende oefeningen en manuele behandelingen en bepaalde oefenvormen bij deze 
patiënten net meer pijn uitlokken. In de klinische praktijk is het daarom belangrijk om bij continu 
chronische patiënten de mogelijke verstoringen in pijnmechanismen eerst op te sporen en te 
behandelen. Op deze manier kan men mogelijks de chronische vicieuze cirkel waarin deze patiënten 
zich bevinden, doorbreken en de pijnklachten doen afnemen [Chapter 3, Part 1].  
 
 De relatie tussen spierkarakteristieken en pijnkarakteristieken 
Er blijkt een positieve associatie te zijn tussen pijngevoeligheid en de totale spieroppervlakte en 
zuivere spieroppervlakte van de erector spinae spier in alle lage rugpijnpatiënten. Bij gevolg zijn 
patiënten met een hogere pijngevoeligheid geassocieerd met smallere spieren en omgekeerd. 
Mogelijks zijn smallere spieren minder bestand tegen de dagdagelijkse impact van buitenaf, wat op 
zijn beurt potentieel bijdraagt aan de recurrentie of chroniciteit van de lage rugpijnklachten. Dat houdt 
dan ook in dat wanneer de verhoogde pijnsensitiviteit weggenomen wordt, er mogelijks ook een 
indirecte invloed op het spierweefsel is, en omgekeerd. 
 
Conclusie 
Voor spierkarakteristieken bestaat er een continuüm binnen de lage rugpijn. Achteruitgang in 
spierkwaliteit, vetinfiltratie en veranderingen in spieractiviteit zijn het meest merkbaar bij de continue 
chronische lage rugpijnpatiënten en het minst merkbaar bij de recurrente lage rugpijnpatiënten. De 
niet-continue chronische lage rugpijnpatiënten lijken tussen deze 2 groepen te zweven.  
Ook voor pijnverwerking bestaat er een continuüm. Aan het ene uiteinde bevinden zich de gezonde 
personen samen met de patiënten met recurrente lage rugpijn, die geen veranderingen in hun 
pijnsysteem vertonen. Aan het andere uiteinde zitten de patiënten met veranderingen in hun 
pijnverwerkingssysteem en een algemeen verhoogde pijngevoeligheid, zoals bijvoorbeeld 
fibromyalgie. De patiënten met continue chronische pijn vertonen ook tekenen van veranderingen in 
pijnverwerking maar niet in de mate van de patiënten met fibromyalgie. De niet-continue chronische 
lage rugpijnpatiënten bevinden zich tussen de recurrente en continue chronische pijn patiënten.  
Verder lijkt een associatie te bestaan tussen de pijngevoeligheid en spierkarakteristieken, waardoor 
lage rugpijnpatiënten met een hoge pijngevoeligheid typisch gekenmerkt zijn door smallere spieren en 
omgekeerd.  
 
 
Addendum 
 
Psychosocial differences 
in different groups of low back pain 
  
Title: Psychosocial differences between recurrent and chronic low back pain 
patients 
 
Authors: Dorien Goubert, Lieven Danneels, Geert Crombez, Mira Meeus,  
 
Background: The relationship between biomechanical issues, pain and psychosocial factors in low 
back pain (LBP) is complex. Psychosocial factors are known to have a strong influence on pain. 
Moreover, pain in his turn affects the psychological function. These relations are mainly investigated 
in patients with chronic pain. Given the clinical differences between LBP patients with chronic pain and 
recurrent pain, it is also plausible that the contribution of psychological factors is different between 
those three LBP groups. Few research however distinguishes recurrent LBP (RLBP) patients from 
chronic LBP (CLBP) patients, even though RLBP patients seem to recover after every episode, whereas 
CLBP patients are not. Furthermore, the CLBP group is a heterogeneous group in which psychosocial 
factors might differ between subgroups as well.  
 
Purpose: To evaluate differences/similarities in psychosocial factors between RLBP (characterized 
by pain flares alternated by long pain free episodes), non-continuous CLBP (characterized by 3 to 4 
pain days per week) and continuous CLBP (characterized by 7 pain days per week). Insights in 
psychosocial differences between these LBP groups might lead to more effective treatment methods 
and potential relevant measures in preventing chronicity. 
 
Methods: The checklist of individual strength (CIS), hospital anxiety and depression scale (HADS), 
multidimensional pain inventory (MPI), pain catastrophizing scale (PCS), pain disability index (PDI), 
survey of pain attitudes (SOPA) and social characteristics are investigated in RLBP, non-continuous 
CLBP and continuous CLBP. Comparisons between groups are performed by Kruskal-Wallis test and 
Mann-Whitney U test are used for comparisons between 2 groups. Significance is set at p<0.05. 
 
Results: In RLBP, the PDI, MPI (pain severity and interference) and SOPA (disability) are significantly 
lower compared to continuous CLBP. Also a significant lower CIS (subjective fatigue, motivation, 
concentration, activity), HADS (fear and depression), MPI (pain severity and interference) is seen in 
RLBP compared to non-continuous CLBP, but not to continuous CLBP. A worse score on CIS 
(concentration) is found in non-continuous CLBP compared to continuous CLBP. No differences 
between groups are found for social factors such as civil state, education level or job characteristics 
(Details can be found in table 2). Overall, the mean scores indicate no generalized erroneous thoughts 
and maladaptive behavior among all groups. 
 
Conclusion: The psychological state between patients with recurrent and chronic pain differs. 
Continuous CLBP patients experience a higher severity of pain and interference in daily living and are 
more disabled compared to RLBP. Non-continuous CLBP patients experience more subjective fatigue, 
concentration problems, motivation problems, anxiety and depressive feelings and disability 
compared to RLBP patients. Furthermore, they are less physically active and experience their pain as 
more severe compared to RLBP patients. Whether these findings are cause or consequence of the 
typical nature of LBP is yet unknown. Possibly, patients with RLBP are less likely to develop a negative 
mindset, because they only experience short episodes of pain flares alternated with longer pain free 
periods. It is also possible that a positive mindset might help RLBP patients to recover after every pain 
episode and prevent them from becoming chronic. Few differences between non-continuous and 
continuous CLBP are seen for psychological factors and no differences between all LBP groups are 
found for social factors. Overall, the mean scores indicate no generalized erroneous thoughts and 
maladaptive behavior among all groups. 
Implications: The differences in psychological state between RLBP and CLBP underline the need 
for different approaches of RLBP patients and CLBP patients in clinical practice. Tailored treatment 
methods with attention to the demanded psychological features in CLBP are strongly advised.  
Keywords: questionnaires, clinical practice 
 
  HC RLBP Non-continuous 
CLBP 
Continuous 
CLBP 
  mean [range] mean [range] mean [range] mean [range] 
CIS subjective fatigue 18.9 [7-36] 19.1 [11-33] * 27.4 [9-47] * 22.6 [10-36] 
 motivation 8.7 [4-17] 8.3 [5-13] * 11.6 [5-18] * 10.4 [4-23] 
 concentration 10.5 [5-25] 19.7 [5-20] * 17.3 [5-25] *◌ 10.6 [5-23] ◌ 
 activity 6.8 [3-16] 8.5 [4-15] * 12.7 [3-20] * 9.9 [4-16] 
 total 44.4 [23-84] 45.5 [30-77] * 69.1 [22-101] * 53.6 [30-93] 
HADS anxiety 2.9 [0-9] 5.3 [1-15] * 8.3 [4-16] * 5.7 [1-9] 
 depression 1.7 [0-8] 2.8 [0-11] * 5.3 [1-10] * 3.2 [0-15] 
MPI pain severity 0.1 [0-1.0] 1.5 [0.3-3.3] * ⱡ 2.4 [1.0-4.0] * 2.7 [1.5-5.0] ⱡ 
 interference 0.3 [0-3.2] 1.2 [0-3.6] * ⱡ 1.9 [0.7-3.3] * 2.3 [0.4-4.5] ⱡ 
 life control 5.0 [3.3-6.0] 4.4 [2.3-5.5] 3.9 [2.6-5.8] 4.2 [3.3-5.5] 
 affective distress 1.1 [0-5.0] 1.2 [0-3.7] 2.1 [0.3-4.3] 1.8 [0.3-4.3] 
 support 3.7 [0-6.0] 2.7 [0-5.7] 2.7 [0-5.7] 2.9 [0-5.7] 
PCS rumination 5.1 [0-10] 7.2 [1-13] 7.2 [3-10] 5.9 [1-12] 
 magnification 2.5 [0-7] 2.0 [0-6] 2.6 [0-6] 1.9 [0-4]  
 helplessness 3.8 [0-13] 5.7 [2-12] 7.4 [4-12] 6.8 [0-18] 
 total 11.0 [0-29] 14.9 [4-27] 17.2 [12-22] 14.5 [2-31] 
PDI total 4 [0-36] 17 [0-39] ⱡ 24 [4-47] 28 [7-60] ⱡ 
SOPA control 2.4 [0.8-3.9] 2.2 [1.0-3.2] 2.2 [1.4-2.7] 1.8 [0.9-3.1] 
 solicitude 1.3 [0-2.7] 0.7 [0-1.7] 1.1 [0-2.3] 0.7 [0-3.3] 
 medication 2.1 [0-3.0] 1.8 [0.3-3.7] 1.7 [0.7-2.8] 1.8 [0.5-3.8] 
 disability 1.4 [0.3-2.8] 1.2 [0.3-2.2] 1.5 [0.7-2.8] 2.0 [1.1-3.4] 
 emotion 1.8 [0-3.3] 1.3 [0.4-2.8] 1.4 [0.3-2.8] 1.0 [0-3.1] 
 medical cure 2.3 [1.22-3.43] 2.1 [0.7-3.1] 1.9 [0.6-2.7] 1.6 [0.4-2.8] 
 harm 1.4 [0-2.5] 1.3 [0.4-2.6] 1.7 [0.9-2.8] 1.7 [0.9-2.9] 
Table 2: Overview of scores on the psychological questionnaires and differences between heathy controls, recurrent low back 
pain patients (=pain flares alternated by pain free episodes), non-continuous chronic low back pain patients (=3 to 4 pain days 
a week) and continuous chronic low back pain patients (=7 pain days a week). Comparisons between groups are performed 
by Kruskal-Wallis tests. For comparisons between 2 groups, Mann-Whitney U tests are performed. Values are represented as 
mean [minimum-maximum] and significance is set at p<0.05. *=significantly different between RLBP versus non-continuous 
CLBP; ⱡ= significantly different between RLBP versus continuous CLBP; ◌= significantly different between non-continuous 
versus continuous CLBP; CIS=checklist of individual strength; HADS=hospital anxiety and depression scale; 
MPI=multidimensional pain inventory; PCS=pain catastrophizing scale; PDI=pain disability index; SOPA=survey of pain 
attitudes; HC=healthy controls; RLBP=recurrent low back pain; CLBP=chronic low back pain. 
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